rsp-0008, 'off-site dose calculation manual (odcm ...2.1.2. reg. guide 1.109, rev. 1, october,...

*G12 1.17

- lw

ENTERGY

RIVER BEND STATIONSTATION OPERATING MANUAL

*RADIATION SECTION PROCEDURE

*OFFSITEJDOSE CALCULA TION MANUAL (ODCM)

PROCEDURE NUMBER: *RSP-0008

REVISION NUMBER: *12

Effective Date: * MAR 1 0 2003

NOTE: SIGNATURES ARE ON FILE.

*INDEXING INFORMATION

RECEIVEDApR 1 0 2003

- DOCUMENT CONTROLINFORMATION USE

TABLE OF CHANGES

LETTER DESIGNATIONTRACKING NUMBER

DETAILED DESCRIPTION OF CHANGES

I

i . . .,_

RSP-0008 REV- 12 PAGE 1 OF 103

TABLE OF CONTENTS

SECTION PAGE NO.

I

2

3

4

5

6

7

8

9

10

I1I

PURPOSE/OBJECTIVES ....................................................... 5

REFERENCES ....................................................... 6

DEFINITIONS ....................................................... 7

RESPONSIBILITIES ....................................................... 8

PRECAUTIONS AND LIMITATIONS .9..................... .................................. .

PREREOUISITES ........................................................ 9

LIOUID EFFLUENT METHODOLOGY ........................................................ .9

7.1 River Bend Site Description ....... I.............................................. 9

7.2 Compliance with IOCFR20 (Liquids) ...................................... ............... 10

7.3 Determination of Setpoints for Radioactive Liquid Effluent Monitors ........................ 11

7.4 Determining the Dose for Radioactive Liquid Effluents .............................................. 13

7.5 Projecting Dose for Radioactive Liquid Effluents ........................................................ 15

GASEOUS EFFLUENT METHODOLOGY . .15

8.1 Introduction .15

8.2 Data Requirements for Gaseous Effluents .6

8.3 Instantaneous Release Rate and Setpoint Determination .16

8.4 Cumulative Dose Determination for Radioactive Gaseous Effluents .24

8.5 Dose Proiection - Determination of Need to Operate Ventilation ExhaustTreatment System......................................................................................................... 30

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM .. 32

4OCFR190 CONSIDERATIONS...........................................................................................32

10.1 Compliance with 40CFR190 .32

10.2 Calculations Evaluating Conformance with 40CFRI90 .32

10.3 Calculations of Total Body Dose .33

10.4 Thyroid Dose .34

10.5 Organ Dose (other than thyroid and sldn. 34

10.6 Skin Dose .35

INTERLABORATORY COMPARISON STUDIES.............................................................36

11.1 Requirement .36

11.2 Program ........ . ....................................................... 3.......6.. ....................... 36-

RSP-0008 REV -12 PAGE 2 OF 103

ATTACHMENT 1- TABLE 4.1 - RADIOLOGICAL ENVIRONMENTALMONITORING PROGRAM .......................... . 37

ATTACHMENT 2- ECL VALUES .41

ATTACHMENT 3- TABLE B-: LIQUID ENVIRONMENTAL DOSE TRANSFERFACTORS .42

ATTACHMENT 4- TABLE C-1: NOBLE GAS DOSE TRANSFER FACTORS .44

ATTACHMENT 5- RESERVED) ............................................................ 45

ATTACHMENT 6- XIO AND D/O VALUES FOR RESTRICTED AREABOUNDARY .46

ATTACHMENT 7- TABLE E-1: ANNUAL AVERAGE CHI/Q VALUES FORRESTRICTED AREA BOUNDARY .50

ATTACHMENT 8 - TABLE E-2: ANNUAL AVERAGE DIG VALUES FORRESTRICTED AREA BOUNDARY .51

ATTACHMENT 9- TABLE F-1: ATMOSPHERIC DISPERSION AND DEPOSITIONRATES FOR THE MAXIMUM INDIVIDUAL DOSE CALCULATIONS . 52

ATTACHMENT 10 - TABLE G-1: DOSE FACTOR CALCULATION PARAMETERS. 53

ATTACHMENT 11 - TABLE G-2: STABLE ELEMENT TRANSFER FACTORS .54

ATTACHMENT 12 - TABLE G-3: BIOACCUMULATION FACTORS .56

ATTACHMENT 13 - TABLE G-4: INDirIDUAL USAGE FACTORS .58

ATTACHMENT 14 - TABLE H-1: ASSIUMTIONS/PARAMETERS FOR DOSES TOA MEMBER OF THE PUBLIC INSIDE SITE BOUNDARY .59

ATTACHMENT 15 - TABLE I-1: DOSE FACTOR TABLE: P m - ADULT,IW HALATION......................................................................................................... 60

ATTACHMENT 16 - TABLE 1-2: DOSE FACTOR TABLE: P (1) - TEEN,INHALATION ......... , 62

ATTACHMENT 17 - TABLE I-3: DOSE FACTOR TABLE: P (D) - CHILD.INHALATI ON .............. 6............................................................... .........................64

ATTACHMENT 18- TABLE 1-4: DOSE FACTOR TABLE: P (I) - INFANT.RiHALATION ...................... 6................................................................................. 66

ATTACHMENT 19- TABLE I-5: DOSE FACTOR TABLE: R (I) - ALL, GR. PLANE 68

ATTACHMENT 20- TABLE 1-6: DOSE FACTOR TABLE: R (I) - ADULT. COWSM LK .. ..................................................I........................................ ........................... 70

ATTACHMENT 21 - TABLE I-7: DOSE FACTOR TABLE: R (I) - TEEN. COWSM LK ............ ..................................................I............. .......................;......................... 72

ATTACHMENT 22 -TABLE I-8: DOSE FACTOR TABLE R (I) - CHILD. COWSMILK .74

RSP-0009 REV - 12 PAGE 3OF 103RSP-00l ---- 1 AG O 0

ATTACHMENT 23 - TABLE 1-9: DOSE FACTOR TABLE: R (I) - INFANT. COWSM ILK ... ........................................................................................................................ ........................... 76

ATTACHMENT 24 - TABLE 1-10: DOSE FACTOR TABLE: R (D) - ADULT, GOATSMILK .................................................... 78

ATTACHMENT 25 - TABLE I-11: DOSE FACTOR TABLE: R (D - TEEN. GOATSMILK ... 0 ..................................................... 80

ATTACHMENT 26 - TABLE I-12: DOSE FACTOR TABLE: R () - CHILD, GOATSM ILK ... 82 ..................................................... 82

ATTACHMENT 27 - TABLE I- 13: DOSE FACTOR TABLE: R (1) - FANT. GOATSMILK ......................................................... 84

ATTACHMENT 28 - TABLE I-14: DOSE FACTOR TABLE: R (1) - ADULT. MEAT ............. 86

ATTACHMENT 29 - TABLE 1-15: DOSE FACTOR TABLE: R d) - TEEN. MEAT ............... 88

ATTACHMENT 30 - TABLE 1-16: DOSE FACTOR TABLE: R L - CID. MEAT ............. 90

ATTACHMENT 31 - TABLE I-17: DOSE FACTOR TABLE: R ( - ADULT,VEGETATION ............................................................... 92

ATTACHMENT 32 - TABLE I-18: DOSE FACTOR TABLE: R (D - TEEN.VEGETATION ............................................................... 94

ATTACHMENT 33 - TABLE I-19: DOSE FACTOR TABLE: R (I) - CHILD.VEGETATION.............................................................................................................96

ATTACHMENT 34 - FIGURE 1: RESTRICTED AREA AND NEAR-FIELDENVIRONMENTAL MONITORING LOCATIONS .................................................. 98

ATTACHMENT 35 - FIGURE 2: SCHEMATIC OF GASEOUS RADWASTESYSTEM ................................................................................ 99

ATTACHMENT 36 - FIGURE 3: EFFLUENT RELEASE POINTS ......................... 1...............too00

ATTACHMENT 37 - FIGURE 4: SCHEMATIC OF LIQUID RADWASTE SYSTEM....i ..... 101

ATTACHMENT 38 - FIGURE 5: FAR-FIELD RADIOLOGICAL ENVIRONMENTALMONITORING LOCATIONS ............................................................... 102

ATTACHMENT 39 - FIGURE 6: SCHEMATIC OF THE SOLID WASTETREATMENT SYSTEM............................................................................................103

114ZP-Aing RE.V - I1 PA Pi' A as' 1 fll

1 PURPOSF/OBJECTIVES

1.1 This manual provides a concise description of the environmental dose models andtechniques used to calculate offsite doses resulting from measured or projected releasesof radioactive materials from River Bend Nuclear Station. It also provides themethodology for calculating effluent monitoring setpoints and allowable release. rates toensure compliance with the Radiological Effluent Technical Requirements of River BendStation. This manual also contains a description of the Radiological EnvironmentalMonitoring Program that includes sample point descriptions for both onsite and offsitelocations and sampling and analysis frequencies.

1.2 The ODCM follows the methodology and models suggested by the "Guidance Manualfor Preparation of Radiological Effluent Technical Specifications for Nuclear PowerPlants" (NUREG-0133, dated October 1978) and "Calculation of Annual Doses to Manfrom Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliancewith 10 CFR Part 50, Appendix I" (Regulatory Guide 1.109, Rev. 1, dated October1977). Alternate calculational methods may be used from those presented as long as theoverall methodology does not change or as long as the alternative methods provideresults that are more limiting. Also, as available, the most, up-to-date revision ofRegulatory Guide 1.109 dose conversion factors and site-specific environmental criteriamay be used.

1.3 The description of information that should be included in the Annual RadiologicalEnvironmental Operating Report is located in Section 5.6.2 of the TechnicalRequirements Manual. The description of information that should be included in theRadioactive Effluent Release Report is located in Section 5.6.3 of the TechnicalRequirements Manual and states as follows:

Annual Effluent Release Report

Routine Annual Radioactive Effluent Release Report covering the operation of the unitduring the previous 12 months of operation shall be submitted as required by TechnicalSpecification 5.6.3

The Annual Radioactive Effluent Release Report shall include a summary of thequantities of radioactive liquid and gaseous effluents and solid waste released from thefacility as outlined in Regulatory Guide 1.21, "Measuring, Evaluating, and ReportingRadioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid andGaseous Effluents from Light Water-Cooled Nuclear Power Plants," Revision 1, June1974, with data summarized on a quarterly basis following the format of Appendix Bthereof. For solid wastes, the format for Table 3 in Appendix B shall be supplementedwith three additional categories: class of solid wastes (as defined by 10 CFR Part 61),type of container (e.g., LSA, Type A, Type B, Large Quantity) and SOLIDIFICATIONagent or absorbent (e.g., cement, urea formaldehyde)


The Annual Radioactive Effluent Release Report shall include a summary of hourlymeteorological data collected over the previous year. This summary may be either in theform of an hour-by-hour listing on magnetic tape of wind speed, wind direction andatmospheric stability, and precipitation (if measured), or in the form of joint frequencydistributions of wind speed, wind direction, and atmospheric stability. This same reportshall include an assessment of the radiation doses due to the radioactive liquid andgaseous effluents released from the unit or station during the previous calendar year. Thereport shall also include an assessment of the radiation doses from radioactive liquid andgaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITEBOUNDARY (USAR section 2.1) during the report period. All assumptions used inmaking these assessments (i.e., specific activity, exposure time and location) shall beincluded in these reports. The assessment of radiation doses shall be performed inaccordance with the methodology and parameters of the ODCM.

The Annual Radioactive Effluent Release Report shall also include an assessment ofradiation doses to the likely most-exposed MEMBER OF THE PUBLIC from reactorreleases and other nearby uranium fuel cycle sources (including doses from primaryeffluent pathways and direct radiation) for the previous calendar year to showconformance with 40 CFR Part 190, Environmental Radiation Protection Standards forNuclear Power Operation. Acceptable methods for calculating the dose contributionfrom liquid and gaseous effluents are given in NUREG-0133, "Preparation ofRadiological Effluent Technical Specifications for Nuclear Power Plants," Rev. 0,October 1978.

The Annual Radioactive Effluent Release Report shall include list and'description ofunplanned releases from the site to UNRESTRICTED AREAS of radioactive materials ingaseous and liquid effluents made during the reporting period.

The Annual Radioactive Effluent Release Report shall include any changes made duringthe reporting period to the PROCESS CONTROL PROGRAM (PCP) and to the ODOM,as well as a listing of new locations for dose calculations and environmental monitoringidentified by the land use census pursuant to Requirement 3.12.2.

2 REFERENCES'

2.1.1. NUREG 0133; Guidance Manual for Preparation of Radiological EffluentTechnical Specifications for Nuclear Power Plants; October, 1978

2.1.2. REG. GUIDE 1.109, Rev. 1, October, 1977; Calculation of Annual Doses toMan from Routine Releases of Reactor Effluents for the Purpose ofCompliance with I0 CFR Part 50, Appendix I

2.1.3. River Bend Environmental Report, OLS

2.1.4. River Bend Environmental Report, CPS

2.1.5. River Bend Station USAR

RSP-0008 REV -12 PAGE 6 OF 103

2. 116. River Bend Technical Specifications

2.1.7. River Bend Technical Requirements Manual (TRM)

2.1.8. River Bend Station Radiological Environmental Operating Report for 1985

2.1.9. REG. GUIDE 1.111; Methods for Estimating Atmospheric Transport andDispersion of Gaseous Effluents in Routine Releases from Light-Water -Cooled Reactors

2.1.10. U.S. Code of Federal Regulations; l OCFR20

2.1.11 . U.S. Code Of Federal Regulations, 1 OCFR50

2.1.12. U.S. Code of Federal Regulations, 40CFR190

2.1.13. NUREG 0543, Methods for Demonstrating LWR Compliance with the EPAUranium Fuel Cycle Standard (40 CFR Part 190)

3 DEFINITIONS

3.1 MEMBER(S) OF THIE PUBLIC shall include all persons who are not occupationallyassociated with the plant. This category does not include employees of the utility, itscontractors or vendors. Also excluded from this category are persons who enter the siteto service equipment or to make deliveries. This category does include persons who useportions of the site for recreational, occupational or other purposes not associated withthe plant.

3.2 The OFFSITE DOSE CALCULATION MANUAL shall contain the methodology andparameters used in the calculation of offsite doses due to radioactive gaseous and liquideffluents and in the calculation of gaseous and liquid effluent monitoring alarm/tripsetpoints. It shall also contain a table and figure defining current radiologicalenvironmental monitoring sample locations.

3.3 The SITE BOUNDARY shall be that line beyond which the land is not owned, leased, orotherwise controlled by the licensee.

3.4 An UNRESTRICTED AREA shall be any area at or beyond the SITE BOUNDARYaccess to which is not controlled by the licensee for purposes of protection of individualsfrom exposure to radiation and radioactive materials, or any area within the site boundaryused for residential quarters or for industrial, commercial, institutional, and/orrecreational purposes.

RSP-0008 REV - 12 PAGE 7 OF 103

3.5 A VENTILATION EXHAUST TREATMENT SYSTEM is any system designed andinstalled to reduce gaseous radioiodine and/or radioactive material in particulate form ineffluents by passing ventilation or vent exhaust gases through charcoal adsorbers andHEPA filters prior to the release to the enviromnent (such a system is not considered tohave any effect on noble gas effluents). Engineered Safety Feature (ESF) atmosphericcleanup systems are not considered to be VENTILATION EXHAUST TREATMENTSYSTEM components.

4 RESPONSIBILITIES

4.1 The Superintendent - Radiation Protection or designee is responsible for the developmentand implementation of the "Offsite Dose Calculation Manual [ODCM] Procedure",which involves review of REMP-related ESPs and program changes, as well ascoordination of revisions to the ODCM necessitated by results of the REMP and/orannual Land Use Census. The Superintendent - Radiation Protection or designee,reviews the ODCM and Annual Radiological Environmental Operating Report prior to itssubmission for approval by the General Manager - Plant Operations. The Superintendent- Radiation Protection or designee, coordinates the preparation of other reports for whichthe ODCM may provide input (e.g., special reports on excessive doses to members of thepublic in unrestricted areas attributable to RBS effluents).

4.2 The Manager - Operations is responsible for the development and upkeep of the RBSTechnical Requirements and Surveillance Test Procedure Cross Reference matrix thatincludes applicable STP's.

4.3 The Director - Nuclear Safety Assurance is responsible for identifying proposed changesto the Technical Requirements and other regulatory documents which would alter theSurveillance Test Program requirements.

4.4 The Manager - Planning & Scheduling Outages is responsible for developing,maintaining, and adjusting a station-wide schedule for performance of Surveillance TestProcedures.

4.5 The Superntendent - Chemisy has overall responsibility for the development andimplementation of the Radiological Environment Monitoring Program (REMP) toinclude, as a minimum: developing ODCM related procedures, sampling, reportgeneration, and immediate notification to the Superintendent - Radiological Programs ofany REMP result which indicates that a reporting level has been exceeded.

4.6 The Supervisor - P Shi has responsibility for supervising the day to day performanceand documentation of SIrveillance of the ODCM.


4.7 The HP/Chern Specialist has responsibility for the implementation of surveillances anddocumentation of the ODCM. This responsibility includes timely notification of theSupervisor - HP Shift of any problem which impacts, or might impact, fulfillment of theRadiological Effluent Technical Requirements and the ODCM.

5 PRECAUTIONS AND LIMITATIONS

5.1 Licensee-initiated changes to the ODCM shall be made per Reference 2.1.6 § 5.5.1.

5.2 No changes(s) shall be made to the ODCM that will reduce the accuracy or reliability.ofdose calculations or setpoint determinations.

5.3 A change to the ODCM may cause a deviation from methodologies used in theimplementing procedures. Any change to RSP-0008 shall have an independent Reviewfrom Chemistry, as a minimum, and also requires Chemistry and Radiation Control tomeet and discuss changes to RSP-0008 prior to approval to ensure ODCM methodologycompliance.

6 PREREQUISITES

6.1 None

7 LIQUID EFFLUENT METHODOLOGY

7.1 River Bend Site Description

The River Bend Station Updated Safety Analysis Report (USAR) contains the officialdescription of the site characteristics. The description that follows is a brief summary for dosecalculation purposes:

-The River Bend Station (RBS) is on a site in West Feliciana Parish, Louisiana, locatedapproximately 24 miles north-northwest of Baton Rouge, Louisiana. This site is just east of the*Mississippi River, which is used as the source of the RBS major water requirements and whichreceives the RBS liquid effluents.

The reactor is a General Electric boiling water reactor of the BWR-6 or 1972 product line.Containment is of the Mark 3 design, a free-standing cylindrical steel structure surrounded by areinforced concrete shield building.


7.2 Compliance with 1OCFR20 (Liquids)

7.2.1. Requirements

In accordance with Technical Requirements 3.11.1.1, the concentration ofradioactive material released in liquid effluents to Unrestricted Areas (Figure 1shall be limited to ten times the concentrations specified in I OCFR20, j 3Appendix B, Table 2, Column 2 for radionuclides other than dissolved orentrained noble gases. For dissolved or entrained noble gases, theconcentration shall be limited to 2 x 10o4 pCi/ml total activity. Theconcentration of radionuclides in liquid waste is determined by sampling andanalysis in accordance with Technical Requirements.

7.2.2. Methodology

This section describes the calculational method to be used to determine FL, thefraction of 1OCFR20 limits of release concentrations of liquid radioactiveeffluents.

I. General Approach

Liquid effluent releases from River Bend Station are discharged throughthe cooling tower water blowdown, which is directed to the MississippiRiver. Principal sources of radwaste are from floor drains, phaseseparators/backwash tank subsystem, recovery sample tanks, and reactorwater cleanup (as shown in Figure 4). The liquid radwaste system isoperated as a batch system. Only one tank of liquid radwaste is released ata time and is considered a batch.

The radioactive content of each batch release will be determined prior torelease in accordance with Table 3.11.1.1.-1 of the RBS TechnicalRequirements. Compliance with TLCO 3.11.1.1 limits will be determinedwith the following equation:

NOTE

Jf shall be administratively controlled to maintain FL to •0.3 for most

discharges, as identified. If X 10%ELi< 0.3 or if the calculatedfi > 75 j -tGPM fi=75 GPM For FL > 0.3, other administrative controls should beimplemented to ensure discharges shall not exceed Technical Requirementlimits.

A CiFL 7.2.2.1-1

RSP-0008 REV- 12 PAGE 10 OF 103

660Where:(fC< 0 0.3 | .'S

FL = The fraction of Technical Requirement limits resulting from therelease source being discharged

f, = The undiluted release rate at monitor location, in gpm

f2 = The cooling tower blowdown release rate, in gpm

CQ = The undiluted concentration of nuclide (i), in gCi/ml from sampleassay.

(I OECL)i = Ten times the Effluent Concentration Limit of nuclide (i) from / 3-Attachment 2, in ±Ci/ml

As long as FL is less than 10, the concentration of the tank is withincompliance with TLCO 3.11.1.1 limits.

2. Simplified Approach

For purposes of simplifying the calculations, the value of 1 x 10-8 gCi/ml(unidentified 10CFR20 ECL value) could be substituted for (BCL)i andthe cumulative concentration (C-Total = sum of all identified radionuclideconcentrations) or the gross beta-gamma concentration should besubstituted for C;. As long as the diluted concentration (C-Total x fI/(f1 +-f) is less than 1 x 104 JCi/ml, the nuclide by nuclide calculation is notrequired to demonstrate compliance with lOCFR20 ECL limits.

7.3 Determination of Setpoints for Radioactive Liquid Effluent Monitors

7.3.1. Requirements

Technical Requirements 3.3.11.2 requires the radioactive liquid effluentmonitor be operable with their high alarm/trip setpoints set to ensure that limitsof Technical Requirements 3.11.1.1 are not exceeded. The high alarm/tripsetpoints shall be determined and adjusted by the methodology which follows:

The high alarm setpoint for the liquid effluent radiation monitor is derivedfrom ten times the concentration limit provided in IOCFR2O, Appendix B,Table 2, Column 2 applied at the restricted area boundary where the dischargeflows into the Mississippi River.

RSP-0008 REV- 12 PAGE 11 OF 103

Liquid Monitor Setpoints calculated in accordance with the methodologypresented in this section will be regarded as upper bounds for the actual highalarm setpoints. That is, a lower high alarm setpoint may be established on themonitor, if desired. Alert level setpoints should be established at anappropriate level to give sufficient warning prior to reaching the high alarmsetpoint.

1. Liquid Effluent Monitor

A General Atomics liquid monitor (radwaste effluent RMS-RE107)equipped with a RD-53 detector with sufficient range (10l to 10 cpm) isprovided to ensure compliance with Technical Requirements limits forliquid releases. The RD-53 is an offline gamma scintillation (Nal)detector designed for detecting radioactivity in liquids. The monitorconsists of a removable sample canister surrounded by Pb shielding. Awell inside the canister holds the detector within the sample fluid

7.3.2. Methodology

The high alarm setpoint does not consider dilution, dispersion, or decay ofradioactive material beyond the site boundary. That is, the alarm setpoint isbased on a concentration limit at the end of the blowdown line.

1. Liquid Radwaste Effluent Monitor (RMS-RE1 07)

A sample of each batch of liquid radwaste is analyzed for 1-13 1 and otherprincipal gamma emitters as specified in Table 3.11.1.1-1 of TechnicalRequirements 3.11.1.1, for total activity concentration prior to release.The fraction, FL, of the TLCO 3.11.1.1 limits for unrestricted areas isdetermined in accordance with the preceding section for the activityconcentration released.

NOTE

A change to the 6DCM may cause a deviation from methodologies used inimplementing procedures (i.e., CSP-0110). Any change to RSP-0008 shallhave an independent Reviewfrom Chemistry, as a minimum, to ensureODCM methodology compliance.

The liquid radwaste effluent monitor will terminate a liquid radwastedischarge if activity levels exceed the Technical Requirements limits. Theautomatic actions associated with a trip of the monitor are:

1) LWS-A0V257 closes

2) LWS-AOV258 opens

An alarm will also be annunciated in the main control room.

RSP-0008 REV- 12 PAGE 12 OF 103

The liquid radwaste effluent line radiation monitor alarm setpoint isdetermined with the equation:

S =F. xgxM 7.3.2.1-1FL

Where:

S = the radiation monitor setpoint (cpm. or gCi/ml)

A = the sum of concentrations of gamma-emitting radionuclides inthe sample, as measured in the laboratory.

FL = the fraction of TLCO 3.11.1.1 limits resulting from the releasesource being discharged.

g "Instrument Correction Factor"; the ratio of effluent radiationmonitor counting rate to laboratory counting rate or activityconcentration in a given batch of liquid (cpm per cpm/ml, cpm perpCi/ml, or RCi/m1 per ±Ci/ml)

M "Setpoint Adjustment Factor", error associated with monitoraccuracy

NOTE

A/FL represents the counting rate of a liquid waste stream that would havethe same radionuclide distribution as the given batch, but that wouldproduce a concentration of 10 ECL at the point of discharge into theUnrestricted Area.

NOTE

A background determination should be performed prior to each release.Background subtraction may be performed in accordance with theapplicable Chemistry procedures.

7.4 Determining the Dose for Radioactive Liquid Effluents

7.4.1. Requirements

Technical Requirements 3.11.1.2 requires the dose or dose commitment to amember of the public from radioactive material released in liquid effluents bedetermined on a cumulative basis at least every 31 days. Dose or dosecommitment shall be limited to:

RSP-0008 REV - 12 PAGE 13 OF 10-3RSP-0008 REV-fl PAGE13OFTO3

1. Less than or equal to 1.5 mrem to the total body and to less than or equalto 5 mrcm to any organ, during any calendar quarter; and

2. Less than or equal to 3 mrem to the total body and less than or equal to 10mrem to any organ during any calendar year.

7.4.2. Methodology

This section provides the methodology to calculate dose to all age groups andorgans from all radionuclides identified in the liquid effluents.

The method is based on the methodology suggested by Sections 4.3 and 4.3.1of NUREG-0133, Rev. 1, November 1978. The dose factors Ai, for all viablepathways are listed in Attachment 3.

The following equation provides a dose calculation to the total body or anyorgan for a given age group based on actual release conditions.

Air * At * Q;Dir = 7.4.2-1

iT DF*Dw

[TOTALr Z Dr 7.4.2-2i=,

Where:

D TOTALt = The total dose commitment to the organ (r) due to all releasesduring the desired time period in mrem.

Di,= Dose commitment from radionuclide (i) received by organ (T) ofthe adult age group during the time period (mrem).

AjC= Site related dose commitment factor to the total body or any organ (t)for each identified radionuclide (i). The Air values listed inAttachment 3 are site-related to RBS (mrernvhr per p±Ci/ml).

At = The total time for all batch releases that occurred in the period (brs).

Qi = The total quantity of nuclide (i) released during the interval At (pCi).

Dw The near field dilution factor. Site specific value is 136.

DF = The total volume of dilution that occurred during the time period(Ol).

The doses associated with each isotope may then be summed to provide thecumulative dose over a desired time period (e.g., sum all doses during a 31 dayperiod, calendar quarter, or a year).

RSP-0008 REV -12 PAGE 14 OF 103

7.5 Projecting Dose for Radioactive Liquid Effluents

7.5.1. Requirements

Technical Requirement 3.11.1.3 requires the liquid radwaste treatment systembe used to reduce the radioactive materials in liquid wastes prior to theirdischarge when projected doses due to liquid effluents, to unrestricted areas(Figure 1) would exceed 0.06 mrem to the total body or 0.2 mrem to any organin a 31 day period.

7.5.2. Methodology

The following calculational methodology shall be performed at least once per31 day period;

LPD- *31+D 7.5.2-1XD

DTOTAL, =The total dose commitment to the organ (') due to all releases duringthe desired time period.

LPD = Projected dose commitment (mrem) to organ (X) during the 31 dayperiod from liquid effluents.

XD = Number of days to date in the current quarter

DA The anticipated dose contribution to the total body or any organ x,due to planned activities during the next 31 day period, if thoseactivities will result in liquid releases that are in addition to routineliquid effluents. If only routine liquid effluents are anticipated, DPA-0.

8 GASEOUS EFFLUENT METHODOLOGY

8.1 Introduction

River Bend Station discharges gaseous effluents through the Main Plant Exhaust Duct, FuelBuilding Exhaust Duct, and Radwaste Building Exhaust Duct. The location of these releasepoints in relation to the River Bend site is found in Figure 3. The gaseous effluent streams,radioactivity monitoring points, ahd effluent discharge points are shown schematically in Figure2. All gaseous effluent releases ftom the Radwaste Building Exhaust Duct and Fuel BuildingExhaust Duct are assumed to be ground level releases. The Main Plant Exhaust Duct routinereleases are treated as a wake split (conditionally elevated) release.

RSP-0008 REV -12 PAGE 15 OF 103

8.2 Data Requirements for Gaseous Effluents

For the purpose of estimating offsite radionuclide concentrations and radiation doses, measuredradionuclide concentrations in gaseous effluents and in ventilation air exhausted from the stationare used. Table 3.11.2.1-1 in the Technical Requirements identifies the radionuclides in gaseousdischarges for which sampling and analysis is done.

When a nuclide concentration is below the LLD for the analysis, it is not reported as beingpresent in the sample.

Historical annual average meteorological information will be used to calculate off-site dose andmonitor set points. Modeling will be performed in accordance with the methodologies describedin Reg. Guide 1.111 Rev. 1.

8.3 Instantaneous Release Rate and Setpoint Determination

8.3.1. Instantaneous Release Rate Determination

The instantaneous release rate determination is performed to show compliancewith the limits set forth in the TRM.

1. Requirements

Technical Requirements 3.11.2.1 states that the dose rate due toradioactive materials released in gaseous effluents from the site to areas atand beyond the site boundary (see Figure 1) shall be limited to thefollowing:

1) For noble gases: Less than or equal to 500 mrem/year to the totalbody and less than or equal to 3,000 mremlyear to the skin; and

2) For 1-131, 1-133, tritium, and for all radionuclides in particulate formwith half-lives greater than 8 days: less than or equal to 1,500-nrem/year to any organ.

2. Methodology

D) Total Body and Skin Instantaneous Dose Rate Calculations

To determine the dose rate from noble gases in unrestricted areas, thefollowing formulae are used:

-i , 8

RtSP-0008 RS 8 REV- 12 PAGE 16 OF 103

I, __ _

DR9S =E(L, +1.L4I)(X/Q)(Q1 ) 8.3.1.2.1-2l-1

Where:

DR sKNi = Dose rate to the skin in mrem/year

DR TB Dose rate to the total body in mrem/year

K i = The total body dose factor due to gamma emissions for eachidentified noble gas radionuclide (i) in mremlyr per gCi/M3

Attachment 4

L= Skin dose factor due to beta emissions for each identified noblegas radionuclide (i) in mremlyr per ,tCi/m

3 Attachment 4

M T= he air dose factor due to gamma emissions for each identifiednoble gas radionuclide (i) in nrad/yr per pCi/M3 Attachment 4

XI Q =The highest calculated annual average relative dispersionfactor for any area at or beyond the unrestricted area boundaryfor all Sectors (sec/m 3). Attachment 9

Q.= The release rate of radionuclide (i) in gaseous effluents from all

releases in gCi/sec

1.1 = Conversion factor for Mi from mrad to Inrem

In order to comply with the limits of the TRM, DRTB 500mrem/year and DRMsn •3,000 mremlyear must be met at the mostlimiting location, at or beyond the site boundary.

The (X/Q) values utilized in equations 8.3.1.2.1-1 and 8.3.1.2.1-2

are based upon maximum long-term annual average X(xiQ) in the

unrestricted area. Attachment 9 lists the maximum (X/Q) values forthe RBS release points at the appropriate receptor locations.

To select the most limiting location, the highest (XIt Q) for eachrelease point is used (from Attachment 9):

(X/)M = 3.31 x 106 sec/m3

RSP-O0008 REV - 12 PAGE 17 OF 103IISP-0008 REV -12 PAGE 17 OF 103

(XYQ)GRD = 4.21 x IO-5 sec/m3

where:

(X I Q)MM = Chi/Q for Main Plant exhaust duct (mixed mode)

(X /Q)0RD = Chi/Q for Radwaste Building exhaust duct (groundlevel) and for Fuel Building exhaust duct (groundlevel)

(Attachment 9 contains the maximum (Xi Q) and DIQ values usedin calculating individual doses.)

Release rates for all release points must be considered at the sametime. If releases are occurring at the same time, the totalinstantaneous dose for all releases must be less than the limits ofTechnical Requirements 3.11.2.1. An administrative control limitsthe release rates for each of the three release points to 1/3 the totalTechnical Requirements doses.

2) Radioiodine, Tritium, and 8-day Particulate Dose Rate Calculations

The following calculational method is provided for determining thedose rate from radioiodine (1-131, I-133), Tritium and particulateswith half-lives greater than 8 days and to determine if they are withinthe limits listed in Section 8.3.1.1.2).

In the calculation to show compliance with the TRM, only theinhalation pathway is considered, since it is the most limitingpathway.Inhalation Pathway:

DRr&SDPr =X( tQ( J 8.3.1.2.2-1

where:

DR = Dose rate to the organ X for the age group of interest

from radioiodines (1-131 and I-133), tritium and 8 dayparticulates via the inhalation pathway (mnrem/yr).

Q. =Release rate of nuclide (i), (gCilsec).

RSP-0008 REV - 12 PAGE 18 OF 103RSP-0008 REV - 12 PAGE 18 OF 103

(X IQ) = The highest calculated annual average relative dispersionfactor for any area at or beyond the unrestricted areaboundary for all sectors (sec/r 3). Attachment 9.

Pi= The dose factor for applicable environmental pathway (mrem/yr

per pCi/m3 ). Attachment 15 through Attachment 18.

Values for Pi were calculated for all age groups using the inhalationpathway methodology of NUREG-0 133.

8.3.2. Setpoint Determination

1. Requirements

Instrumentation is provided to monitor beta-gamma radiation fromradioactive materials released from the River Bend Station in gaseouseffluents. Each release point process monitor listed in the TRM includesan alarm (HIGH ALAR) that is set to report when the radioactive noblegas in gaseous effluents (Main Plant exhaust duct, Fuel Building exhaustduct and/or Radwaste Building exhaust duct) is expected to cause a noblegas concentration at ground level offsite resulting in a dose rate equal to orgreater than 500 mrem/yr to the total body and/or 3000 mrem/yr to theskin.

The ALERT alarm is set to report when the radioactive noble gas ingaseous effluents (Main Plant exhaust duct, Fuel Building exhaust ductand/or Radwaste Building exhaust duct) is expected to cause a noble gasconcentration at ground level offsite that would result in meeting orexceeding either the 5 mrad per quarter gamma air dose or 10 mrad perquarter beta air dose limit (Technical Requirements 3.11.2.2). It ispermissible to set the ALERT alarm at twice (2.0) normal (approximately100 % unit power) detector background if nuisance alarms would resultfrom setpoints based on gamma and beta air dose.

The distribution of radioactive noble gases in a gaseous effluent stream isdetermined by gamma spectrum analysis of identifiable radionuclides in.effluent gas sample(s). Results of one or more previous analyses may beaveraged to obtain a representative sample. In the event the distribution isunobtainable from measured data, the distribution of radioactive noblegases based on past data or calculated by the BWR-GALE code may beused.

To allow for multiple sources of releases from the three different releasepoints, the allowable operating setpoints will be administrativelycontrolled to allocate one-third (1/3) of the total allowable release to eachof the release sources.

RSPA009 RE-V- 12 PAGE 190 OF IQ-'lISP-ODOR REV -12 PAGE 19 OF 103

2. Methodology

1) HIGH ALARM Setpoint Determination

This section describes the methodology for determining and adjustingHIGH ALARM setpoints for the three release points:

a) Wide Range Gas Monitor (WRGM)

Step 1. Determine QT8 as follows:

Q 500 8.3.2.2-1(X/ Qt(Kx i)

where:

QT2 = maximum acceptable total release rate of all noble gasradionuclides in the gaseous effluent (jxCi/sec).

(X/Q) = The highest calculated annual average relativedispersion factor for any area at or beyond theunrestricted area boundary for all Sectors (sec/n 3 ).Attachment 9

Ki = The total whole body dose factor due to gamma emissionsfrom noble gas radionuclide (i) mrem/yr per gCi/m3 )from Attachment 4.

f= Fraction of noble gas radionuclide (i) to total noble gasconcentration.

500 Whole body exposure limits of 500 miern/year.

Step 2. Determine Q. as follows:

Q (3000) 8.3.2.2-2

(xIQt[(L, + l r )fI]'a'

where:

Q= the maximum acceptable release rate of all gas

radionuclides in the gaseous effluent [gCi/sec]

RS3P-0008 REV - 12 PAGE 20 OF 103RS-008 RV-l PGE0F

L, + 1. 1Mi = Calculated total skin dose factor due to emissionfrom noble gas radionuclide (i) mrem/yr/lpCi/m3 fromAttachment 3.

fi = Fraction of noble gas radionuclide (i) to total noble gasconcentration

(x/I) = The highest calculated annual average relativedispersion factor for any area at or beyond the unrestrictedarea boundary for all Sectors (sec/r 3 ), Attachment 9.

3000 = Skin exposure limit of 3000 mrem/year

Step 3. Select the lower of the Q values (QTB or Qs) obtained inStep l and Step 2.

NOTE

Actual alarm setpoint in the data base may be modified toaccount for loop accuracy.

Step 4. Multiply the Q value selected in Step 3 by 0.33. Bymultiplying the Q value by a factor of 0.33, the allowableoperating setpoints will be administratively controlled to allocateone-third (1/3) of the total allowable release rate to each of therelease points. The resultant product will be the actual ODCMrelease rate HIGH ALARM setpoint for the appropriate WRGMMonitor.

b) Particulate and Gas Monitor (P&G) (gas channel only).

Stp 1. Perform Steps 1 through 3 of Section 8.3.2.2.1)a) above.

Step 2. Determine C. (the maximum acceptable totalradioactivity concentration of all noble gas radionuclides for allrelease points in the gaseous effluent [gtCi/cc]):

C (2.12x10-3) Q 8.3.2.2-3F

where:

2A12 x 1o3 = Unit conversion factor to convert gCi/sec/cftn toMCi/cc

Q = Lower of the two Q values, Q-M or Qs

RSP-00flg REV - 12 PA GE 21 OF 103RSP-0008 REV - 12 PAGE 21 OF 103

F =The maximum acceptable effluent flow rate at the point ofrelease based on design flow rates (cfin)

NOTE

Actual alarm setpoint in the database may be modified toaccountfor loop accuracy.

Step 3. Multiply the C value determined in Step 2 by 0.33. Bymultiplying the CQ value by a factor of 0.33, the allowable .operating setpoints will be administratively controlled to allocateone-third (1/3) of the total allowable release to each of therelease points. The resultant product will be the actual ODCMactivity concentration HIGH ALARM setpoint for theappropriate P&G monitor gas channel.

2) ALERT Setpoint Determination (Reference 2.1.6)

This section describes the methodology for determining and adjustingALERT setpoints for the three release points.

a) Wide Range Gas Monitor (WRGM)

Step 1. Determine QG-A utilizing one of the following methods:

QG- = (X)8.3.2.2-4

(7Q) MI A

where:

QC-A = The maximum acceptable total release rate of all noble

gas radionucdides in the gaseous effluent [guCi/sec]

(x/Q) = The highest calculated annual average relativedispersion factor for any area at or beyond theunrestricted area boundary for all Sectors .(sec/M3),Attachment 9

5 =5 mrads/quarter gamma air dose limit at the unrestricted areaboundary

i= The gamma air dose factor for radioactive noble gas- I nuclide (i) in mrad-m34aCi-yr, Attachment 4

= The fractional abundance of noble gas radionuclide i

RSP-0008 RtEV - 12 PAGE 22 OF 103_S-OO _E 1 PAGEZ__FO_

4 = Number of Quarters Per Year

Step 2. Determine QB-A utilizing one of following methods:

- (4X10) 8.3.2.2-5(xIQ) Nfi

i=]

Where:

QB-A = maximum acceptable total release rate of all noble gasradionuclides in the gaseous effluents pCi/sec)

(XIQ) = The highest calculated annual average relativedispersion factor for. an area at or beyond the unrestrictedarea boundary for all sectors (sec/m3), Attachment 9

10 = 10 mrad/quarter (92 days) beta air dose limit at theunrestricted area boundary

Ni = The air dose factor due to beta emissions from each noblegas radionuclide (i) in Attachment 4

f= The Factional abundance of noble gas radionuclide i

4 Number of Quarters Per Year

Step 3. Select the lower of the Q values obtained in Steps 1 and2,Neither QG-A or QB-A.

Step 4. Multiply the Q value selected in Step 3 by 0.33. Bymultiplying the Q value by this factor, the allowable operatingsetpoints will be administratively controlled to allocate one-third(1/3) of the total allowable release rate to each of the releasepoints. The resultant product will be the actual ODCM ALERTsetpoint to be entered into the applicable WRGMs RM-80.

Sten 5. If the actual ODCM ALERT setpoint determined in Step4 is less than two times (2.0) the detector background, it ispermissible to enter an ALERT setpoint equal to two times (2.0)the normal (approximately 100% unit power) detectorbackground to reduce the possibility of nuisance alarms. thetwice background setpoint should provide sufficient indicationthat an offsite dose limit could possibly be exceeded.

'R~qPnflfl RliV_ 12 7 PAG CR o 1 ARIl31WV �17 PACJ? flfll? lOt

b) Particulate and Gas Monitor (P&G) (gas channel only)

Step 1. Perform Steps 1 through 3 of Section 8.3.2.2.2)a) above.

Step 2. Determine Cm (the maximum acceptable totalradioactivity concentration of all noble gas radionuclides for allrelease points in gaseous effluent [jxCi/cc]):

C= (2.12xl0 3 Q 8.3.2.2-6

Where:

2.12 x 10-3 = Unit conversion factor to convert jsCi/sec/cfin togci/cc.

Q = Lower of the two Q values, QGA or QB-A

F = The maximum acceptable effluent flow rate at the point ofrelease based on design flow rates (cfin).

Sten 3. Multiply the Cm value determined in Step 2 by 0.33. Bymultiplying the C. value by this factor, the allowable operatingsetpoints will be administratively controlled to allocate (1/3) ofthe total allowable release to each of the release points. Theresultant product will be the actual ODCM activity concentrationALERT setpoint. This value is the setpoint to be entered into theapplicable P&G monitor's RM-80.

Step 4. If the actual ODCM ALERT setpoint determined in Step3 is less than two times (2.0) the gas detector background, it ispermissible to enter an ALERT setpoint equal to two times (2.0)the normal (approximately 100% unit power) gas detectorbackground to reduce the possibility of nuisance alarms. Thetwice background setpoint should provide sufficient indicationthat an offsite dose limit could possibly be exceeded.

8.4 Cumulative Dose Determination for Radioactive Gaseous Effluents

8.4.1. Noble Gases

1. Air Dose

1) Requirements

Technical Requirements 3.11.2.2 states that the air dose due to noblegases released in gaseous effluents to areas at and beyond the siteboundary (see Attachment 34) shall be limited to the following:

RSP-0008 REV- 12 PAGE 24 OF 103

a) During any calendar quarter: less than or equal to 5 mrads forgamma radiation and less than or equal to 10 mrads for betaradiation; and

b) During any calendar year: less than or equal to 10 mrads forgamma radiation and less than or equal to 20 mrads for betaradiation.

2) Methodology

This section provides the methodology to calculate the gamma andbeta air doses to a maximum receptor location at the site boundaryfrom all noble gas radionuclides identified in the gaseous effluents.

The method is based on the methodology suggested by sections 5.3and 5.3.1 of NJREG-0133, Rev. 1, November 1978. The dosefactors for beta and gamma air dose are listed in Attachment 4 and areobtained from Table B-1 of RG 1.109, Revision 1, October 1977.

The following equations provide for air dose calculations based onactual noble gas releases during a specific time interval forradioactive gaseous release sources at the site boundary:

Da =3.17E-8 (M; XX/QXQi) 8.4.1.1.2-1

DBetaAir =3.l7E -8 (No )(XQxQi) 8.4.1.1.2-2* i=1

where:

D The gamma air dose from radioactive noble gases inCGanmi-Adr

mrad.

M; = The gamma air dose factor for radioactive noble gasnuclide (i) in mrad-m3/jtCi-yr (Attachment 4)

3.17-8 = Inverse of number of Seconds Per Year in Year/Sec

XI ) = The highest calculated annual average relative dispersionfactor for an area at or beyond the unrestricted areaboundary for all sectors (sec/m3), Attachment 9

= The quantity of ,uCi of nuclide (i) released during theperiod of interest

RSP-0008 REV -12 PAGE 25 OF 103

D = Beta air dose from radioactive noble gases in mradBeta-Ar

Ni = The beta air dose factor for radioactive noble gasnuclide (i) in mrad-m 3/pjCi-yr (Attachment 4), Table C-1

2. Total Body and Skin Dose

1) Requirements

a) Technical Requirements 3.11.4 states that the annual (calendaryear) dose or dose commitment to any MEMBER OF THEPUBLIC, due to releases of radioactivity and to radiation fromuranium fuel cycle sources, shall be limited to less than or equalto 25 mrem to the total body or any organ, except the thyroid,which shall be limited to less than or equal to 75 mrem.

b) Technical Specification 5.5.4.j requires the limitations on theannual dose or dose commitment to any member of the publicdue to releases of radioactivity and to radiation from uranium fuelcycle sources, conforming to 40 CFR 190.

Cumulative doses from liquid effluents and gaseous pathways(radioiodines (1-131, I-133), Tritium and particulates with T 1/2> 8 days) are determined in accordance with Sections 7.4.2 and8.4.1.3. Cumulative total body and skin doses from noble gasreleases are determined in accordance with Section 8.4.1.2.2).

2) Methodology

This section provides the methodology to calculate the total body andskin doses to the likely most-exposed MEMBER OF THE PUBLICfrom all noble gas radionuclides identified in the gaseous effluents.

The method is based on the methodology suggested in section C.2and Appendix B of NRC Regulatory Guide 1.109, revision 1, October1977 and is used to calculate the doses in this section. The dosetransfer factors required for the calculations are listed in Attachment 4of this document and are-obtained from Table B-I of RG 1.109,Revision 1, October 1977.

Doses to the total body and to the skin, due to actual noble gasreleases during a specific time interval, at the location of the likelymost, exposed MEMBER OF THE PUBLIC, are calculated asfollows:

DThaBod =(SFXFO X3.17E - 8)X. 0KXI7kQ 1) 8-4.1.2.2 -1' ' i-l

RREV- 12 PAGE 26 (IF 103-'REV- 12 PAGE 26 (W 1(fl

Dsk =(F0 X3.17E -8) +1M(SF))1(x/QXQj) 8.4.1.2.2-2i'=1

Where:

DTotal Body = The total body dose from radioactive noble gases in mrem

K= The total whole body dose factor due to gamma emissions fromnoble gas radionuclide (i) (mrem/yr per uCi/m3) fromAttachment 4, Table C-1

(XIQ) = The highest calculated annual average relative dispersionfactor for an area at or beyond the unrestricted areaboundary for all sectors (sec/m3 ) (Attachment 9)

NOTE

When calculating DTO:t, B0dY and Dskn for determining 40CFRJ190compliance as reported in the Annual Radioactive Effluent ReleaseReport, (XQ) values based on either historical annual-averagemeteorological data, or on data for the actual period of release, maybe used.

Qj = The number of pCi of noble gas nuclide (i) released during theperiod of interest

Dski.= The skin dose from radioactive noble gases in nirem

Mi= The gamma air dose factor due to gamma emissions from eachnoble gas radionuclide (i) released Attachment 4, Table C-I

Fo = Occupancy factor determined for the receptor at the givenlocation (default = 1.0)

NOTE

If a time period is less than one full year, determine the fraction of ayear and multiply the fraction by 3.1 7E-8 for use in equations8.4.1.2.2-1 and -2.

3.17E-8 Inverse of the number of seconds per year in yrisec

I,='The skin dose factor due to beta emissions from noble gasI radionuclide (i) (mrem/yr per pCi/m3) from Attachment 4,

Table C-I

-RqP-0(1()R RRV - 12 PAGEF 27 OF 103RSP-Ofl08 REV - 12 PAGE 27 or 103

1.1 = Average ratio of tissue to air energy absorption coefficients

SF= 1.0, attenuation factor accounting for shielding provided byresidential structures for maximally exposed individual

3. Radioiodine, Tritium, and 8 Day Particulate Dose to Any Organ fromCumulative Releases

1) Requirements

a) Technical Requirements 3.11.2.3 states that the dose to a Memberof the Public from Radioiodines (I-13 1, I- 133), Tritium, andParticulates with Ti/2> 8 days in gaseous effluents released toareas at and beyond the site boundary shall be limited to thefollowing:

i. During any calendar quarter: less than or equal to 7.5 mremto any organ; and

ii. During any calendar year: less than or equal to 15 mrem toany organ.

The dose to a member of the Public shall be determined at leastonce per 31 days for the current calendar quarter and currentcalendar year.

b) Technical Requirement 3.11.4 states that the Annual (Calendaryear) dose or dose commitment to any Member of the Public, dueto releases of radioactivity and to radiation from Uranium FuelCycle sources, shall be limited to less than or equal to 25 mrem tothe total body or any organ, except the thyroid, which shall belimited to less than or equal to 75 mrem.

2) Methodology

a) The following calculational method is provided for determiningthe organ dose due to releases of radioiodines (I131, 1133),tritium and particulates. It is based on Section 5.3.1 of NUREG-0133, Rev. 1, November 1978. The equation can be used for anyage group provided that the appropriate dose factors are used andthe total dose reflects only those pathways that are applicable tothe age group. The total dose to an organ can then be determinedby summing the pathways that apply to the receptor. Theequations are:

flRP-flflR 1VRV - I1 PACV. 172 n1W in';

NOTE

When calculating or an doses due to the release of C-14 and/ortritium (H-3), (Xi Q) values, not (pD 1Q) values, must be usedforcow milk, goat milk, meat and vegetation pathway calculations,

Inhalation Pathways:

D1&SDPr =(3.17x10- XF,)X(PIXX/QXQi) 8.4.1.3-1

Ground Plane Pathway:

Dr&SDP=r :(3.17xl ° - ) XZ) (R 1, ,D / QQ)iQ) 8.4.1.3-21-1

Contaminated Forage/Cow/Milk Pathway:

Dl&8DPr = (3. 17x1O- XFO ) (Ri# XD /QXQ,) 8.4.1.3-3i..I

Contaminated Forage/Goat/Milk Pathway:

DI&8Dpr=(3.17AlO 8Xl, (2RjD-1QXQ,) 8.4.1.3 -4

Contarminated Forage/Meats:

D,&BDpr =(3.17xlO-BXFO) (RiXD/QXQ1) 8.4.1.3-5,=,

Fresh Fruits and Vegetables:

DI&SDPr =(3-17xlOsXFO ) (Ri )D /QQ 8.4.1.3-6i-I

Total Dose:

Dr =zDI&8DPr 8.4.1.3-7z=l

Where:

1RSP-0008 RS-08 REV -12 PAGE 29OF 103

DI&8Dp, = Dose to the organ (-c) for the age group of interest fromradioiodines (I-131, I-133), tritium and 8-day particulatesvia the pathway of interest

Fo = Occupancy factor defined for the receptor at the givenlocation

,= Total dose in mrem to the organ (t) of a specified age groupsummed over all applicable pathways (Z)

z = All the applicable pathways for the age group of interest

Pi, = Inhalation dose conversion factor mrem/yr per jLCi/m3

Qi= The number of jLCi of nuclide (i) released during the year ofinterest

Rig= The dose factor for nuclide (i) for pathway (Z) to organ (X)of the specified age group. For tritium, a site-specificabsolute humidity (H) value of 12.9 gmln 3 was used forcalculation. (See Attachment 15 through Attachment 33.)The units are:

Ae-in for pathways using (X /Q)

or

2mremM - _m-se for pathways using (D J Q)

'UCi -yr

(DJIQ) = A long-term relative deposition value for elevated andground level releases (on2)

(X / Q) = The highest calculated annual average relativedispersion factor for an area at or beyond the unrestrictedarea boundary for all sectors (sec/r ), Attachment 9.

3.17X104= The inverse.of the number of seconds per year(years/sec).

8.5 Dose Projection - Determination of Need to Operate Ventilation Exhaust TreatmentSystem

RSP-0008 REV - 12 PAGE 30 OF 103R�P-OOOR REV-12 PAGE300F103

8.5.1. Requirement

Technical Requirements 3.11.2.5 requires that the ventilation exhaust treatmentsystem be used to reduce radioactive material in waste prior to discharge whenthe projected dose due to gaseous effluents (radioiodines (I-131, I-133),particulates T 1/2 > 8 days and H-3) would exceed 0.3 mrem to any organ in a31 day period.

NOTE

The ventilation exhaust treatment system does not reduce the noble gasconcentration in plant effluents (See Definition 3.5).

8.5.2. Methodology

The following calculation method is provided for determining the projecteddoses:

G =kk* 3 1+D 8.5.2-1PD X PA

D

Where:

G = Projected dose due to radioiodines (1-131, 1-133), particulates with T 1/2> 8 days and H-3 during the current 31 day period (mnrem)

XD = The number of days to date in the current quarter

D, = Cumulative total dose due to radioiodines (I-131, 1-133), particulates withT 1/2 > 8 days and H-3 during the current quarter (mrem)

DPA= The anticipated dose contribution to the total body or any organ -r due toplanned activities during the next 31 day period, if those activities willresult in gaseous releases that are in addition to routine gaseouseffluents. If only routine effluents are anticipated, DPA 0. This valuemay be adjusted to account for any changes in operating conditions thatcould significantly alter actual releases, such as failed fuel or changes inventilation flow rate.

A dose projection would be based on the latest results of the monthly calculations of thedose due to radioiodines (I-131, I-133), particulates with T 1/2 > 8 days, and H-3 (Section8.4.1.3).

RSP-0008 REV- 12 PAGE 31 OF 103

9 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM

Attachment I contains the sample point description, sampling and collection frequency, analysis,and analysis frequency for various exposure pathways in the vicinity of RBS for the RadiologicalEnvironmental Monitoring Program. Attachment 34 and Attachment 38 indicate the locations ofthe various onsite and offsite sampling points and TLD locations.

This section describes only those elements of the Radiological Environmental MonitoringProgram required by the RBS Technical Requirements Manual. Additional exposure pathways,sample points, analyses, and/or frequencies may be performed as described in Reference 2.1.3Section 6.2.

Samples of groundwater are taken from onsite wells located to intercept any potentialcontamination of the Upland Terrace Aquifer so that any such contamination would be detectedbefore migrating beyond RBS site boundaries.

10 40CFR190 CONSIDERATIONS

10.1 Compliance with 40CFR190

Compliance with 40CFR190 as prescribed by Technical Requirements 3.11.4 is to bedemonstrated onlywhen one ormore of Technical Requirement(s) 3.11.1.2.a, 3.11.1.2.b,3.11 .2.2.a, 3.11 .2.2.b, 3.11 .2.3a, and 3.11.2.3 .b, including direct radiation are exceededby a factor of 2. Once this occurs, EOI has 30 days to submit a report in accordance withRequirement 3.11.4.

10.2 Calculations Evaluating Conformance with 40CFR1 90

To perform the calculations to evaluate conformance with 40CFR190, an effort is madeto develop doses that are realistic by removing assumptions that lead to overestimates ofdose to a Member of the Public (i.e., calculations for compliance with 10CFR50Appendix I). To accomplish this, the following calculational rules are used:

10.2.1 . Doses to Members of the Public via the liquid release pathway are consideredto be < 1 mrem/yr (Ref NUREG-0543).

I0.2.2. Doses to a member of the Public due to a milk pathway will be evaluated onlyas can be shown to exist. Otherwise, doses via this pathway will be estimatedas Cl mrem/yr.

10.2.3. Environmental sampling data that demonstrate that no pathway exists may beused to delete a pathway to man from a calculation.

10.2.4. To sum numbers represented as "less than" (<), use the value of the largestnumber in the group.

RSP-0008 RIEV- 12 PAGE 32 OF 103

e.g., <5+ <1 + <1 + <3 = <5

10.2.5. When doses via direct radiation are added to doses via inhalation pathway,they will be calculated for the same distance in the same sector.

10.2.6. The calculational locations for a Member of the Public will only be atresidences or places of employment.

NOTE

Additional assumptions may be used to provide situationspecific parameters, provided they are documented alongwith their concomitant bases.

NOTE

Estimates for each of the calculations below will be madefor each of the following exposure pathways to the samelocation by age class. Only those age classes known to

- exist at a location are considered.

10.3 Calculations of Total Body Dose

10.3.1. Direct Radiation (from storage tanks, N-16 sources, etc.)

The component of dose to a Member of the Public due to direct radiation willbe determined by thennoluminescent dosimeters (TLDs).

10.3.2. Inhalation Dose

The inhalation dose will be determined at the calculational locations for eachage group according to the methods outlined in Section 8 of this manual.

10.3.3. Ingestion Pathway (cow milk, goat milk, meat, vegetation)

The dose via the ingestion pathway will be calculated at the consumerlocations for the consumers at risk. If no milk pathway exists in a sector, thedose via this pathway will be treated as < 1 mrem/yr.

10.3.4. Total Body Noble Gas Imnersion Dose

This dose will be calculated in accordance with Section 8.4.1.2.2). for themaximally exposed MEMBER OF THE PUBLIC in the limiting sector.

10.3.5. Ground Plane Deposition

10.3.6. Other Uranium Fuel Cycle Sources

RSP-0008' REV - 12 PAGE 33 OF 103RSP000 =E-1 =AGE3-OF1O

The dose from other fuel sources will be treated as < 1 mrem/yr.

10.4 Thyroid Dose

The dose to the thyroid will be calculated for the limiting sector as the sum of:


The component of dose to the thyroid due to direct radiation will be determinedby thermoluminescent dosimeters (TLDs).


The inhalation dose to the thyroid will be determined at the calculationallocations for each age group according to the methods outlined in Section 8 ofthis manual.


The dose to the thyroid via the ingestion pathway will be calculated at theconsumer locations for the consumers at risk. If no milk pathway exists in asector, the dose via this pathway will be treated as < 1 mremlyr.

10.4.4. Noble Gas Immersion Dose

It is assumed that an external total body dose from noble gases irradiatesinternal body organs at the same numerical rate (Reference 2.1.8). This dosefor the thyroid will therefore be equal to the dose calculated in Step 10.3.4above.



The dose from other fuel cycle sources will be treated as <1 mrem/yr.

10.5 Organ Dose (other than thyroid and skin)

The dose to any organ will be calculated for the limiting sector as the sum of:


The component of dose to an organ due to direct radiation will be determinedby thermoluminescent dosimeters (TLDs).


RSP-0008 R1EV -12 PAGE 34 OF 103

The inhalation dose to an organ will be determined at the calculationallocations for each age group according to the methods outlined in Section 8 ofthis manual.


The dose to an organ via the ingestion pathway will be calculated at theconsumer locations for the consumers at risk. If no milk pathway exists in asector, the dose via this pathway will be treated as < 1 mrem/yr.

10.5.4. Noble Gas Immersion Dose

It is assumed that an external total body dose from noble gases irradiatesinternal body organs at the same numerical rate (Reference 2.1.8). This dosefor an organ will therefore be equal to the dose calculated in Step 10.3.4 above.



The dose from other fuel cycle sources will be treated as < 1 mrem/yr.

10.6 Skin Dose

The dose to the skin will be calculated for the limiting sector as the sum of:


The component of dose to the skin due to direct radiation will be determinedby thermoluminescent dosimeters (TLDs).


The inhalation dose to the skin (only tritium is considered) will be determinedat the calculational locations for each age group according to the methodsoutlined in Section 8 of this manual.


The dose to the skin via the ingestion pathway (only titium and 0-14considered) will be calculated at the consumer locations for the consumers atrisk. If no milk pathway exists in a sector, the dose via this pathway will betreated as < I mrem/yr.

10.6.4. Skin Noble Gas Immersion Dose

This dose will be calculated in accordance with Section 8.4.1.2.2) for themaximally exposed MEMBER OF THE PUB3LIC in the limiting sector(s).

RSP-0008 REV -12 PAGE 35 OF 103



This dose from other fuel cycle sources will be treated as < 1 mrem/yr.

11 INTERLABORATORY COMPARISON STUDIES

11.1 Requirement

Technical Requirements 3.12.3 states that analyses shall be performed on radioactivematerials, that correspond to samples required by Table 3.12.1-1, supplied as part of anJnterlaboratory Comparison Program.

11.2 Program

11.2.1. Environmental Sample Analyses Comparison Program

Environmental samples from the River Bend Station are to be analyzed by theRiver Bend Station Environmental Services Group or by a qualifiedcontracting laboratory. These laboratories will participate in an EnvironmentalRadioactivity Laboratory Intercomparison Studies (Crosscheck) Program. Thisparticipation will include all of the determinations (sample-radionuclidecombinations) that are included in the licensee's Radiological EnvironmentalMonitoring Program. Results of the Interlaboratory Program will be includedin the Annual Radiological Environmental Operating Report.

11.2.2. Effluent Release Analyses Program

RBS Chemistry Group will perform sample analyses for gamma-emittingradionuclides in effluent releases. The radiochemistry laboratory willparticipate annually in a corporate interlaboratory comparison study or anequivalent study. The results of these studies will be provided to the NRCupon request.

11.2.3. Abnormal Results

The RBS laboratory values and the vendor laboratory "known values" shouldbe compared by some evaluation criteria such as the EPA method, where theacceptable result lies between ± three normalized standard deviations from the"known value"; or the NIST traceability method, where the difference betweenthe RBS value and the "known value" should be less than the total propagateduncertainty of the difference. If deviations from such criteria exist, anevaluation will be performed to identify any recommended remedial actions toreduce anomalous errors. Complete documentation on the evaluation will beprovided to the NRC upon request,

RSP-0008 REV -12 PAGE 36 OF 103

ATTACHMENT IPAGE I OF 4

TABLE 4.1 - RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM

Exposure Pathwayand/or Sample

1. Airborne Particulates and 1--131

Sample Point, Description,Distance, and Direction

Samples from 4 locations:

Sampling andCollection Frequency

Type and Frequencyof Analysis

API. Behind River Bend Station ActivityCenter; 0.9 kIn WNW.

Continuous air sampler with filter collectionevery two weeks, or as required by dust loading,whichever is more fiequent.

Charcoal cartridge: analysis every two weeksfor 1-13 31 Particulate sampler: gross betaactivity following filter changes every twoweeks.

AQS2. St. Francis Substation on US Hwy.(Bus.) 61 in St. Francisville; 5.8 km NW(Community Location).AGC. Entergy Service Center compound inZachary; 17 kn SE (Control)

ANI. RBS site Hwy 965; 0.4 km south ofActivity Center; 0.9 km W.

2. Direct Radiation Measurements from 24 locations:

INDICATOR STATIONS

TAL. River Bend Training Center; 1.7 km N.

TB1. Utility pole near River Bend Stationcooling tower yard area; 0.5 km NNE.

Thermoluminescence dosimeters (TLDs);deployment/retrieval quarterly.

mR exposure quarterly.

TCI. Stub pole at Jet US Hwy. 61 and OldHighway 61; 1.7 kan NE.

TD1. Stub pole along WF7, 150m S of JctWF7andUSHwy. 61; 1.6kmENE.

TE I. Stub pole along WF7,1 km S of Jct. WF7and US Hwy. 61; 1.3 kn E.

TF1L Stub pole along WF7, 1.6km S of Jct.WF7 and US Hwy. 61; 1.3kmESE.

TGI. Stub pole along WF7, 2 kn S of Jet. WF7and US Hwy. 61; 1.6 km SE.

RSP-0008 REV -12 PAGE 37 OF 103

ATTACHMENT 1PAGE2OF4


Exposure Pathway Sample Point, Description, Sampling and Type and Frequencyand/or Sample Distance, and Direction Collection Frequency of Analysis

THiL. Stub pole at power line crossing of WF7(near Grants Bayou); 1.7 km SSE.

TJI. Stub pole near River Bend Station Gate#23 on Powell Station Road (LA Hwy. 965); 1.5km S.

TKI. Utilitypole on Powell Station Road (LAHwy. 965), 20 m S of River Bend Station RiverAccess Road; 0.9 Ian SSW.

TLI. First utility pole on Powell Station Road(LA Hwy. 965) S offormer Illinois Central GulfRR crossing; 1.0 km SW.

TMI. Third utility pole on Powell Station Road(LA Hwy. 965) N of former Illinois CentralGulf RR crossing, 0.9 km WSW.

mNl. Utility pole along Powell Station Road(LA Hwy. 965), near garden and ANI airsampler location; 0.9 kn W.

TP I . Behind River Bend Station ActivityCenter at API air sampler location; 0.9 kmWNW.

TQI. Across from MAI on RBS North AccessRoad; 0.6 km NW.

TRI. River Bend Station North Access Roadacross from Main Plant entrance; 0.8 km NNW.

CONTROLUSPECIAL STATIONS

TAC. Utility pole at Jt. of US Hwy. 61 and LAHwy. 421, 7.9 km north of Bains; 15.8 km N.(Control)

TQSL. Utility pole front of Pentecostal church(opposite West Feliciana Parish Hospital) nearJct. US Hwy. 61 and Ferdinand Street; 4 kmNW (Special)

RSP-0008 REV -12 PAGE 38 OF 103

ATTACHMENT 1PAGE 3 OF 4



* . Sample Point, Description,Distance, and Direction

TQS2. St. Francis Substation on business USHwy.61 in St. Francisville; 5.8 km NW(Special).

TNS. Utility pole with electrical meter at westbank ferry landing (LA Hwy. 10); 6.0 kmn W.(Special)

TEC. Stub pole at jct. of Hwy. 955 and MidwayRoad, 4.8 km North of lot. of Hwys 955 and964; 16 km E. (Control)

TCS. Utility pole at gate to East Louisiana StateHospital in Jackson; 12.3 km NE. (Special)

TGS. Entergy Service Center compound inZachary; 17 km SE (Special).

TRS. Stub pole at Jct. of US Hwy. 61 and WF2near Bains. (West Feliciana High School); 9.2km NNW. (Special)



3. Waterbome SURFACE WATER (1)

SWU. Mississippi River about 4 km upstreamfrom the plant liquid discharge outfall, near LAHwy. 10 ferry crossing. (5km, W)

SWD. Mississippi River about 4 kmdownstream from plant liquid discharge outfall,near paper mill. (7.75 kmn, S)

GROUND WATER

Quarterly grab.Quarterly: gamma isotopic analysis; quarterlytritium analysis.

WU. Upland Terrace Aquifer well upgradientfrom plant, about 470 m NNE.

Semiannual grabGamma isotopic and tritium analysis .semiannually.

WD. Upland Terrace Aquifer welldowngradient from plant, about 470 m SW.

RSP-0008 i REV -12 PAGE 39 OF 103


. C TABLE 4.1 - RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM


Sample Point, Description,Distance, and Direction



SHORELINE SEDIMENT

SEDD. Mississippi River downstream fromplant liquid discharge outfall, near paper mill.(7.75 kin, S)

Annual grab Gamma isotopic analysis annually.

4. Ingestion(2) FISH AND INVERTEBRATES

FU. One sample of a commercially and/orrecreationally important species from upstreamarea not influenced by plant discharge. (4 km,.WSW)

Annually. Gamma isotopic analysis on edible portionsannually.

FD. One sample of a commercially and/orrecreationally important species fromdownstream area influenced by plant discharge.(7.75 km, S)

FOOD PRODUCTS

(iNI. One sample of leafy vegetation fromonsite garden near site boundary in sector ofhighest calculated average ground level D/Q,(0.9km, W)

Quarterly during growing season. Gamma isotopic and 1-131 analyses quarterly.

GQC. One sample of similar vegetation fromLA State Penitentiary at Angola, 32 km NW(Control).

NOTES:

1. The upstream sample will be taken at a distance beyond signif cant influence of the plant discharge. The downstream sample will be taken in an area beyond but near the mixing zone.

2 If milk-producing animals become available within a 8-km radius of the plant, sampling will beperformed in accordance with Table 3.12.1-1, Section 4.a of the Technical RequirementsManual.

RSP-0008 REV - 12 PAGE 40 OF 103

ATTACHMENT 2PAGE I OF I

ECL VALUESEFFLUENT CONCENTRATION LIMIT (gCi/ml)

NUCLIDEH-3BE-7C-14NA-24P-32CR-51MN-54MN-56FE-55FE-59C0-56CO-57CO-58CO-60Nl-63NI-65CU-64ZN-65ZN-69ZN-69MSE-75BR-82BR-83BR-84R86RB-88RB-89SR-85SR-89SR-90SR-91SR-92Y-88Y-90Y-91MY-91Y-92Y-93ZR-95ZR-97NB-94NB-95NB-97MO-90MO-99TC-99MTC-101RU-103RU-105RU-106AG-I IOMCD-109CD-1 13MSN-1 13SN-117MSB- 122SB-124SB-125

AIR-1-073E-083E-097E-095E-103E-08lE-092E-083E-095E-103B-109E-10IE-09SE-lII E-092B-083E-084E-102B-07IE-088E-105E-099B-os8E-081E-099E-082E-072E-092E-1062-125E-099E-093E-109E-102E-072E-10I-083E-094E-102E-092E-112B-09I-076E-0925-092E-075E-079E-102E-0825-1112107E-1 I5E-128E-102E-092E-093E-107E-10

WATER1E-036E-043E-055E-059E-065E-043E-057E-051B-0415-056E-066E-052E-053E-06IE-04IE-042E-045E-068E-046E-057E-064E-059E-044E-047E-064E-049E-044E-058E-06SE-072B.054E-05IE-057E-062M-038E-064E-052E-052E-059E-061E-053B-053E-043E-052E-05IB-032E-033E-057E-053E-066E-066E-065E-073B-053E-05IE-057E-063E-05

NUCLIDESB-126SB-127TE- 127MTE-127TE-129MTE-129TE-131MTE-131TE-1321-1301-1311-1321-1331-1341-135CS-134CS-135CS-136CS-137CS-138BA-133BA-139BA-140BA-141BA-142LA-140LA-142CE-139CE-141CE-143CE-144PR-143PR- 144ND-147EU-152W-187NP-239AR-41KR-83MKR-85MKR-85KR-87KR-88KR-89KR-90XE-131MXE-133MXE-133XE-135MXE-135XE-137XE-138G-APLHAG-BETAOMERRHI-105SC-46AS-76

.

AIR7E-101E-094E-102E-083E-IO9E-081E-092E-089E-103E-092E-102E-08IE-096E-086E-092E-102E-099E-102E-10SE-089E-104E-082E-09IE-072E-072E-093E-089E-108E-102E-092E-119E-102E-07I E-093E-11IE-083E-091E-085E-05I E-077E-072E-089E-09IE-09I E-092E-066E-075E-074E-087E-08IE-0928-08IE-151E-12OE+008E-093E-102E-09

WATER7f-06IE-059E-061E-047E-064E-048E-06SE-059E-162E-05IE-06I E-047E-064E-043E-059E-07I E-056E-06IB-064E-042E-052E-048E-063E-047E-049E-06IE-047E-053E-052E-053E-062E-056B-042E-051F-053E-052E-05OE+000+00OE+000E+00OB+00OE+00.OE+00OE+000+00OE+00OE+00OE+00OE+00OE+00.OE+002E-09IE-08

OE+005E-051ES051E-05

RSP-0008 REV- 12 PAGE 41 OF 103


TABLE B-i: LIQUID ENVIRONMENTAL DOSE TRANSFER FACTORS

Ai, Table B-1DOSE FACTOR TABLE: Ai, - Adult, liquid

Units are mremlhr per gCi/ml

Nuclide Bone Liver Thody . Thyroid Kidney Lung GI Tract Skin

H-3C-14NA-24P-32CR-51MN-54MN-S6FE-55FF-59C0-57C0-58C0-60NI-63NI-65CU-64ZN-65ZN-69ZN-69MBR-82BR-83BR-84BR-85RB-86RB-88RB-89SR-89SR-90SR-91SR-92Y-90Y-91MY-91Y-92Y-93ZR-95ZR-97NB-95NB-97MO-99TC-99MTC-I01RU-103RU-105RU-106'AG-Il OMSB-124SB-125TE-125MTB-127MTE-127

O.OOE+00 2.81E-01 2.81E-01 2.81E-01 2.81E-01 2.81E-01 2.81B-01 0.OOE+004.618+04 9.22E+03 9.22E+03 9.22E+03 9.22E+03 9.22E+03 9.22E+03 O.OOEt006.02E+02 6.02E+02 6.02E+02 6.02E+02 6.02E+02 6.02E+02 6.02E+02 O.OOE+004.85E+07 3.01E+06 1.87E+06 O.OOE+00 O.OOE+00 0.008+00 5.45E+06 0.00E+000.ooE+0o 0.00E+00 4.31E+00 2.58E+00 9.50E-01 5.72E+00 1.08E+03 O.OOE+000.OOE+0O 2.39E+05 4.56E+04 O.OOE+00 7.12E+04 O.OOE+00 7.33E+05 O.OOE+00O.OOE+00 6.02E+03 1.07E+03 O.OOE+00 7.64E+03 0.00E+00 1.92E+05 O.OOE+005.68E803 3.93E+03 9.16E+02 O.OOE+00 0.00E+00 2.19E+03 2.25E+03 0.00E+008.97E+03 2.11B+04 8.08E+03 O.OOE+00 O.OOE+00 5.89E+03 7.03E+04 O.OOE+00O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+000.00E+00 1.74E+02 3.91E+02 O.OOE+00 O.OOE+00 O.OOE+00 3.54E+03 0.00E+000.00+00 5.01B+02 1.1IE+03 O.OOE+00 O.OOB+00 O.OOE+00 9.41E+03 O.OOB+003.86E+04 2.68E+03 1.29E+03 O.OOE+00 O.OOE+00 0.00E+00 5.58E+02 O.OOE+001.57E+02 2.04E+O1 9.29E+00 O.OOE+00 O.OOE+00 0.00E+00 5.17E+02 O.OOE+00O.OOE+00 2.90E+01 L.36E+01 O.OOE+00 7.31E+01 0.00+00 2.47E+03 O.OOE+005.09E+04 1.62E+05 7.3 1E+04 O.OOE+00 1.08E+05 0.00E+00 1.02E+05 O.OOE+0O1.0SE+02 2.07E+02 1.44E+01 O.OOE+00 1.34E+02 O.OOE+00 3.1 1E+01 O.O+00O.OOE+00 O.OOE+00 0.00O+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00+00O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.00E+000.00E+00 O.OOE+00 4.81E+01 O.OOE+00 O.OOE+00 0.00E+00 6.92E+01 O.OOE+00O.OOE+00 O.OOE+00 6.23E+01 O.OOE+00 O.OOE+00 O.OOE+00 4.89E-04 O.OOE+00O.OOE+00 O.OOE+00 2.56E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00O.OOE+00 1.13E+05 5.28E+04 O.OOE+00 O.OOE+00 O.OOE+00 2.23E+04 O.OOE+00O.OOE+00 3.258+02 1.72E+02 0.00E+00 O.OOE+00 O.OOE+00 4.49E-09 0.008+000.00E+00 2.15E+02 1.51E+02 0.00E+00 O.OOE+00 0.00E+00 1.25E-11 O.OOE+003.97E+04 O.OOE+00 1.14E+03 0.0OE+00 O.OOE+00 O.OOE+00 6.38E+03 0.0OE+009.78E+05 0.00E+00 2.40E+05 O.OOE+OO O.OOE+00 O.OOE+00 2.83E+04 O.OOE+007.32E+02 O.OOE+00 2.96E+01 O.OOE+00 O.OOE+00 O.OOE+O 3.48E+03 0.00E+002.77E+02 O.OOE+00 1.20E+01 O.OOE+00 O.OOE+00 O.OOE+00 5.50E+03 O.OOE+006.07E+00 O.OOE+00 1.63E-01 O.OOE+00 0.OOE+00 O.OOE+00 6.44E+04 O.OOE+005.74E-02 O.OOE+00 2.22E-03 O.OOE+00 O.OOE+00 O.OOE+00 1.68E-01 O.OOE+008.90E+01 0.00E+00 2.38E+00 0.00E+00 O.OOE+00 0.OOE+00 4.90E+04 O.OOE+005.33E-01 O.OOE+00 1.56E-02 O.OOE+00 O.OO+00 O.OOE+000 9.34E+03 O.OOE+001.69B+00 0.00E+00 4.67E-02 O.OO+00 O.OO8+00 O.OOE+00 5.36E+04 O.OOE+003.57E-01 1.14E-01 7.75E-02 O.OOE+00 1.80E-01 O.OOE+00 3.638+02 O.OOE+00I.97E-02 3.98E-03 1.828-03 0.00E+00 6.01E-03 0.00E+00 1.23E+03 0.008+004.48E+02 2.49E+02 1.34E+02 O.OOE+00 2.46E+02 O.OOE+00 1,51E+06 O.OOE+00O.OO+00 O.OOE+00 0.008+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00O.OOE+00 1.28E+02 2.44E+01 O.OOE+00 2.90E+02 0.00E+00 2.97E+02 O.OOE+009.59E-03 2.71E-02 3.45E-01 O.OOE+00 4.12E-01 1.33E-02 1.60E+01 0.00E+009.86E-03 1.42E-02 1.39E-01 O.OOE+00 2.56E-01 7.26E-03 4.27E-14 O.OOE+003.61E+01 O.OO+00 1.56E+01 O.OOE+00 1.38E+02 O.OOE+00 4.22E+03 O.OOE+003.01E+00 O.OOE+00 1.19E+00 O.OOE+00 3.89E+01 O.0E+00 1.84E+03 O.OOE+005.37E+02 0.OOE+00 6.80E+01 O.OOE+00 1.04E+03 O.OOE+00 .3.48E+04 O.OOE+005.38E-04 4.98E-04 2.95E-04 O.OOE+00 9.78E-04 O.OOE+00 2.03E-01 O.OOE+00O.OOE+00 0.00E+00 O.OOE+00 O.OOE+09 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00O.OO+00 O.OOE+O0 0.008+00 0.008+00 O.OO+00 O.OOE+00 O.OOE+00 O.OOE+001.19E+04 4.31E+03 1.59E+03 3.58E+03 4.84E+04 O.OOE+00 4.75E+04 O.OOE+003.01E+04 1.08E+04 3.66t+03 7.69E+03 1.22E+05 O.OOE+00 1.01E+05 O.OOE+004.89E+02 1.75E+02 1.068+02 3.628+02 1.998+03 0.00E+00 3.86E+04' O.OO+00

RSP-0008 REV -12 PAGE 42 OF 103


TABLE B-i: LIQUID ENVIRONMENTAL DOSE TRANSFER FACTORSNucide Bone Liver Tbody Thyroid Kidney Lung GI. Tract Skin

TE-t29M 5.11E+04 1.91E+04 8.09E+03 1.75E+04 2.13E+05 O.OOE+00 2.57E+05 O.OOE+00TE-129 1.39E+02 5.24E+01 3.40E+01 1.07E+02 5.86E+02 0.008+00 1.05E+02 O.OOE+00TE131M 7.69E+03 3.76E+03 3.13E+03 5.95E+03 3.81E+04 O.OOE+00 3.73E+05 O.OOE+00TE-131 8.75E+01 3.66E+01 2.76E+01 7.20E+01 3.83E+02 O.OOE+00 1.24E+01 O.OOE+00TE-132 1.12E+04 7.24E+03 6.80E+03 8.00E+03 6.97E+04 O.OOE+00 3.43E+05 O.OOE+001-130 2.94E+01 8.66E+01 3.42E+01 7.34E+03 1.35E+02 0.00E+00 7.46E+01 0.00E+001-131 1.62E+02 2.31E+02 1.32E+02 7.57E+04 3.96E+02 O.OOE+00 6.10E+OI 0.00E+OO1-132 7.88E+00 2.1 IE+0I 7.38E+00 7.38E+02 3.36E+01 O.OOE+00 3.96E+00 O.OOE+001-133 5.51E+01 9.59E+01 2.92E+01 1.41E+04 1.67E+02 O.OOE+00 8.62E+01 0.00E+001-134 4.12E+00 1.12E+01 4.00E+00 1.94E+02 1.78E+01 O.OOE+00 9.75E-03 0.00E+001-135 1.72E+01 4.50E+01 1.66E+01 2.97E+03 7.22E+01 O.OOE+00 5.09E+01 O.OOE+00CS-134 3.348+05 7.94E+05 6.49E+05 O.OOE+00 2.57E+05 8.53E+04 1.39E+04 O.OOE+00CS-136 3.49E+04 1.38E+05 9.93E+04 O.OOE+00 7.68E+04 1.05E+04 1.57E+04 0.008+00CS-137 4.28E+05 5.85E+05 3.83E+05 O.OOE+00 1.99E+05 6.60E+04 1.13E+04 0008E+OOCS-138 2.96E+02 5.85E+02 2.90E+02 0.00E+OO 4.30E+02 4.258+01 2.50E-03 O.OOE+00BA-139 1.20E+01 8.55E-03 3.52E-01 0.00E+OO 8.008-03 4.85E-03 2.13E+01 0.00E+00BA-140 2.51E+03 3.16E+00 1.65E+02 O.OOE+00 1.07E+00 1.81E+00 5.17E+03 O.OOE+00BA-141 5.83E+00 441E-03 1.97E-01 O.OO+00 4.10E-03 2.50E-03 2.758-09 O.OOE+00BA-142 2.64E+00 2.71E-03 1.66E-01 O.OOE+OO 2.29E-03 1.54E-03 3.71E-18 O.OOE+00LA-140 1.58E+00 7.958-01 2.108-01 O.OOE+OO O.OOE+00 O.OOE+00 5.848+04 0.00E+OOLA-142 8.08E-02 3.67E-02 9.15E-03 O.OO+00 0.008E+00 0.00E+00 2.68E+02 0.00E+00CE-141 5.37E+00 3.63E+00 4.12E-01 O.OOE+00 1.69E+00 O.OOE+00 1.39E+04 0.00E+0C0-143 9.46E-01 7.00E+02 7.74E-02 0.00E+OO 3.08E-01 0.00E+00 2.61E+04 O.OOE+00CE-144 2.80E+02 1.17E+02 1.50E+01 O.OOE+00 6.94E+01 O.OOE+00 9.46E+04 0.0OE+00PR-143 5.80E+00 2.33E+00 2.88E-01 0.008+00 1.34E+00 0.00E+00 2.54+04 0.008+00PR-144 1.90E-02 7.89E-03 9.65E-04 O.OOE+00 4.45E-03 O.OOE+00 2.73E-09 O.OOE+00ND-147 3.97E+00 4.598+00 2.74E-01 O.OOE+00 2.68E+00 0.00E+00 2.20E+04 0.008+00W-187 2.97E+02 2.48E+02 8.68E+01 O.OOE+00 O.OOE+00 O.OOE+00 8.13E+04 0.00E+00NP-239 3.00E-01 2.958-02 1.63E-02 O.OO+00 9.218-02 O.OOE+00 6.06E+03 O.8OE+00

RSP-0008 REV -_ 2_ PAGE 43 OF 103RSP-0008 REV-12 PAGE43OF1O3


TABLE C-i: NOBLE GAS DOSE TRANSFER FACTORS

TABLE C-1

FACTOR FOR EXPOSURE TO A SEMI-IFNTE CLOUD

DOSE TO PEOPLE + DOSE OF AIR #

Nuclide Gamma-Body Beta-Skdn Gamma BetaK(i) L(i) M i) N )

AR-41KR-83MKR-S5KR-85MKR-87KR-88KR-89KR-90XE-13iMXE-133XE-133MXE-135XE-135MXE-137XE-138

8.840E+037.560E-021.610E+O1I. 170E+035.920E+031.470E+041.660E+041.560E+049.1 50E+O12.940E+022.5 1OE+021.8tOE+033.120E+031.420E+038.830E+03

2.690E+03O.OOOE+001.340E+031.460E+039.730E+032.370E+031.0l OE+047.290E+034.760E+023.060E+029.940E+021.860E+037.1 10E+021.220E+044.130E+03

9.300E+031.930E+011.720E+011.230E+036.170E+031.520E+041.730E+04I.630E+041.560E+023.530E+023.270E+021.920E+033.360E+031.5 IOE+039.210E+03

3.280E+032.880E+021.950E+031.970E+031.030E+042.930E+031.060E+047.830E+03I. I 1OE+031.050E+031.480E+032.460E+037.390E+021.270E+044.750E+03

+ -- mnremyr per ,uCi/cu.m.

- nirad/yr per p.Cilcu.m.

IRSPAG04} REVY - 12 PAGE 44 OF 103-RSP-41008 REV-12 PAGE44OFI(13

ATTACHMENT 5PAGE l OF I

(RESERVED)

RSP-0008 REV - 12 PAGE 45 OF 103RSP-0008 REV¶12 PAGE4SOF1O3


X/Q AND D/Q VALUES FOR RESTRICTED AREA BOUNDARY

Long Term Diffusion Estimates

E. 1 Obiective

Annual average CHIIQ and D/Q estimates for continuous and intermittent releases were calculated foreach of the sixteen 22.5-degree sectors at receptor locations used to determine the maximum individualand population dose receptors.

The methodology described in Regulatory Guide 1. 111, Rev. 1 provided guidance for the aforementionedanalysis. The resultant CHIIQ and D/Q values for the maximum individual dose receptors are displayedin Attachment 9.

E.2 Calculation Techniques

Nomenclature2.032= (2 1r)"2 (2 7r/ 16)-'

7= 3.14159...EXP= 2.71828ET = ENTRAINMENT COEFFICIENTnT= TERRAIN RECIRCULATION FACTORX = DOWNWIND RECEPTOR DISTANCECFz = VERTICAL DISPERSION (PLUME SPREAD) COEFFICIENTLim = 30-FT AVERAGE WIND SPEED CORRESPONDING TO A

GIVEN HOUR OF ONSITE METEOROLOGICAL DATAU=50 150-FT AVERAGE WIND SPEED CORRESPONDING T A

GIVEN HOUR OF ON-SITE METEOROLOGICAL DATA(CHI/Q) = AVERAGE CONCENTRATION NORMAL-IZED BY SOURCE

STRENGTH(CHI/QD) DEPLETED CHI/QFM = MOMENTUM FLUXH3 = MAXIMUM ADJACENT BUILDING HEIGHTHR = RELEASE HEIGHTHE = EFFECTIVE RELEASE HEIGHTHPR= NONBUOYANT PLUME RISEHT = TOPOGRAPHIC HEIGHT OF RECEPTOR ABOVE PLANT

GRADED - STACK OR VENT DIAMETERUE= EFFLUX VELOCITYN TOTAL NUMBER OF VALID HOURS OF ONSITE WIND DATA

IN ALL SECTORS FOR APPLICABLE AVERAGING PERIOD8/Q = RELATIVE DEPOSITION RATE NORMALIZED BY SOURCE

STRENGTHD/Q = RELATIVE DEPOSITION PER UNIT AREA NORMALIZED BY

SOURCE STRENGTH0 -GROUND RELEASE (SUBSCRIPT)

(DIMENSIONLESS)(DIMENSIONLESS)(DIMENSIONLESS)(DIMENSIONLESS)(DIMENSIONLESS)

(M)(M SEC')

(SEC M-3 )

(SEC M-')(M4 SEC3 )(M)M)

(M)

(M 5EC1')(DIMENSIONLESS)

(M-2)

(DIMENSIONLESS)

RSP-0008 REV- 12 PAGE 46 OF 103


X/Q AND DIQ VALUES FOR RESTRICTED AREA BOUNDARYI = INDEX FOR ATMOSPHERIC STABILITY GROUP (CLASSES A (DIMENSIONLESS)

THROUGH G)J = INDEX FOR NUMBER OF HOURS (DIMENSIONLESS)K = INDEX FOR A PARTICULAR RECEPTOR DISTANCE (DIMENSIONLESS)£ = INDEX FOR A PARTICULAR 22.5-DEGREE SECTOR (DIMENSIONLESS)N = NUMBER OF HOURS ONSITE WIND DATA IN A (DIMENSIONLESS)

PARTICULAR 22.5-DEGREE SECTORS = STABILITY PARAMETER (SECri

E.3 CHIIO Modeling Technique

Annual average values of relative concentration were calculated for continuous gaseous releases ofactivity from the containment building vent and the radwaste building vent according to the straight-line airflow (Gaussian) model described in Regulatory Guide 1.1 11, Rev. 1. An adjustment wasmade to the model to characterize the regional airflow pattern. The equation of this model is asfollows:

2.032 i F (1-EE )explIr(C+ = I ] E.3-1

Q - NJ-1 x) - 3o(a' - chb/-)2 U150az

Since the River Bend Station site is located in relatively open terrain, the terrain recirculation factor(2k) (presented in Figure 2 of Regulatory Guide 1.1 11) was applied.

The entrainment coefficient (ET) is a function of the ratio of efflux velocity (ue) to elevated windspeed (ui so) for the conditionally elevated release points.

For vent releases occurring below the level of a nearby structure, 100 percent downwash (totalentrainment) is conservatively assumed (ET = 1). For vent releases occurring between I and 2times the height of a nearby structure, a conditionally elevated release is assumed, and theentrainment coefficient is defined as follows:

ET = 0.0 when ue/ui50 Ž 5.0 (totally elevated)

ET = 0.30-0.06 when 1.5 < uJulo $ 5.0 (partially entrained)

ET = 2.58-1.58 when 1.0 • u/u 150 < 1.5 (partially entrained)

ET = 1.0 when u,/u 50 $ 1.0 (totally entrained)

Within 5 km in each downwind sector, Equation E.3-1 was evaluated by sector at the property and- restricted area boundaries and nearest regident, vegetable garden, milk cow, and meat animal. There

were no goats whose milk is consumed in the area of interest. This evaluation was performed for eachcontinuously emitting release point and the intermittent release from the mechanical vacuum pump withonsite data collected during the period of March 17, 1977 through March 16, 1979.

RSP-0008 REV -12 PAGE 47 OF 103


X/Q AND D/Q VALUES FOR RESTRICTED AREA BOUNDARYThe effective release height was computed from the following equation:

h, = (hr - ht)k + hpr E.3-2

Where the downwash correction factor (as defined by Equation (5) in Regulatory Guide 1.111, Rev.1) is included in the equation for hpr (see Equation E.34).

Values of topographic heights were conservatively assessed as the maximum height within aparticular annulus-sector (annsect). An annsect is an area bounded by a 22.5-degree sector and anytwo radial distances from the release point.

For A-D stability conditions, plume rise for nonbuoyant sources was calculated by the followingalgorithm:

when:

ue l u150 > 1.5

hpr = 1.44(ue /u,50) 23 (x/d)"3 d E.3-3

when:

u0 I u150 < 15

hpr= l.44(u, /u50 ) 2/3(x/d)"3 (d-3) [l.5-(u0 /u 150)d] E.3-4

and,

h, <3(u0 /U150) E.3-5

The result from Equation E.3-3 or E.3-4 (whichever condition exists) is then compared to EquationE.3-5 and the smaller value of hp, is used.

For E-G stability conditions, Equations E.3-3, E.3-4, and E.3-5 are compared with:

hpr =4F

and

hpr =1l.5(Fm / U:5 o)Y"s-Iz6

where:

(uJ 2 d2

4

and the smallest value was chosen.

RSP-0008 REV- 12 PAGE 48 OF 103


X/Q AND D/Q VALUES FOR RESTRICTED AREA BOUNDARYIn the ground level portion of Equation E.3-1, the vertical dispersion term:

2(ar +O.5hb / z)" 2

was constrained to be less than or equal to 1.732 _zi k

E.4 (CHI/O) and D/O Modeling Techniques

Annual average depleted relative concentration values were conservatively assumed to be equal toannual average relative concentration values (CHJ/Q = (CHIIQ)D). Therefore, no credit was takenfor attendant plume depletion of radioiodines and particulates.

Annual average relative deposition values were calculated using Regulatory Guide 1. 111, Rev. 1with the following equation:

(2Dk =XC*t( 1)Ty'{ [{(aJET + -L[I- (ET)i nJ.JJ]} E.4-1

For the conditionally elevated release points, Figures 6 through 9 of Regulatory Guide 1 .111, Rev. 1were used to calculate the ( 6 /QJG and (&/Q)i values, while for the ground level release points, Figure6 (Attachment 39) was utilized to calculate the (S/Q)G value.

E.5 Methodologv Employed for Intermittent Release

The methodology employed in the calculation of intermittent release CHJIQs and D/Qswas as follows:

1. Two-hour sector-averaged CHI/Q values were calculated without terrain recirculation factors.

2. The 15 percent, I hour value was plotted at 2 hours on log-log coordinates, while the annualaverage value was plotted at 8,760 hr. A straight line connecting the two points was drawn.

3. Log-log interpolation based on total ground intermittent release hours versus annual hoursyielded a CHJ/Q multiplier.

4. The multiplier was applied to annual average CHIIQ and D/Q values to obtain intermittentCHIYQ and D/Q values.

For River Bend Station, a 320 hr/yr intermittent release through the containment building vent fromthe mechanical vacuum pump was evaluated

RSP-0008 REV -12 PAGE 49 OF 103


TABLE E-1: ANNUAL AVERAGE CHIIQ VALUES FOR RESTRICTED AREA BOUNDARY

TABLE E-1ANNUAL AVERAGE CIT/Q VALUES x 107 (sec/m3)

FOR RESTRICTED AREA BOUNDARY

Sector

SSSWSW

WSWW

WNWNW

NNWN

NNENE

ENEE

ESESE

SSE

Mixed Mode Releases(coniuous)

11.419.716.419.523.633.115.714.818.824.916.6-12.29.0710.48.197.69

Ground Level ReleasesExhaust (Continuous)

10518621532665442126213818021115014616815493.145.6

RSP-0008 REV - 12 -PAGE 50 OF 103RSP-0008 REV-12 �PAGE5OOF1o3


TABLE E£4: ANNUAL AVERAGE D/Q VALUES FOR RESTRICTED AREA BOUNDARY

TABLE E-2ANNUAL AVERAGE D/Q VALUES x 1lo (MI)

FOR RESTRICTED AREA BOUNDARY

Sector

SSSWSW

WSWW

WNWNW

* NNWN

NNENE

ENEE

ESESE

SSE

Mixed Mode Releases(Continuous)

7.6111.310.49.7913.818.08.6810.511.811.28.269.737.757.766.605.34

Ground Level Releases(Continuous)

21.439.636.138.568.850.340.824.728.627.122.322.723.024.617.211.8

RSP-0008 REV - 12 PACE 51 OF 163RSP-OOO8 REV-12 PAGE51OFlO3

ATTACHMENT 9PAGE 1 OF I

TABLE F-i: ATMOSPHERIC DISPERSION AND DEPOSITION RATES FOR THE MAXIMUMINDIVIDUAL DOSE CALCULATIONS

TABLE F-1ATMOSPHERIC DISPERSION AND DEPOSITION RATES FOR

TEE MAXIMUM INDIVIDUAL DOSE CALCULATIONS

Analysis Location Ground level Mixed Mode(meters) Releases Releases

Gamma air dose (3) and Beta 994 m WNW (Containment) CHIIQ - 421.0 CBII/Q - 33.1Air DoseMaximum Receptor (4) 994 m WNW CHIQ - 421.0 CHIIQ - 33.1Resident D/Q - 50.3 D/Q - 18.1GardenMeat animalImmersion

Milk animal (5) 7,000 m WNW CHB/Q - 3.58 CHI/Q - .870DIQ - 0.38 DIQ - .223

Other on-site Receptors (6) 115 m ENE CHI/Q - 5977.0 CHI/Q - 407.5DIQ - 529.7 D/Q - 46.9

275 mN CHI/Q - 1644.0 CHI/Q - 169.1DIQ - 345.6 D/Q - 68.4

500 WNW CHI/Q - 916.7 CHI/Q - 105.4DIQ - 148.1 DIQ - 45.6

2500 SW CHJ/Q- 34.45 CHYQ - 4.65DIQ - 3.35 D/Q - 1.40

* Reference 2.1.8 and 2.1.6

Notes:(1) All CHI/Q = 0-7 sec/rM3

(2) All D/Q = I0-9"m 2

(3) Maximum offsite location (property boundary) with highest CHI/Q (unoccupied).(4) Maximum hypothetical occupied offsite location with highest CHI/Q and D/Q.(5) No milk animal within 5 miles radius, hypothetical location in worst sector.(6) Other on-site receptors.

RSP-0008 REV-12 PAGE 52 OF 103

ATTACEIMENT 10. PAGE IlOF I

TABLE G-1: DOSE FACTOR CALCULATION PARAMETERS

CODE DESCITON . VALE UIS

CsdNesfgfifl

fshfsjgshkc

thv1w

1wtl

tm

P1

Ps

gf,

riyprrsf

tblteitertei%tfbtgrthi

tinti

tmitstw

yp.ys

yv

f Harvest stored feed to cow 7.776]v Drinking Water Dilution Factor 2.4801f Stored feed exp. to deposition 5.184]

Fraction Stored Veg. Intake 7.600]Fraction Vegetation Irrigated 1.000]Fraction Leafy Veg. Intake 1.O001

c Fraction Year Cow On Pasture 1.0001g Fraction Year Goat On Pasture 1.0001c Fraction Cow Feed-Pasture Grass 1.0001

Fraction Goat Feed-Pasture Grass 1.0001f Harvest stored feed to goat 7.7761

Absolute Humidity 1.2901Water to sediment xfer coeff. 7.2201

f Liq conv fact pCi*rm*yr/4Ci*1 *hr 1.1421Water content of Leafy Veg 9.2001

* Surface Weather Decay Constant 5.7301r Iodine Surface Wx Decay Constant 5.7301v Mass density of sediment 4.0001

Effective surface density, soil 2.40014 Fractional equilibrium ratio 1.0001c Cows Feed Consumption Rate 5.0001

Goafs Feed Consumption Rate 6.0001Fraction Deposited Liquid 2.5001Fraction Deposited Particulate 2.0001Fraction Deposited Radioiodine 1.0001Shielding Factor 1.0001Long term sediment exposure 0.0001Long term sediment exp. liquid 4.7161Veg. Exposure in Growing Season 5.1841

m Seasonal forage exposure (milk) 2.5921v Seasonal crop exposure (veg) 8.0001* Fresh Fish Transit Time 0.0001m Time, goat milking to receptor 1.728E

Transit Time-Harvest Irrig. Veg 8.640Ev Transit Time-Harvest-Stored Veg 5.184E

Fresh Non-Fish Transit Time 0.000ETransit Time-Harvest-Leafy Veg 8.6401

o Time, cow miling to receptor 1.728ETime, slaughter to consumer 1.728EDrinking Water Transit Time O.OOOEIrrigated Veg. Areal Density 2.000EPasture Grass Areal Density 7.000EStored Feed Areal Density 2.000EStored Vegetable Areal Density 2.000EVegetation Areal Density 2.000E

mtb-needs to be 4.716E+08 when calculating Ground Plane Dose Factors** NRC Regulatory Guide l.109 deflt 0.7

E+06 secondsE+04 none2+06 seconds2-01 none2-01 none2+00 noneE+00 none

1+00 noneE+00 noneE+00 none2+06 seconds,+01 gnl/m32E-02 L/kg hrE+052E-01 LJkg2-07 I/secondsi-07 I/secondsE+01 kg/m22+02 kg/m22+00 none2+01 kg/day2+00 kglday2-01 noneE-01 noneE+00 noneE+00 none **

2+00 secondsE+08 seconds2+06 secondsE+06 secondsE+06 secondsE+00 seconds'+05 secondsE+04 seconds1+06 seconds+-00 secondsE+04 secondsE+05 secondsE+06 secondsE+00 seconds:+OO kg/m2:-oI kg/m2E+00 kg/m2+00 kg/m2+00 kg/m2

(cfs)(dw)(esf)(fg)(fi)(fi)

(fpg)(fsc)(fsg)(gst)

(c)(ksl)(Iv)(lwv)(Lw)(lwr)(mtv)(p )(P14)-(qfc)(qfg)(rI )(rp)(rr)(sf)(tb)(thl)(tei)(tern)(tev)(tfh3(tgm)(thi){thv)(ti)(tl)(tmc)(ts)(tw)(yiv)(yP)(ys)(ysv)6w)

RSP-0008 REV -12 PAGE 53 OF 103


TABLE G-2: STABLE ELEMENT TRANSFER FACTORS

NuclideH-3C-14NA-24P-32CR-51MN-54MN-56FE-55FE-59CO-57CO-58CO-60NI-63NI-65CU-64ZN-65ZN-69ZN-69MBR-82BR-83BR-84BR-85RB-86RB-88RB-89SR-89SR-90SR-91SR-92Y-90Y-9lMY-91Y-92Y-93ZR-95ZR-97NB-95NB-97MO-99TC-99MTC-101RU-103RU-105RU-106AG-llOM

Milk Cow1.OOOE-021.200E-024.OOOE-022.500E-022.200E-032.500E-042.500E-041.200E-031.200E-031.OOOE-03I.OOOE-031.OOOE-036.700E-036.700E-031.400E-023.900E-023.900E-023.900E-025.OOOE-025.000-025.OOOE-025.OOOE-023,OOOE-023.OOOE-023.OOOE-028.OOOE-048.OOOE-048.000E-048.OOOE-04.OOOE-05

1.OOOE-05l.OOOE-051.OOOE-051.OOOE-055.OOOE-065.000E-062.500E-032.500E-037.500E-032.500E-022.500E-021.OOOE-061.OOOE-061 .OOOE-065.OOOE-02

Milk Goat1.700E-011.OOOE-Ol4.OOE-022.500E-O12.200E-032.500E-042.500E-041.300E-041.300E-041.OOOE-031.OOOE-031.OOOE-036.700E-036.700E-031.300E-023.900E-023.900E-023.900E-025.000E-025.000E-025.OOOE-025.OOOE-023.OOOE-023.OOOE-023.000E-021.400E-021.400E-021.400E-021.400E-021.OOOE-05I.OOOE-051.OOOE-051.OOOE-05l.OOOE-055.OOOE-065.OOOE-062.500E-032.500E-037.500E-032.500E-022.500E-021.OOOE-06I.OOOE-06I.OOOE-065.OOOE-02

Meat1.200E-023.100E-023.OOOE-024.600E-022.400E-038.OOOE-048.OOOE-044.O0OE-024.OOOE-021.300E-021.300E-021.300E-025.300E-025.300E-028.000E-033.000E-023.000E-023 .000E-022.600E-022.600E-022.600E-022.600E-023.100E-023.IOOE-023.lOOE-026.OOOE-046.OOOE-046.OOOE-046.OOOE-044.600E-034.600E-034.600E-034.600E-034.600E-033.400E-023.400E-022.800E-OI2.800E-O18.OOOE-034.000E-014.OOOE-O14.OOOE-O14.000E-O14.OOOE-O11.700E-02

Veg./Soil4.800E+OO5.500E+OO5.200E-021. lOOE+OO2.500E-042.900E-022.900E-026.600E-046.600E-049.400E-039.400E-039.400E-031.900E-021.900E-021.200E-O I4.OOOE-Ol4.OOOE-O 14.000E-017.600E-Ol7.600E-Ol7.600E-017.600E-O I1.300E-O11.300E-O11.300E-O11.700E-021.700E-021.700E-021.700E-022.600E-032.600E-032.600E-032.600E-032.600E-031.700E-041.700E-049.400E-039.400E-031.200E-O12.500E-O12.500E-O15.000E-025.OOOE-025.000E-021.500E-O1

RSP-0008 REV - 12 PAGE 54 OF 103RSP-0008 REV-12 PAGE54OF1O3


TABLE G-2: STABLE ELEMENT TRANSFER FACTORSNuclide Milk Cow Milk Goat Meat Veg.ISoil

SB-124SB-125

TE-125MTE-127MTE-127

TE-129MTE-129

TE-131MTE-131TE-132I-130I-1311-1321-1331-134I-135

CS-134CS-136CS-137CS-138BA-139BA-140BA-141LA-140LA-142CE-141CE-143CE-144PR-143PR-144ND-147W-187NP-239

1.500E-031.500E-03l.OOOE-031.OOOE-031.OOOE-031.OOOE-031.00E-031.OOOE-03I.OOOE-03I.OOOE-036.OOOE-036.OOOE-036.00OE-036.000E-036.OOOE-036.OOOE-031E200E-021.200E-021,200E-021.200E-024.000E-044.OOOE-044.OOOE-045.000E-065.000E-06I.OOOE-04l.000E-04l.OOOE-045.OOOE-065.000E-065.OOOE-065.000E-045.000E-06

1.500E-031.500E-03l.OOOE-031.OOOE-031.OOOE-03l.OOOE-03I.OOOE-031.OOOE-03I.OOOE-031.OOOE-036.0OOE-026.OOOE-026.000E-026.OOOE-026.OOOE-026.OOOE-023.000E-013.OOOE-013.OOOE-013.OOOE-O14.OOOE-044.000E-044.O0OE-045.OOOE-065.OOOE-061.OOOE-041.OOOE-041.OOOE-045.OOOE-065.OOOE-065.OOOE-065.OOOE-045.OOOE-06

O.OOOE+00O.OOOE+OO7.700E-027.700E-027.700E-027.700E-027.700E-027.700E-027.700E-027.700E-022.900E-032.900E-032.900E-032.900E-032.900E-032.900E-034,000E-034.OOOE-034.OOOE-034.OOOE-033 .200E-033.200E-033 .200E-032.O0OE-042.OOOE-041.200E-031.200E-031.200E-034.700E-034.700E-033.300E-031.300E-032.OOOE-04

0.OOOE+00O.OOOE+001.300E+001.300E+001.300E+001.300E+001.300E+-001.300E+001.300E+001.300E+O02.OOOE-022.000E-022.OO0E-022.OOOE-022.OOOE-022.00OE-021.OOOE-02I .OOE-021 .OOOE-021.OOOE-025.OOOE-035.000E-035.OOOE-032.500E-032.500E-032.500E-032.500E-032.500E-032.500E-032.500E-032.400E-031.800E-022.500E-03

Units: Milk - days/literMeat - days/kgSoil - unitless

RSP-0008 REV- 12 PAGE 55 OF 103


TABLE G-3: BIOACCUMIJLATION FACTORS

TABLE G-3

BIOACCUMILATION FACTORS

Freshwater Freshwater Saltwater SaltwaterNuclide Fish Non-Fish Fish Non-Fish

H-3C-14NA-24P-32CR-51MN-54MN-56FE-55FE-59CO-57CO-58CO-60Nl-63NI-65CU-64ZN-65ZN-69ZN-69MBR-82BR-83BR-84BR-85RB-86RIB-88RB-89SR-89SR-90SR-91SR-92Y-90Y-91MY-91Y-92Y-93ZR-95ZR-97NB-95NB-97MO-99TC-99MTC-101RU-103RU-105RU-106AG-I lOM

9.OOOE-O14.600E+031.OOOE+02I.OOOE+052.OOOE+024.OOOE+024.OOOE+02I.OOOE+031.000E+025.OOOE+O15.OOOE+015.000E+O11.OOOE+021.OOOE+025.OOOE+012.OOOE+032.000E+032.OOOE+034.200E+024.200E+024.200E+024.200E+022.OOOE+032.OOOE+032.OOOE+033.OOOE+013.OOOE+013.OOOE+O13.000E+012.500E+O12.500E+O 12.500E+012.500E+O 12.500E+O13.300E+OO3.300E+O03.000E+043.OOOE+041 .OOOE+011.500E+O11.500E+O11.OOOE+O I1.OOOE+O11 .OOOE+I01O.OOOE+O0

9.OOOE-O I9. 100E+032.OOOE+022.OOOE+042.OOOE+039.OOOE+049.OOOE+043.200E+033.200E+032.OOOE+022.OOOE+022.OOOE+021.OOOE+021.OOOE+024.OOOE+021.OOOE+041.OOOE+041.OOOE+043.300E+023.300E+023.300E+023.300E+021.OOOE+031.OOOE+031.OOOE+031.OOOE+021.OOOE+021.OOOE+021.OOOE+021.OOOE+031.OOOE+031.OOOE+031.OOOE+031.OOOE+036.700E+O06.700E+OO1.OOOE+021.OOOE+021.OOOE+015.OOOE+005.000E+OO3.000E+023.000E+023.OOOE+02O.OOOE+OO

9.000E-O I1.800E+036.700E-022.900E+044.OOOE+025.500E+025.500E+023.OOOE+033.OOOE+031.OOOE+021.OOOE+021.OOOE+021.OOOE+021.OOOE+026.700E+022.OOOE+032.000E+032.00OE+-031.500E-021.500E-021.500E-021.500E-028.300E+4O8.300E+O08.300E+002.000E+O02.000E+O02.000E+OO2.000E+OO2.500E+Ol2.500E+OlI2.500E+OI2.500E+OI2.5001E+0l2.000E+022.000E+023.000E+043.000E+041.OOOE+O11.OOOE+011.OOOE+013.OOOE+0O3.OOOE+0O3.000E+O0O.OOOE+OO

9.300E-OI1.400E+031.900E-013.OOOE+042.OOOE+034.OOOE+024.OOOE+022.OOOE+042.OOOE+041l.OOOF+031.OOOE+031 .OOOE+032.500E+022.500E+021.700E+035.OOOE+045.OOOE+045.OOOE+043.100E+0O3.100E+O03.100E+O03.100lE+001.700E+0 11.700E+011.700E+012.000E+012.OOOE+O12.OOOE+012.OOOE+O11.OOOE+031.OOOE+031.OOOE+031 .OOOE+031 .OOOE+038.000E+018.OOOE+011.000+021.OOOE+021.OOOE+O I5.000E+O 15.000E+011.000E+031.OOOE+031.0003E+030.OOOE+00

RSP-0008 REV - 12 PAGE 56 OF 103


TABLE G-3: BIOACCUMULATION FACTORS

Nuclide,SB-124SB-125TE-125MTE-127MTE-127TE-129MTE-129TE-13 IMTE-131TE-132I-1301-1311-1321-133I-1341-135CS-134CS-136CS-137CS-138BA-139BA-140BA-141BA-142LA-140LA-142CE-141CE-143CE-144PR-143PR-144ND-147W-187NP-239RH-105

FreshwaterFish

O.OOOE+00O.OOOE+004.OOOE+024.000E+024.000E+024.000E+024.OOOE+024.OOOE+024.OOOE+024.000E+021.500E+O11,500E+O11.500E+O11.500E+O11.500E+O 11.500E+012.000E+032.OOOE+032.OOOE+032.000E+034.OOOE+OO4.OOOE+OO4.000E+OO4.OOOE+OO2.500E+012.500E+OIl.OOOE+OO1.OOOE+OO1.OOOE+O02.500E+012.500E+012.500E+O11.200E+031.OOOE+O11.OOOE+01

FreshwaterNon-Fish

O.OOOE+00O.OOOE+OO6.100E+036.100E+036. 100E+036.100E+036.100E+036.100E+036. IOE+036.100E+035.OOOE+OO5.OOOE+OO5.OOE+005.000E+OO5.OOOE+OO5.000E+OO1.OOOE+031.OOOE+03l.OOOE+031.OOOE+032.OOOE+022.000E+022.000E+022.OOOE+021.000E+031.OOOE+031.OOOE+031.OOOE+031.OOOE+031.OOOE+031.OOOE+03I .OOOE+031 .OOOE+O14.OOOE+023.OOOB+02

SaltwaterFish

O.OOOE+00O.OOOE+001.OOOE+031 .OOOE+O11.OOOE+O11.OOOE+011 .OOOE+011.OOOE+O11.OOOE+O1l .OOOE+0l1.OOOE+011.OOOE+O11.OOOE+O11 .OOOE+O11.OOOE+011.OOOE+014.OOOE+0 14.OOOE+OI4.OOOE+Ol4.000E+01l .OOOE+01l .OOOE+O11.OOOE+011.OOOE+O I2.500E+012.500E+O11.OOOE+01I .OOOE+O11.OOOE+O12.500E+012.500E+O12.500E+O13.OOOE+O11.OOOE+iO11 .OOOE+O1

-

SaltwaterNon-Fish

O.OOOE+OOO.OOOE+O0l.OOOE+021.OOOE+021.OOOE+02I.OOOE+021.OOOE+021.OOOE+021 .OOOE+021.OOOE+025.000E+O15.OOOE+O15.OOOE+O15.OOOE+O 15.OOOE+015.OOOE+O I2.500E+O12.500E+O I2.500E+O12.500E+O11.OOOE+021.OOOE+021.OOOE+021.OOOE+021.OOOE+031.OOOE+036.OOOE+026.OOOE+026.OOOE+02l.OOOE+031.OOOE+031.OOOE+033.OOOE+O1l .OOOE+012.OOOE+03

Units --> pCi/kg per pCi/liter

RSP-0008 RE -1 :PG 57O10RSP-0008 REV-12 PAGE57OFIO3


TABLE GC4: INDIVIDUAL USAGE FACTORS

TABLE G4

INDIVTDUAL USAGE FACTORS

Descripton Infant Child Teenager Adult Units

Fresh Non-fishDrinking WaterMilkShoreline Rec.Fresh FishFresh Leafy Veg.Stored Veg.hrrigated Veg.BreathingMeat

O.OOOE+003.300E+023.300E+02O.OOOE+OOO.OOOE+OOO.OOOE+OOO.OOOE+OOO.OOOE+OO1.400E+03O.OOOE+OO

1.700E+OO5.100E+023.300E+02I .400E+016.900E+OO2.600E+O15.200E+022.600E+013.700E+034.100E+O1

3.800E+OO5.100E+024.OOOE+026.700E+O11.600E+O14.200E+O16.300E+024.200E+O18.OOOE+036.500E+O1

5.OOOE+OO7.300E+023. 100E+021.200E+O12. 100E+O16.400E+O15.200E+026.400E+O18.OOOE+031.IOOE+02

kg/yearliters/yearliters/yearhours/year

kg/yearkg/yearkg/yearkg/yearm3/yearkg/year

RSP-0008 REV -12 PAGE 58 OF 103


TABLE H-i: ASSUMPTIONS/PARAMETERS FOR DOSES TO A MEMBER OF THE PUBLICINSIDE SITE BOUNDARY

TABLE H-1

NOTE

This table contains default location, distance, sector and duration information. Other locations and variablescould be used if they are more limiting and will be documented in the Annual Radiological Effluent Reportforthe applicable year if needed.

ASSUMPTIONS/PARAMETERS FOR DOSES TO AMEMBER OF THE PUBLIC INSIDE SITE BOUNDARY

MEMBER OF LOCATION DISTANCE (1) SECTOR DURATIONTHE PUBLIC METERS .HR/YEAR)

Private Driver North Parking Lot 275 N 125(3)

Employee Service Building 115(2) ENE 5

People Entering Alligator Bayou 2500 SW 40Site Without

Consent .

Casual Drivers Main Admin. 500 WNW 76(4)_ _Building .

(1) The approximate distance from main plant vent exhaust to location.(2) Midpoint of building.(3)An individual is assumed to be on site 0.25/hr in the morning and 0.25/br in the evening, 5

days per week, 50 weeks per year (0.5 hr/day *5 days/week * 50 weeks/year = 125 hours).(4)An individual is assumed to be on site .5 hr/day.(5) Liquid pathways dose is not considered due to nature of activities that individuals are engaged in.(6) Evaluate the dose, if applicable, to the National Guard/State Police while stationed on site as a

member of the public. Ij3/

RSP-0008 -- REV;- 12 PAGE 59 OF 103RSP-0008 REV-12 PAGE59OFIO3

ATTACHMENT 15PAGE 1 OF2

TABLE I-1: DOSE FACTOR TABLE: P (1) - ADULT, INHALATION

TABLE I-1DOSE FACTOR TABLE: P (1) - Adult, Inhalation

Units are mrem/yr per jCi/cu.m.Nuclide Bone Liver Tbody Thyroid Kidney

H-3 O.OOE+00 1.26E+03 1.26E+03 1.26E+03 1.26E+03C-14 1.82E+04 3.41E+03 3.41B+03 3.41E+03 3.418E+03NA-24 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04P-32 1.32E+06 7.71E+04 5.01B+04 O.OOE+00 O.OO+00CR-51 O.OO+00 O.OOE+800 1.00+02 5.95E+01 2.28E+01MN-54 O.OOE+00 3'96E+04 6.30E+03 0.00E+00 9.84E+03MN-56 O.OOE+00 1.24E+00 1.83E-01 O.OOE+00 1.30E+00FE-55 2.46E+04 1.70E+04 3.94E+03 O.OOE+00 O.OOE+00FE-59 1.18E+04 2.78E+04 1.06E+04 O.OOE+00 0.00+00CO-57 0.00+00 0.00E+00 O.OOE+00 0.00+00 O.OOE+00CO-S8 O.OOE+00 1.58E+03 2.07E+03 O.OOE+0O O.OOE+00CO-60 O.OOE+00 1.15E+04 1.48E+04 O.OOE+00 O.OOE+00NI-63 4.32E+05 3.14E+04 1.45E+04 O.OOE+OO O.OOE+0ONI-65 1.54E+00 2.108-01 9.12E-02 0.00+00 0.OOE+00CU-64 0.00+00 1.46E+00 6.15E-01 O.OOE+00 4.62E+O0ZN-65 3.24E+04 1.03E+05 4.66E+04 O.OOE+00 6.90E+04ZN-69 3.38E-02 6.51E-02 4.52E-03 O.OO+00 4.22E-02ZN-69M O.OOE+00 0.00+00 O.OOE+800 O.OOE+00 O.OOE+00BR-82 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00BR-83 O.OOE+00 O.OOB+00 2.41E+02 O.OOE+00 O.OOE+00BR-84 O.OOE+00 O.OOE+00 3.13E+02 O.OOE+00 0.00E+00BR-85 O.OOB+00 O.OOE+00 1.28E+01 O.OOE+00 O.OOE+00RB-86 O.OOE+00 1.35E+05 5.90E+04 O.OOE+00 O.OOE+00RB-88 O.OOE+00 3.87E+02 1.93E+02 O.OOE+00 O.OOE+00RB-89 0.0OE8+O 2.56E+02 1.70E+02 O.OOE+00 0.00E+OOSR-89 3.04E+05 0.00E+00 8.72E+03 O.OOE+00 O.OOBE+OSR-90 9.92E4-07 0.00E+00 6.10E+06 O.OOE+00 O.OOE+00SR-91 6.19E+01 O.OOE+00 2.50E+OO 0.OOE+00 000E+00SR-92 64E+EOO 0.00E+00 2.91E-01 O.OOE+00 0.00E+00Y-90 2.09E+03 0.00E+00 5.61E+OI 0.00E+00 O.OOE+00Y-91M 2.61E-0I O.OOE+00 1.02E-02 O.OOE+00 O.OO+00Y-91 4.62E+05 O.OOE+00 1.24E+04 O.OOE+00 O.OOE+00Y-92 1.03E+01 O.OOE+OO 3.02B-01 O.OOE+00 O.OOE+00Y-93 9.44E+01 O.OOB+00 2.61E+00 0.00E+00 O.OOE+00ZR-95 1.07E+05 3.44E+04 2.33E+04 0.008+00 5.42E+04ZR-97 9.68B+01 1.96E+01 9.04E+00 O.OOE+00 2.97E+01NB-95 1.41E+04 7.82E+03 4.2 1E+03 0.00+00 7.74E+03NB-97 O.OOE+00 O.OOE+00 O.OOE+00 0.00+00 O.OOE+00MO-99 O.OOE+00 1.21E+02 2.30E+01 O.OOE+00 2.91E+02TC-99M 1E03E-03 2.91E-03 3.70E-02 O.OOE+00 4.42E-02TC-101 4.18E-05 6.02E-05 5.90E-04 O.OOE+00 1.08E-03RU-103 1.53E+03 O.OOE+00 6.58E+02 O.OOE+00 5.83E+03RU-105 7.90E-01 O.OOE+00 3.11E-01 O.OOE+00 1.02E+00RU-106 6.91E+04 O.OOE+00 8.72E+03 O.OOE+00 1.34E+05AG-IIOM 1.08E+04 1.00E+04 5.94E+03 O.OOE+00 1.97E+04SB-124 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00SB-125, 0.00E+00 O.OO+00 O.OOE+00 O.OOE+00 O.OOE+00TE-125M 3.42E+03 1.58E+03 4.67E+02 1.05E+03 1.24E+,04TE-127M 1.26E+04 5.77E+03 1.57E+03 3.29E+03 4.58E+04TE-127 1.40E+00 6.42E-01 3.10E-01 1.06E+00 5.10E+00TE-129M 9.76E+03 4.67E+03 1.58E+03 3.44E+03 3.66E+04TE-129 4.98E-02 2.39E-02 1.24E-02 3.90E-02 1.87E-01

Lung GI Tract1.26E+03 1.26E+033.41 E+03 3.41E+031.02E+04 1.02E+04O.OOE+00 8.64E+041.44E+04 3.32E+031.40E+06 7.74E+049.44B+03- 2.02E+047.21E+04 6.03E+031.02E+06 1.88E+05O.OOE+00 O.OOE+009.28E+05 1.06E+055.97E+06 2.85E+051.78E+05 1.34E+045.60E+03 1.23E+046.78E+03 4.90E+048.64E+05 5.34E+049.208+02 1.63E+01O.OOE+00 O.OOE+00O.OOE+00 O.OOE+000.00+00 2.32E+02O.OOE+00 1.64E-030.00+00 8.00E-15O.OOE+00 1.66E+04O.OOE+00 3.34E-09O.OOE+00 9.28E-121.40B+06 3.50E+059.60E+06 7.22E+053.65E+04 1.91E+051.65B+04 4.30E+041.70E+05 5.06E+051.92E+03 1.33E+001.70E+06 3.85E+051.57E+04 7.35E+044.85B+04 4.22E+051.77E+06 1.50E+057.87B+04 5.23E+055.05E+05 1.04E+05O.OOE+00 O.OOB+009:12E+04 2.48E+057.64E+02 4.16E+033.99E+02 1.09E-I I5.05E+05 1.10E+051. IOE+04 4.82E+049.36E+06 9.12E+054;63E+06 3.02E+050.00E+00 O.OO+00O.OOE+00 O.OOE+003.14E+05 7.06E+049.60E+05 1.50B+056.15E+03 5.74E+041.16E+06 3.83B+051.94E+03 1.57E+02

SkinO.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+000.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOB+00O.OOB+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00o.ooe+0oO.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+OO0.00E+00O.OOE+00O.OOE+OOO.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+000.00E+000.00E+000.00E+000.00E+00O.OOE+00O.OOE+00

RSP-0008 - REV - 12 PAGE 60 OF 103RSP 000 . E -1 P. G. 6 0F..


TABLE I-1: DOSE FACTOR TABLE: P_) - ADULT, INHALATIONNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Sin

TE-131M 6.99E+01- 4.36E+01 2.90E+01 5.50O+01 3.09E+02 1.46E+05 5.56E+05 0.00E+00TE-131 1.11E-02 5.95E-03 3.59E-03 9.36E-03 4.37E-02 1.39E+03 1.84E+01 0.00E+00TE-132 2.60E+02 2.15E+02 1.628+02 1.90E+02 1.46E+03 2.88E+05 5.10E+05 0.00E+001-130 4.58E+03 1.34E+04 5.28E+03 1.14E+06 2.09E+04 0.OOE+00 7.69E+03 0.00E+001-131 2.52E+04 3.58E+04 2.05E+04 .19E+07 6.13E+04 0.00E+00 6.28E+03 0.00E+001-132 1.16E+03 3.26E+03 1.16B+03 1.14B+05 5.18E+03 0.00E+00 4.06E+02 0.OOE+'001-133 8.64E+03 1.48E+04 4.52E+03 2.15E+06 2.58E+04 0.00E+00 8.88E+03 0.00E+001-134 6.44E+02 1.73E+03 6.15E+02 2.98E+04 2.75E+03 0.00E+00 1.01E+00 0.00E+001-135 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.1 IE+04 0.00E+00 5.25E+03 0.00E+00CS-134 3.73E+05 8.48E+05 7.28E+05 0.00E+00 2.87E+05 9.76E+04 1.04E+04 0.00E+00CS-136 3.90E+04 1.46E+05 1.10E+05 0.008+00 8.56E+04 1.20E+04 1.17E+04 0.00E+00CS-137 4.78E+05 6.21E+05 4.28E+05 0.00E+00 2.22E+05 7.52E+04 8.40E+03 0.00E+00CS-138 3.31E+02 6.21E+02 3.24E+02 0.008+00 4.80E+02 4.86E+01 1.86E-03 0.00E+00BA-139 9.36E-01 6.66E-04 2.74E-02 0.00E+00 6.22E-04 3.76E+03 8.96B+02 0.00B+00BA-140 3.90E+04 4.90E+01 2.57E+03 0.008+00 1.67E+01 1.27E+06 2.18E+05 0.00E+00BA-141 1.00-E01 7.53E-05 3.36E-03 0.00E+00 7.00E-05 1.94E+03 1.16E-07 0.00E+00BA-142 2.63E-02 2.708-05 1.66E-03 0.00E+00 2.29E-05 1.19E+03 1.57E-16 0.00E+00LA-140 3.44E+02 1.74E+02 4.58E+01 0.00E+00 0.00E+00 1.36E+05 4.58E+05 0.00E+00LA-142 6.83E-01 3.10E-01 7.72E-02 0.00E+00 0.00E+00 6.338+03 2.11E+03 0.00E+00CE-141 1.99E+04 1.35E+04 1.53E+03 0.OOE+00 6.26E+03 3.62E+05 1.20E+05 0.008+00CE-143 1.86E+02 1.38E+02 1.53E+01 0.00E+00 6.08E+01 7.98E+04 2.26E+05 0.00E+00CE-144 3.43E+06 1.43E+06 1.84E+05 0.00E+00 8.48E+05 7.788+06 8.16E+05 0.00E+00PR-143 9.36E+03 3.75E+03 4.64E+02 0.00E+00 2.16E+03 2.81E+05 2.00E+05 0.00E+00PR-144 3.01E-02 1.25E-02 1.53E-03 0.00E+00 7.05E-03 1.028+03 2.15E-08 0.00E+00ND-147 5.27E+03 6.10E+03 3.65E+02 0.00E+00 3.56E+03 2.21E+05 1.73E+05 0.00E+00W-187 8.488+00 7.08E+00 2.48E+00 0.008+00 0.00E+00 2.90E+04 1.50E+05 0.008+00NP-239 2.308+02 2.26E+01 1.24E+01 0.008+00 7.00E+01 3.76E+04 1.19E+05 0.00E+00

RSP-0008- REIV - 12 PAGE 61 OF 103RSP-0008 REV-12 PAGE61OF1O3

ATTACHMENT 16PAGE I OF 2

TABLE 1-2: DOSE FACTOR TABLE: P (1) - TEEN, INHALATION

TABLE 1-2DOSE FACTOR TABLE: P (i) - Teen, inhalation,

Units are mrem/yr per j!Ci/cu.mNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin

H-3 O.OOE+OO 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 O.OOE+OOC-14 2.60E+04 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 O.OOE+OONA-24 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38Et04 1.38E+04 O.OOE+OOP-32 1.89E+06 1I.IOE+05 7.16E+04 O.OOE+ OE O.ooE+OO O.OOE+OO 9.28E-+04 O.OOE+OOCR-SI O.OOE+OO O.OOE4-OO 1.35E+02 7.50E+01 3.07E+01 2.10E+04 3.O0E+03 O.OOE+OOMN-54 O.OOE+OO S. 1 lE+04 8.40E+03 O.OOE+OO 1.27E*04 1.98E+06 6.68E+04 O.OOE+OOMN-56 O.OOE+OO 1.70E+00 2.52E-OI O.OOE--OO 1.79B+00 1.52E+04 5.74E+04 O.OOE+OOFE-55 3.34E+04 2.38E+04 5.54E+03 O.OOE+OO O.OOE+OO 1.24E+05 6.39E+03 O.OOE+OOPE-59 1.59E+04 3.70E+-04 1.43E+04 O.OOE+OO O.OOE+OO 1.53E+06 1.78E+05 - O.OOE+OOC0-57 O.OOE+OO O.QO+OO O.OOE+OO O.OO+00 O.OOE+OO O.OOE+OO O.OOEOO O.OOE+OO .OCO-58 O.OOE+OO 2.07E+03 2.78E+03 O.OOE+OO O.OOE+OO 1.34E+06 9.52E+04 O.OOE+OOC0-60 O.OOE+00 1.51 E+04 1.98E+04 0.OOE+0O O.OOE+O0 8.72E+06 2.59E+05 O.OOE+O0NI-63 5.80E+05 4.34E+04 1.98E+04 O.OOE+0O O.OOE+OO 3.07B+05 1.42E+04 0.OOE0+ONI-65 2.18E+00 2.93E-01 1.27E-O1 O.OOE+OO 0.OOE+OO 9.36E+03 3.67E+03 O.OOE+OOCU-64 O.OOE+00 2.03E+00 8.483301 O.OOE+O0 6.41E+0O 1. llE+04 6.14E+04 O.OOE+OOZN-65 3.86E+04 1.34E+05 6.24E+04 O.OOE+O0 8.64E+04 1.24E+06 4.66E+04 Q.OOE+OOZN-69 4.83E-02 9.20E-02 6.46E-03 O.OOE+OO 6.02E-02 1.58E+03 2.85E+02 0.OOE+OOZN-69M O.OOE+OO O.OOE+O0 O.OOE+OO O.OOE+OO O.OOE+IOO Q.OOE+O0 0.OOE+OO O.OOE+OOBR-82 O.OOE+OO 0.OOE+O0 0.00E+00 O.OOE+O0 O.OOE+00 O.0OE+O0 0OE-O0 0.OOE+00BR-83 O.OOE+OO O.OOE+OO 3.44E+02 O.OOE+OO O.OOE+O0 O.OOE+OO O.OOE+0O O.OOE+OOBR-84 0.OOt+OO O.OOE+O0 4.33E+02 0.OOE+0t O.OOEtOO O.OOE+OO O.OOE+OO O.OOE+OOBR-85 O.OOE+O0 O:OOE+O0 1.83E+O1 0.OOE+00 0.OOE+OO O.OOE+00 O.OOE+O0 0.OOB+00RB-86 O.OOE+OO 1.90E+05 8.40E+04 O.OOE+OO 0.OOE+0O O.OOE+0O 1.77E+04 O.OOE+OORB-88 O.OOE+O0 5.46E+02 2.72E+02 O.OOE+OO O.OOE+OO O.OOE+OO 2.92E-05 O.OOE+0ORB-89 O.OOE+O0 3.52E+02 2.33E+02 O.OOE+O0 O.OOE+O0 O.OOE+O0 3.38E-07 O.OOE+00SR-89 4.34E+05 O.OOE+OO 1.25E+04 0.OOE+0 O.OO+O0O 2.42E+06 3.71B+05 O.OOE+00SR-90 1.08E+08 0.OOE+OO 6.68E+06 O.OOB+OO O.OOE+OO 1.65E+07 7.65E+05 O.OOE+OOSR-91 8.80E+O1 0.OOE+OO 3.51E+O0 O.OOE+OO O.OOE+OO 6.07E+04 2.59E+05 O.OOE+OOSR-92 9.52E+OO O.OOB+00 4.06E-O1 0.OOE+0O O.OOE+O0 2.74E+04 1.19E+05 O.OOE+O0Y-90 2.98E+03 O.OOE+00 8.00E+01 O.OOE+OO O.OOE+OO 2.93E+05 5.59E+05 O.OOE+OOY-91M 3.70E-Ot O.OOE+0O 1.42E-02 O.OOE+O0 O.OOE+O0 3.20E+03 3.02E+0I 0.OOE+O0Y-91 6.61 E+05 O.OOE+O0 1.77E3+04 O.OOE+00 O.OOE+O0 2.94E+06 4.09E+0S O.OOE+O0Y-92 1.47E+O1 0.OOE+0O 4.29E-01 O.OOE+O0 O.OOE+OO 2.68E+04 1.65E+05 0.OOE+OOY-93 1.35E+02 O.OOE+OO 3.72E+00 O.OOE+O0 O.OOE+O0 8.32E+04 5.79E+O5 O.OOE+OOZR-95 1.46E+05 4.58E+04 3.15E+04 O.OOE+O0 6.74E+-04 2.69E+06 1.49E+05 O.OOE+OOZR-97 1.38E+02 2.72E+01 1.26E+O1 O.OOB+OO 4.12E+01 1.30E+05 6.30E+05 0.OOE+00NB-95 1.86E+04 1.03E+04 5.66E+03 O.OOE+OO l;OOE+04 7.51E+O5 9.68E+04 O.OOE+-0ONB-97 0.OOE+0O 0.OOE+O0 O.OOE+O0 O.OOE+OO O.OO O.OOE+OO O.OOE+O0 O.OOE+OOMO-99 0.OOE+O0 1.69E4-02 3.22E+01 0.OOE+00 4.1 1E+02 1.54E+05 2.69E+05 O.OOE+00TC-99M 1.38E-03 3.86E-03 4.99E-02 0.OOE+O0 5.76E-02 I.I5E+03 6.13E+03 0.OOE+OOTC1-01 5.92E-05 8.40E-OS 8.24E-04 O.OOE+OO 1.52E-03 6.67E+02 8.72E-07 O.OOE+OORU-103 2. 1OE+03 O.OOE+OO 8.96E,+02 O.OOE4-00 7.43E+03 7.83E+05 1.09E+O5 0.OOE+OORU-IOS 1.12E+OO O.OOE+OO 4.34E-O1 O.OOE+OO 1.41E+OO 1.82E4-04 9.04E+04 O.OOE+OORU-106 9.84E+04 O.OOE+OO 1.248+O4 O.OOE+OO I.90E+05 1.61E+07 9.60E+05 O.OOE+OOAG-1 1OM 1.38E+04 1.31E+04 7.99E+03 0.OOE+OO 2.50E+04 6.75E+06 2.73E+05 O.OOE+OOSB-124 O.OOE+OO O.OOE+ OO O.OOB+OO O.OOB+OO O.OOE+0O O.OOE+-O0SB-125, O.OOE+ O.OOE+OO O.OOE+OO O.OOB+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOTE-125M 4.88B+03 2.24E+03 6.67E+Q2 1.40E+03 O.OOE+0O 5.36E+O5 7.50E+-04 O.OOE+QOTE-127M 1.80E+04 8.16E+03 2.1.8E+03 4.38E+03 6.54E+04 1.66E+06 1.59E+05 QO00E+00TE-127. 2.01B4O0 9.12E-01 .4.42E-01 1.42E+OO 7.28E+00 1.12E+04 8.08E+04 O.OOE+OOTE-129M 1.39E+04 6.58E+03 2.25E+03.! . 4,58E+03 5.19E+04 1.98B+06 4.05E+05 O.OOE+OOTE-129 7.1OB-02 3.38E-02 1.76EA2 5.18E-02 2.66E-01 3.30E+03 1.62E+03 O.OOE+00

RSP-0008 REV -12 PAGE 62 OF 103


TABLE 1-2: DOSE FACTOR TABLE: P (1) - TEEN, INHALATIONNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin

TE-131M 9.84E+01 6.01E+01 4.02E+01 7.25E+01 4.39E+02 2.38E+05 6.21E+05 O.OOE+00TE-131 1.58E-02 8.32E-03 5.04E-03 1.24E-02 6.18E-02 2.34E+03 1.51E+01 O.OOE+00TE-132 3.60E+02 2.90E+02 2.19E+02 2.466+02 1.956+03 4.49B+05 4.63E+05 O.OOE+OO1-130 6.24E+03 1.79E+04 7.17E+03 1.49E+06 2.75E+04 O.OOE+00 9.12E+03 O.OOE+001-131 3.54E+04 4.91E+04 2.64E+04 1.466+07 8.40E+04 O.OOE+00 6.49E+03 O.OOE+001-132 1.59E+03 4.38E+03 1.58E+03 1.51E+05 6.92E+03 O.OOE+OO 1.27E+03 O.OOE+001-133 1.22E+04 2.05E+04 6.22E+03 2.92E+06 3.59E+04 0.00E+00 1.03E+04 0.00E+001-134 8.88E+02 2.32E+03 8.40E+02 3.95E+04 3.66E+03 O.OO+00 2.04E+01 0.00E+001-135 3.70E+03 9.44E+03 3.49E+03 6.2 1E+05 1.49E+04 O.OOE+00 6.95E+03 O.OOE+00CS-134 5.02E+05 1.13E+06 5.496+05 O.OOE+00 3.75E+05 1.46E+05 9.76E+03 O.OOE+00CS-136 5.15E+04 1.94E+05 1.37E+05 O.OOE+00 1.10E+05 1.78E+04 1.09E+04 O.OOE+00CS-137 6.70E+05 8.48E+05 3.11E+05 O.OOE+00 3.04E+05 1.21E+05 8.48E+03 O.OOE+00CS-138 4.66E+02 8.56E+02 4.46E+02 0.00E+00 6.62E+02 7.87E+01 2.70E-01 0.00E+00BA-139 1.34E+00 9.44E-04 3.90E-02. O.OOE+00 8.88E-04 6.46E+03 6.45E+03 0.006+00BA-140 5.47E+04 6.70E+01 3.52E+03 O.OOE+00 2.28E+01 2.036+06 2.29E+05 0.00E+00BA-141 1.42E-01 1.06E-04 4.74E-03 0.00E+00 9.84E-05 3.29E+03 7.46E-04 O.OOE+00BA-142 3.70E-02 3.70E-05 2.27E-03 0.006+00 3.14E-05 1.91E+03 4.79E-10 0.00E+00LA-140 4.79E+02 2.36E+02 6.26E+01 O.OOE+00 O.OOE+00 2.14E+05 4.87E+05 O.OOE+00LA-142 9.60E-01 4.25E-01 1.06E-01 O.OOE+00 O.OOE+00 1.02E+04 1.20E+04 0.00E+00CE-141 2.84E+04 1.906+04 2.17E+03 O.OOE+00 8.88E+03 6.14B+05 1.26E+05 O.OOE+00CE-143 2.66E+02 1.94E+02 2.16E+01 O.OOE+00 8.64E+01 1.30E+05 2.55E+05 O.OOE+00CB-144 4.89E+06 2.02E+06 2.62E+05 0.00E+00 1.21E+06 1.346+07 8.64E+05 0.00+00PR-143 1.34E+04 5.3 1E+03 6.62E+02 O.OOE+00 3.09E+03 4.83E+05 2.14E+05 O.OOE+00PR-144 4.30E-02 1.766-02 2.18E-03 0.00E+00 1.01E-02 1.75E+03 2.35E-04 O.OOE+00ND-147 .7.86E+03 8.566+03 5.136+02 0.00E+00 5.02E+03 3.72E+05 1.82B+05 0.00E+00W-187 1.20E+01 9.76E+00 3.43E+00 0.0OE+00 O.OO+00 4.74E+04 1.77E+05 O.OOE+00NP-239 3.38E+02 3.19E+01 1.77E+01 O.OOE+00 1.00E+02 6.49E+04 1.32E+05 0.00E+00

RSP-0008 REV - 12 PAGE 63 OF 103RSP-0008 REV-fl PAGE63OFIO3


TABLE 1-3: DOSE FACTOR TABLE: P (1) - CHILD, INHALATION

TABLE 1-3DOSE FACTOR TABLE: P (i) - CHILD, inhalation,

Units are mrenilyr per pCilcu.mNuclide Bone . Liver Tbody Thyroid Kiduey Lung GI Tract Skin

H-3 O.OOE+00 E12E+03 1.12E+03 1.12E+03 1.12E+03C-14 3.592+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03NA-24 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04P-32 2.60E+06 1.14E+05 9.88E+04 0,00E+00 O.OOE+00CR-51 0.002+00 O.OOE+00 1.54E+02 8.55E+01 2.43E+01MN-54 O.OO+00 4.29E+04 9.51E+03 0.00E+00 1.00E+04MN-56 O.OOE+00 1.66B+00 3.12E-01 O.OOE+00 1.672+00FE-55 4.74E+04 2.52E+04 7.77E+03 0.00E+00 0.0OE+O0FE-59 2.07E+04 3.34E+04 1.67E+04 O.OOE+00 0.00E+00CO-57 O.OOE+00 O.OOE+00 O.OOE+O0 0.00E+00 O.OOE+00CO-58 0.00E+00 1.77E+03 3.16E+03 O.OOE+00 O.OOB+00CO-60 O.OOE+00 1.31E+04 2.26E+04 0.00E+00 O.OOE+00NI-63 8.21E+05 4.63E+04 2.80E+04 0.00E+00 0.00E+00NI-65 2.99E+00 2.96E-01 1.64E-01 O.OOE+00 0.00E+00CU-64 O.OOE+00 1.99E+00 1.07E+OO O.OOE+00 6.032+00ZN-65 4.26E+04 1.13E+05 7.03E+04 O.OOE+00 7.14E+04ZN-69 6.70E-02 9.66E-02 8.92E-03 O.OOE+00 5.85E-02ZN-69M O.OOE+00O O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00BR-82 O.OOE+00O O.OOE+00 O.OOE+00 0.00E+00 0.00E+00BR-83 0.00E+00 O.OOE+00 4.74E+02 O.OOE+00 O.OOE+00BR-84 O.OOE+00 O.OOE+00 5.48E+02 O.OOE+00 O.OOE+00BR-85 0.00E+00 O.OOE+00 2.53E+01 O.OOE+00 0.OOE+00RB-86 O.OOE+00 1.98E+05 1.14E+05 O.OOE+00 O.OOE+00RB-88 0.00E+00 5.62E+02 3.66E+02 O.OOE+00 O.OOE+00RB-89 O.OOE+00 3.45E+02 2.90E+02 O.OOE+00 O.OOE+00SR-89 5.99E+05 0.00E+00 1.72E+04 O.OOE+00 O.OOE+00SR-90 I.01E+08 0.00E+00 6.44E+06 O.OOE+00 O.OOE+00SR-91 1.21E+02 0.00E+00 4.59E+00 O.OOE+00 O.OOE+00SR-92 1.3 1E+01 O.OOE+00 5.25E-01 O.OOE+00 O.OOE+00Y-90 4.1tE+03 O.OOE+O 1.11E+02 O.OOE+00 O.OOE+00Y-91M 5.07E-01 O.OO+00 1.84B-02 O.OOE+00 O.OOE+00Y-91 9.14E+05 O.OOE+00 2.44E+04 O.OOE+00 O.OOB+00Y-92 2.04E+01 O.OOE+00 5.81E-01 O.OOE+00 O.OOE+00Y-93 1.86E+02 O.OOE+00 5.1 1E+00 O.OOE+00 O.OO+00ZR-95 1.90E+05 4.18E+04 3.70E+04 O.OOE+00 5.96E+04ZR-97 1.88E+02 2.72E+01 1.60E+01 O.OOE+00 3.88EtOlNB-95 2.35B+04 9.18B+03 6.55E+03 O.OOE+00 8.62E+03NB-97 0.00E+00 O.OOE+00 O.OOE+0O O.OOE+00 O.OOE+00MO-99 0.002+00 1.72E+02 4.25E+01 O.OOE+00 3.92E+02TC-99M 1.78E-03 3.48E-03 5.77E-02 O.OOE+00 5.07E-02TC-101 8.10E-05 8.51E-05 1.08E-03 O.OOE+00 1.45E-03RU-103 2.79E+03 O.OOE+00 1.07E+03 O.OOE+00 7.03E+03RU-105 1.532+00 O.OO+00 5.55E-01 O.OOE+00 1.34E+00RU-106 1.36E+05 0.O02+0O 1.69E+04 O.OOE+00 1.84E+05AG-1IOM 1.69E+04 1.14E+04 9.14E+03 O.OOE+00 2.12E+04SB-124' O.0OE+00 0.OOE+O0 0.00E+00 0.OOE+O0 0.002+00SB-125 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+000 0.002+0TE-125M 6.73E+03 2.332+03 9.14E+02 1.922+03 0.00E+00TE-127M 2.49E+04 8.552+03 3.02E+03 6.07E+03 6.36E+04TE-127 2.77E+00 9.51B-01 6.10B-01 1.96E+00 7.07E+00TE-129M 1.92B+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04TE-129 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01.

1. 12E+036.73E+031.61E+04O.OOE+001.70E+041.58E+061.31E+041.11E+051.27E+060.OOE+001.1 1E+067.07E+062.75E+058.18E+039.58E+039.95E+051.42E+030.OOE+000.00E+00O.OOE+O0O.OOE+00O.OOE+00O.OOE+000.002+00O.OOE+00OO2.16E+061.48E+075.33E+042.40E+042.62E+052.81E+032.63E+062.39E+047.44E+042.23E+061.13E+056.14E+05O.OOE+001.35E+059.51E+025.85E+026.62E+051.59E+041.43E+075.48E+06O.OOE+00O.OOE+004.77E+051.48E+061.00E+041.76E+062.93E+03

1.12E+03 0.00+006-73E+03 O.OOB+001.61E+04 O.OOE+004.22E+04 O.OOE+001.08E+03 0.002+002.29E+04 O.OOE+001.23E+05 O.OOE+002.87E+03 O.OOE+007.07E+04 O.OOE+00O.OOE+00 O.OOE+003.44E+04 O.OOE+009.62E+04 O.OOE+006.33E+03 O.OOE+008.40E+04 O.OOE+003.67E+04 O.0E+001.63E+04 0.00E+001.02E-04 O.OOE+000.00E+00 O.OOE+000.OOE+00 O.OOE+00O.OOE+00 0.OOE+00O.OOE+00 0.00E+00O.OOE+00 O.OOE+007.992+03 O.OOE+001.72E+01 O.OOE+001.89E+00 0-.00E+001.67E+05 O.OOE+003.43E+05 O.OOE+001.74E+05 O.OOE2002.42E+05 O.OOE+002.68E+05 O.OOE+001.72E+03 0.002+001.84E+05 O.OOE+002.39E+05 0.00E+003.89E+05 O.OOE+006.11 E+04 0.00E+003.51E+05 O.OOE+003.70E+04 0.002+00O.OOE+00 0.00E+001.27E+05 0.00E+004.812+03 O.OO+001.63E+01 O.OOE+004.48E+04 O.OOE+009.95E+04 O.OOE+004.29E+05 O.OOE+001.00E+05 O.OOE+00O.OOE+00 O.OOE+00O.OOE+00 O.OOE+003.38E+04 O.OOE+007.14E+04 O.OOE+005.62E+04 O.OOE+001.82E+05 O.OOE+002.55E+04 O.OOB+00

RSP-0008 REV- 12 PAGE 64 OF 103


TABLE I-3: DOSE FACTOR TABLE: P (I - CHILD, INHALATIONNuclide Bone Liver Tbody Thyroid Kidney . Long GI Tract Skin

TE-131M 1.34E+02 5.92E+01 5.07B+01 9.77E+01 4.00E+02TE-131 2.17E-02 8.44E-03 6.59E-03 1.70E-02 5.88E-02TE-132 4.818+02 2.72E+02 2.63E+02 3.17E+02 1.77E+031-130 8.18E+03 1.64E+04 8.44E+03 1.85E+06 2.45E+041-131 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88E+041-132 2.12E+03 4.07E+03 1.88E+03 1.94E+05 6.25E+031-133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+041-134 1.17E+03 2.16E+03 9,95E+02 5.07E+04 3.30E+031-l35 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04CS-134 6.51E+05 1.0IE+06 2.25E+05 O.OOE+00 3.30E+05CS-136 6.51E+04 1.71E+OS 1.16E+05 O.OOE+00 9.55E+04CS-137 9.07E+05 8.25E+OS 1.28+05 O.OOE+00 2.82E+05CS-138 6.33E+02 8.40E+02 5.55E+02 0.00E+00 6.22E+02BA-139 1.84E+00 9.84E-04 5.36E-02 O.OOE+00 8.62E-04BA-140 7.40E+04 6.48E+01 4.33E+03 O.OOE+00 2.1 1E+OIBA-141 1.96E-01 1.09E-04 6.36E-03 O.OOB+00 9.47E-05BA-142 4.99E-02 3.60E-05 2.79E-03 O.OOE+00 2.91E-05LA-140 6.448±02 2.25E+02 7.55E+01 O.OOE+00 O.OOE+00LA-142 1.29E+00 4.11E-01 1.29E-01 0.008+O0 0.008+O0CE-141 3.92E+04 1.95E+04 2.90E+03 O.OOE+00 8.55E+03CE-143 3.66E+0Z 1.99E+02 2.87E+01 O.OOE+00 8.36B+01CE-144 6.77E+06 2.128+06 3.618+05 O.OOE+00 1.17E+06PR-143 1.85E+04 5.558+03 9.14E+02 O.OOE+00 3.00E+03PR-144 5.96E-02 1.85E-02 3.00E-03 0.00+00 9.77E-03ND-147 1.08E+04 8.73E+03 6.81E+02 O.OOE+00 4.81E+03W-187 1.63E+01 9.66E+00 4.33E+00 O.OOE+00 O.OOE+00NP-239 4.66E+02 3.34E+01 2.35E+01 0.008+00 9.73E+01

2.06E+05 3.08E+052.05E+03 1.33E+033.77E+05 1.38E+05O.OOE+00 S. I1B+03O.OOE+00 2.84E+030.00E+00 3.20E+03O.OOE+00 5.48E+03O.OOE+00 9.55E+02O.OOE+00 4.44E+031.2 1E+05 3.85E+031.45E+04 4.188+031.04E+05 3.62E+036.81E+01 2,70E+025.77E+03 5.77E+041.74E+06 1.028+052.92E+03 2.75E+021.64E+03 2.74E+001.83E+05 2.26E+058.70E+03 7.59E+045.44E+05 5.66E+041.15E+05 1.27E+051.20E+07 3.89E+054.33E+05 9.73E+041.57E+03 1.97E+023.28E+05 8.21E+044.11E+04 9.10E+045.81E+04 6.40E+04

0.00E+00O.OOE+00O.OOE+000.00+00O.OOE+00O.OOE+00O.OOE+00O.OOE+OOO.OOE+00O.OOE+000.OOE+00O.OOE+00O.OOE+OO0.00+00O.OE+00O.OOE+OOO.OOE+00O.OOB+OOO.OOE+00O.OOE+00O.OOE+000.00+00O.OOE+00O.OOE+000.00+00O.OOE+000.00o+00

RSP-0008 REV - 12 PAGE 65 OF 103.

ATTACHMENT 18PAGE 1 0F2

TABLE 1-4: DOSE FACTOR TABLE: P (1) - INFANT, INHALATION

TABLE 1-4DOSE FACTOR TABLE: P (i) - Infant, Inhalation,

Units are mrem/yr per CiL/cu.mNuclide Bone Liver Thody Tbyroid Kidney Lung GI Tract Skdn

H-3 O.OOE+00 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.473+02 O.OOE+00C-14 2.65E+04 5.31E+03 5.31E+03 5.31E+03 5.31E+03 5.31E+03 5.31E+03 O.OOE+00NA-24 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 O.OOE+00P-32 2.03E+06 1.12E+05 7.74B+04 O.OOE+00 0.00E+00 O.OOE+00 1.61E+04 O.OOE+00CR-51 O.OOE+00 O.OOE+00 8.95E+01 5.75E+01 1.32B+01 1.28E+04 3.57E+02 O.OOE+00MN-54 O.OOE+00 2.53E+04 4.98E+03 0.00E+00 4.98E+03 1.00E+06 7.06E+03 0.OOE+00MN-56 0.00E+00 1.54B+00 2.21E-01 0.00E+00 1.10E+00 1.25E+04 7.17E+04 O.OOE+00FB-55 1.97E+04 1.17B+04 3.33E+03 O.OOE+00 0.00B+00 8.69E+04 I.09E+03 O.OOE+00FP-59 1.36E+04 2.35E+04 9.48E+03 0.00E+00 O.OOE+00 1.02E+06 2.48E+04 0.00E+00CO-57 O.OE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+OO O.OOE+00 0.00E+00 O.OOE+00CO-58 O.OOE+00 1.22E+03 1.82E+03 O.OOB+00 0.008+00 7.77E+05 1.11+04 O.OOE+00CO-60 O.OOE+00 8.02E+03 1.18E+04 O.OOE+0O 0.00E+00 4.51E+06 3.19E+04 O.OOE+00NI-63 3.39E+05 2.04E+04 1.16E+04 O.OOE+00 0.00+00 2.09E+05 2.42E+03 O.OOE+00NI-65 2.39E+00 2.84E-01 1.23E-01 O.OOE+00 O.OOE+00 8. 12E+03 5.01E+04 O.OOE+00CU-64 O.OOE+00 1.88E+00 7.74E-01 O.OOE+CO 3.98E+00 9.30E+03 1.50E+04 O.OOE+00ZN-65 1.93E+04 6.26E+04 3.11E+04 O.OOE+00 3.25E+04 6.47E+05 5.14E+04 0.00E+00ZN-69 5.39E-02 9.67E-02 7.18E-03 O.OOE+00 4.02E-02 1.47E+03 1.32E+04 0.00E+00ZN-69M 0.00+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 O.OOE+00BR-82 0.00+00 O.OOE+00 0.OOB+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OO.+00 0.00+00BR-83 O.OOE+00 O.OOE+00 3.81E+02 O.OOE+00 O.OOE+00 O.OOE+00 0.008+00 O.OOE+00BR-84 O.OOE+00 0.00E+00 4.00E+02 0.0OE+00 0.008+OO O.OOE+00 O.OOE+00 O.OOB+00BR-85 O.OOE+00 0.00E+00 2.04E+01 O.OOE+00 0.008+00 O.OOE+00 0.00E+00 O.OOE+00RB-86 O.OOE+00 1.90E+05 8.82E+04 O.OOE+00 O.OOE+00 O.OOE+00 3.04E+03 0.00+00RB-88 O.OOE+00 5.57E+02 2.87E+02 O.OOE+00 0.00E+00 0.OOE+00 3.39E+02 0.008+00RB-89 0.OOE+00 3.21E+02 2.06E+02 O.OOE+00 O.OOE+00 O.OOE+00 6.82E+01 O.OOE+00SR-89 3.98E+05 O.OOE+00 1.14E+04 O.OOE+00 0.00E+00 2.03E+06 6.40E+04 0.OOE+00SR-90 4.09E+07 0.00E+00 2.59E+06 0.00E+00 O.OOE+00 1.12E+07 1.31E+05 0.00E+00SR-91 9.56B+01 O.OOE+00 3A6E+00 O.OOE+00 . O.OOE+00 5.26E+04 7.34E+04 O.OOE+00SR-92 1.05B+01 O.OOB+00 3.91E-01 O.OOE+00 O.OOE+00 2.38E+04 1.40E+05 0.00E+00Y-90 3.29E+03 O.OOE+00 8.82E+01 O.OOE+00 O.OOE+00 2.69E+05 1.04E+05 O.OOE+00Y-91M 4.07E-01 O.OOE+00 1.39E-02 O.OOE+00 0.00E+00 2.79E+03 2.35E+03 O.OOE+00Y-91 5.88E+05 O.OOE+00 1.57E+04 O.OOE+00 O.OOE+00 2.45E+06 7.03E+04 0.00E+00Y-92 1.64B+01 O.OOE+00 4.61E-01 O.OOE+00 0.00+00 2.45E+04 1.27E+05 0.0OE+00Y-93 1.50E+02 O.OOE+00 ,4.07E+00 0.00+00 O.OOE+00 7.64E+04 1.67E+05 O.OOE+00ZR-95 1.15E+05 2.?9E+04 2.03E+04 0.00E+00 3.11E+04 - 1.75E+06 2.17E+04 O.OOE+00ZR-97 1.50+02 2.56E+01 1.17E+01 0.OOE+00 2.59E+oi 1.10E+05 1.40E+05 O.OOE+00NB-95 1.57E+04 6.43E+03 3.78E+03 O.OOE+00 4.72E+03 4.79E+05 1.27E+04 0.00E+00NB-97 O.OOE00 0:00-+00 O.OOE+00 O.OOE+00 O.OOE00 0.00+00 0.00+OO O.OOE+00MO-99 O.OOE+OO 1.65E+02 3.23E+01 O.OOE+00 2.65E+02 1.35E+05 4.87B+04 0.00+00TC-99M 1.40E-03 2.88E-03 3.72E-02 0.00E+OO 3.11E-02 8.11-+02 2.03E+03 O.OOE+00TC-lOI 6.51E-05 8.23E-05 8.12E-04 0.OOE+00 9.79E-04 5.84E+02 8.44E+02 0.00E+00RU-103 2.02E+03 O.OOE+00 6.79E+02 0.00E+00 4.24E+03 5.52E+05 1.61E+04 0.00E+00RU-I05 1.22E*00 O.OOE+00 4.10E-01 O.OOE+00 8.998-01 1.57E+04 4.84E+04 O.OOE+00RU-106 8.68E+04 O.OOE+00 1.09B+04 O.OOE+00 1.07E+05 1.16E+07 1.64E+05 0.0OE+00AG-I IOM 9.98E+03 7.22E+03 5.00E+03 O.OOE+00 1.09E+04 3.67E+06 3.30E+04 0.00E+00SB-124, O.OOE+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE*+00 0.00+O0 0.00E+00 O.OOE+00SB-125 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00TE-125M 4.76E+03 1.99E+03 6.58E+02 1.62E+03 0.00E+00 4A7E+05 1.29E+04 O.OOE+00TE-127M 1.67E+04 6.908+03 2.07E+03 '4.87E+03 3.75E+04 1.31E+06 2.73E+04 O.OOE+00TE-127 2.23E+00 9.53E-01 4.89E-01, 1;85E+00 4.86B+00 1.03E+04 2.44E+04 O.OE*+00TI-129M 1.41E+04 6.09E+03 2.23E+03 5.47E+03 3.18E+04 1.68E+06 6.90E+04 0.00E+00TE-129 7.88E-02 3.47E-02 1.88E-OZ 6.75E-02 1.75E-01 3.00E+03 2.63E+04 0.00E+00

RSP-0008 REV- 12 PAGE 66 OF 103

ATTACHIMENT 18PAGE 2 OF 2

TABLE 14: DOSE FACTOR TABLE: P (1) - INFANT, INRALATIONNuclide Bone Liver Thody Thyroid Kidney Lung GI Tract Sldn

TE-131MTE-131TE- 1321-1301-1311-1321-1331-1341-135CS-I134CS-136CS-137CS-138BA-139BA-140BA-141BA-142LA-140LA- 142CE-141CE-143CE-144PR-I 43PR-144ND-147W-187NP-239

1.07E+02 5.50B+011.74E-02 8.22E-033.72B+02 2.37E+026.36E+03 1.39E+043.79E+04 4.44E+041.69E+03 3.54E+031.32E+04 1.92E+049.21E+02 1.88E+033.86E+03 7.60E+033.96E+05 7.03E+054.83E+04 1.35E+055.49E+05 6.12E+055.05E+02 7.81E+021.48E+00 9.84E-045.60E+04 5.60E+011.57}-01 1.08E-043.98E-02 3.30E-055.05E+02 2.OOE+021.03E+00 3.77B-012.77E+04 1.67E+042.93E+02 1.93B+023.19E+06 1.216+061.40E+04 5.24E+034.796-02 1.856-027.94E+04 8.13E+031.30E+01 9.02E+003.71E+02 3.32E+01

3.63E+015.00E-031.76E+025.576+031.96E+041.26E+035.60E+036.65E+022.77E+037.45E+045.29E+044.55E+043.98E+024.30E-022.90E+034.97E-031.96E-035.15E+019.04E-021.99E+032.21E+O11.76E+056.99E+022.41E-035.00E+023.12E+001.88B+01

8.936+01 2.65E+021.58E-02 3.99E-022.79E+02 1.03E+031.60E+06 1.53E+041.48E+07 5.18E+041.69E+05 3.95E+033.56E+06 2.24E+044.45E+04 2.90E+036.96E+05 8.47E+03O.OOE+00 1.906+05O.OOE+00 5.64E+040.OOE+00 1.72E+050.OO+00 4.10E+020.OOE+00 5.92E-040.00E+00 1.34E+01O.OOE+00 6.50B-05O.OOE+00 1.90E-05O.OOE+00 O.OOE+000.00E+00 0.00+00O.OOE+00 5.25E+030.00E+00 5.64E+010.00E+00 5.38E+05O.OOE+00 1.97E+03O.OOE+00 6.72E-02O.OOE+00 3.15E+03O.OOE+00 0.00E+000.00+00 6.62E+01

1.99E+052.06E+033.40E+OSO.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+007.97E+041.18E+047.13E+046.54E+015.95E+031.60E+062.97E+031.55E+031.68E+058.22E+035.17E+051 .16E+059.84E+064.33E+051.61E+033.22E+053.96E+045.95B+04

1.19E+058.22E+034.41E+041.99E+031.06E+031.90E+032.166+031.29E+031.83E+031.33E+031.43E+031.33E+038.76E+025. 1 OE+043.84E+044.75E+036.93E+028.48E+045.95E+042.16E+044.97E+04IA8E+053.72E+044.28E+033.12E+043.56E+042.49E+04

0.00E+000.00±+000.00E+000.00+00O.OOE+00O.OOB+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00+00O.OOE+000.00+000.00+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+000.00+00O.OOE+00

IRSP-0008 REV- 12 PAGE 67 OF 103


TABLE 1-5: DOSE FACTOR TABLE: R (I) - ALL, GR. PLANE

TABLE I-5DOSE FACTOR TABLE: R (i) -All, gr. plane,

Units are ml*mremlyr per pxCilsecNaclide Bone Liver Tbody Thyroid Kidne . Lung GI Tract Skin

H-3 O.OOE+00 0.008E+O00 0.008+00 .OOE+OO 0.00+00 0.00+00 0.OE+OO O.OOE+00C-14 O.OOE+00 0.008+00 0.00+00 0.008+00 0.OOE+00 0.00+00 0.008+00 0.00E+00NA-24 1.198+07 1.19E+07 1.19E+07 1.19t+07 1.19E+07 1.198+07 1.19E+07 I.39E+07P-32 O.OOE+00 0.008+00 0.OOE+OO 0.008+00 0.008+00 0.00+00 0.00E+00. O.OOE+00CR-51 4.66E+06 4.66E+06 4.66E+06 4.668+06 4.66E+06 4.668+06 4.668+06 5.518+06MN-54 1.39E+09 1.398+09 1.39t+09 1.398+09 1.398+09 1.398+09 1.39E+09 1.628+09MN-56 9.03E+05 9.038+05 9.038+05 9.038+05 9.03E8+05 9.038+05 9.038+05 1.07E+06FE-55 .OOE+00 0.008+00 0.006+00 0.00+00 0.008E+00 O.OOE+OO 0.008+00 O.OOE+O0FE-59 2.73E+08 2.738+08 2.736+08 2.738+08 2.73E+08 2.732+08 2.73E+08 3.21E+08CO-57 O.OOE+00 0.0OE+00 0.006+00 O.OOE+00 0.006+00 0.006+00 0.008+00 O.OOE+00CO-58 3.79B+08 3.79E+08 3.79E+08 3.79E+08 3.79E+08 3.79E+08 3.798+08 4.44E+08CO-60 2.15E+10 2.15E+10 2.156+10 2.158+10 2.158+10 2.156+10 2.158+10 2.53E+10NI-63 0.00+00 O.OOE+00 0.006+O00 O.OOE+00 0.008+00 O.OOE+00 0.008+00 O.OE+00NI-65 2.976+05 2.97E+05 2.97t+05 2.978+05 2.97E+05 2.976+05 2.97E+05 3.458+05CU-64 6.078+05 6.07E+05 6.07E+05 6.07t+05 6.07E+05 6.076+05 6.078+05 6.88E+05ZN-65 7.47E+08 7.47E+08 7.47E+08 7.476+08 7.47E+08 7.47E+08 7.48E+08 8.59E+08ZN-69 0.008+00 O.OO+00 O.OOE+00 O.OOE+00 0.008+00 O.OOE+00 O.OO+00 0.008+00ZN-69M O.OOE+00 0.0OE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+000 0.008+00 O.OE+00BR-82 0.008+00 0.00E+00 0.006+00 0.006+00 0.008+00 0.00+00 O.OOE+00 0.00+00.BR-83 4.87E+03 4.87E+03 4.878+03 4.878+03 4.876+03 4.878+03 4.87E+03 7.08E+03BR-84 2.038+05 2.03E+05 2.03E+05 2.038+05 2.03E+05 2.03E+05 2.038+05 2.36E+05BR-85 0.008+00 O.OOE+00 0.006+00 0.00+00 0.008+00 0.006+00 0.008+00 0.00+00RB-86 8.998+06 8.998+06 8.996+06 8.998+06 8.99E+06 8.998+06 8.998+06 1.03E+07RB-88 3.318+04 3.31E+04 3318+04 3.31t+04 3.31E+04 3.316+04 3.31E+04 3.78E+04RB-89 1.23E+05 1.23E+05 1.236+05 1.23t+05 1.23E+05 1.23E+05 1.238+05 1.48E+05SR-89 2.162+04 2.168+04 2.16E+04 2.168+04 2.16E+04 2.16E+04 2.168+04 2.51E+04SR-91 2.158+06 2.158+06 2.156+06 2.15E+06 2.158+06 2.15E+06 2.15E+06 2.51E+06SR-92 7.778+05 7.77E+05 7.77E+05 7.776t+05 7.77E+05 7.77E+05 7.778+05 8.638+05Y-90 4.49E+03 449E+03 4.49E+03 4.498+03 4.49E+03 4.498+03 4.498+03 5.316+03Y-91M 1.00E+05 1.008+05 1.008+05 1006+05 1.008+05 1.008+05 1.00E+05 1.16E+05Y-91 1.07E+06 1.07E+06 1.07E+06 1.078+06 1.07E+06 1.078+06 1.07E+06 1.21E+06Y-92 1.808+05 1.808+05 1.80E+05 1.80E+05 1.80E+05 1.80E+05 .1.80E+05 2.148+05Y-93 1.83E+05 1.83E+05 1.838+05 1.83E+05 1.83E+05 1.83E+05 1.838+05 2.518+05ZR-95 2.45E+08 2.458+08 2.45E+08 2.45E+08 2.45E+08 2.45E+08 2.458+08 2.84E+08ZR-97 2.968+06 2.968+06 2.96E+06 2.96E+06 2.96E+06 2.968+06 2.968+06 3.448+06NB-95 1.37E+08 1.378+08 1.378+08 1.376+08 1.37E+08 1.378+08 1.37E+08 1.61E+08NB-97 O.OOE+00 0.0OE+00 0.008+00 O.OOE+00 0.008+00 O.OOE+00 0.00E+00 O.OOE+00MO-99 3.998+06 3.996+06 3.998+06 3.99E+06 3.99E+06 3.99E+06 3.998+06 4.63E+06TC-99M 1.848+05 1.84B+05 1.84E+05 1.846+05 1.846+05 1.84E+05 1.84E+05 2.11E+05TC-101 2.048+04 2.048+04 2.048+04 2.04E+04 2.04E+04 2.04E+04 2.048+04 2.268+04RU-103 1.086+08 1.08E+08 1.088+08 1.088+08 1.08E+08 1.086+08 1.088+08- 1.268+08RU-105 6.368+05 6.36E+05 6.366+05 6.368+05 6.368+05 6.36E+05 6.368+05 7.21E+05RU-106 4.228+08 4.228+08 4.226+08 4.228+08 4.228+08 4.228+08 4.228+08 5.078+08AG-11OM 0.006+00 0.008+00 0.00E+00 0.0063+00 0.008+00 0.008+00 O.OOE+00 4.016+09SB-124 0.00E+00 0.008+00 O.OOE6+00 0.008E+00 0.00+00 O.OOE+00 0.00E+00 0.008+00S1-125' 0.008+00 O.OOE600 O.OOE+00 O.OOE+00 0.008+00 0.00E+00 O.OOE+00 O.OOE+00TE-125M 1.558+06 1.556+06 1.558+06 1.5SE+06 1.558+06 1.55E+06 1.55E+06 2.13E+06TB-12iM 9.16E+04 9.166+04 9.166+04 9.16E+04 9.16E+04 9.162+04 9.16E+04 1.08E+05TE-127 2.98E+03 2.98E+03 2.988+03 2.98E+03 2.98E+03 2.98E+03 2.986+03 3.288+03TE-129M 1.98E+07 1-.986+07 1.982+07 1.98E+07 1.988+07 1.98E+07 1.98E+07 2.31E+07TE-129 2.628+04 2.628+04 2.628+04 2.628+04 2.62E+04 2.62E+04 2.62E+04 . 3.10E+04

RSP-0008 REV- 12 PAGE 68 OF 103


TABLE 1-5: DOSE FACTOR TABLE: R (1) - ALL, GR. PLANENuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Sldn

TE-lilM 8.03E+06TE-131 2.92E+04TE-132 4.23E+061-130 5.SIE+061-131 1.72E+071-132 1.25E+061-133 2.45E+061-134 4.47E+051-135 2.53E+06CS-134 6.86E+09CS-136 1.51E+08CS-137 1.03E+10CS-138 3.59E+05BA-139 1.06B+05BA-140 2.05E+07BA-141 '4.17E+04BA- 142 4.49B+04LA-140 1.92E+07LA-142 7.60E+05CE-141 1.37E+07CE-143 2.31E+06CE-144 6.95E+07PR-143 O.OOE+00PR-144 1.83E+03ND-147 8.39E+06W-187 2.35E+06NP-239 1.71E+06

8.03E+062.92E+044.23E+065.51E+061.72E+071.25E+062.45E+064.47E+052.53E+066.86B+091.51E+081.03E+103.59E+051.06E+052.05E+074.17E+044.49E+041.92E+077.60E+051.37E+072.3 IE+066.95E+07O.OOE+001.83E+038.39E+062.35E+061.71E+06

8.03E+062.92E+044.23E+065.51E+061.72E+071.25E+062.45E+064.47E+052.53E+066.86E+091.51E+081.03E+103.59E+051.06E+052.05E+074.17E+044.49E+041.92E+077.60E+051.37E+072.318+066.95E+07O.OOE+001.83E+038.39E+062.35E+061.71E+06

8.03E+062.92E+044.23E+065.5 1E+061.72E+071.25E+062.45E+064.47E+052.53E+066.86E+091.51E+081.03E+103.59E+051.06E+052.05E+074.17E+044.49E+041.92E+077.60E+051.37E+072.31E+066.95E+070.0OE+001.83E+038.39E+062.35E+061.71E+06

8.03E+062.92E+044.23E+065.5 IE+061.72E+071.25E+062.45E+064.47E+052.53E+066.86E+091.51E+081.03E+103.59E+051.06E+052.05E+074.17E+044.49E+041.92E+077.60E+051.37E+072.31E+066.95E+07O.OOE+00

8.03E+062.92E+044.23E+065.5 1 E+061.72E+071.25E+062.45E+064.478+052.53E+066.86E+091.5 1E+081.03E+103.59E+051.068+052.05E+074.17E+044.49E+041.92E+077.60E+051.37E+072.31E+066.95E+07O.OOE+00

8.03E+062.92E+044.23E+065.51 E+061.72E+071.25E+062.45E+064.47E+052.53E+066.86E+091.51E+081.03E+103.59E+051.068+052.05E+074.17E+044.49E+041.92E+077.60E+051.37E+072.31E+066.95E+07O.OOE+001.83E+038.39E+062.35E+061.71 E+06

9.46E+063.45E+074.98E+066.69E+062.09E+071.46E+062.98E+065.30E+052.95E+068.00E+091.71 E+081.20E+104. 1OE+051. 19E+052.35E+074.75E+045.11 E+042.18E+079.1 IE+051.54E+072.63E+068.04E+07O.OOE+002.1 IE+031.01E+072.73E+061.98E+06

1.83E+03 1.83E+038.39E+06 8.39E+062.35E+06 2.35E+061.71E+06 1.718+06

RSP-0008 RUNV - I?RSP-OOD8 R�v - 12 PAGE 69 OF 103PAGE 69 OF 103


TABLE 1-6: DOSE FACTOR TABLE: R (1) - ADULT, COWS MILK

TABLE 1-6DOSE FACTOR TABLE: R (i) -Adult, cows' milk

Units are m2*mrem/yr per MCl/secNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin

H-3 O.OOE+00C-14 3.63E+05NA-24 2.44E+06P-32 1.62E+10CR-51 O.OOE+00MN-54 0.00E+00MN-56 0.O02+00FE-55 1.95E+07FE-59 2.55E+07CO-57 0.00+00CO-58 O.OOE+00CO-60 O.OOE+00NI-63 5.21E+09NI-65 3.76E-01CU-64 O.OOE+00ZN-65 1.09E+09ZN-69 2.1 SE- 12ZN-69M 0.00E+00BR-82 O.OOE+00BR-83 O.OOE+00BR-84 0.OOE+00BR-85 O.OOE+00RB-86 O.OOE+00RB-88 O.OOE+00RB-89 O.OOE+00SR-89 1.232+09SR.-90 3.62E+10SR-91 2.90E+04SR-92 4.95E-01Y-90 7.09E+01Y-91M 6.27E-20Y-91 7.22E+03Y-92 5.64E-05Y-93 2.24E-01ZR-95 7.89E+02ZR-97 4.34E-01NB-95 7.22E+04NB-97 0.002+00MO-99 O.OOE+00.TC-99M 3.34E+00TC-10L O.0OE+00RU-103 8.82E+02RU-105 8.64E-04RU-106 1.60E+04AG-I OM 4.61E+07SB-124 0.00E+00SB-125 0.00E+00TE-125M 1.37E+07TE-127M 3.72E+071P-127 6.56E+02TE-129M 5.29E+07TB-129 2.922-10

4.73E+027.26E+042.44E+061.OIE+O90.OOE+006.63E+064.21E-031.35E+075.99E+07O.OO+003.92E+061.27E+073.61E+084.88E-022.39B+043.46E+094.17E-12O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+002.40E+09O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+OOO.OOE+000.00+000.00E+00O.OOE+002.53E+028.76E-024.02B+040.00E+002.48E+079.44E+00O.OOE+00O.OOE+00O.OOE+000.00E+004.26E+07O.OOE+00O.OOE+004.97E+061.33E+072.35E+021.97E+071.1OE-10

4.73E+02 4.73E+02 4.73E+027.26E+04 7.26E+04 7.26E+042.44E+06 2.44E+06 2.44E+066.26E+08 0.00E+00 O.OOE+002.55E+04 1.53E+04 5.62E+031.27E+06 O.OO2+00 1.97E+067.47E-04 0.002+00 5.342-033.15E+06 0.00+00 O.OOE+002.30E+07 O.OOE+00 O.OOE+000.00E+00 0.00E+00 0.00E+008.78B+06 O.OOE+00 O.OOE+002.81E+07 O.OOE+00 0.00E+001.75E+08 O.OOE+00 O.OOE+002.23202 0.00E+00 . O.OOE+001.12E+04 0.OOE+00 6.03E+041.56E+09 0.002+00 2.31E+092.90E-13 O.OOB+00 2.71E-12O.OOE+00 0.00E+00 0.00+000.00+00 0.00E+00 O.OOE+009.87E-02 0.00E+00 O.OOE+001.73E-23 O.OOE+00 0.00+00O.OOE+00 O.OOE+00 O.OOE+001.12E+09 O.OOE+00 O.OOE+00O.OOE+00 0.OOE+00 O.OOE+000.00E+00 0.00E+00 O.OO+003.54E+07 O.OOE+00 0.00+008.89E+09 O.OOE+00 O.OOE+001.17E+03 0.00E+00 O.OO2+002.14E-02 0.002E+00 0.02+OO1.90E+00 0.002+00 0.00E+0O2.43E-21 O.OOE+00 O.OOE+001.932+02 0.002+00 O.OOE+001.65E-06 0.002+00 O.OOE+006.19E-03 0.00E+00 O.OOE+001.71E+02 0.00E+00 3.972+024.01E-02 O.OOE+00 1.32E-012.16E+04 0.00E+00 3.97E+04O.OO+00 0.00E+00 O.OO+004.712+06 O.OOE200 5.61E+071.202+02 0.00E+00 1.43E+02O.OOE+00 0.002+00 0.002+003.80E+02 0.00E+00 3.37E+033.41E-04 0.00E+00 1,12E-022.03E+03 O.OOE+00 3.10E+042:53E+07 O.OO+200 8.38E+070.002+00 O.OOE+00 O.OO+000.00E+00 O.OOE+O O.OOE+001.84E+06 4.122+06 5.582+074.53E+06 9.512+06 1.51E+081.42E+02 4.86E+02. 2.672+038.37E+06' 1.82E+07 2.21E+087.112-Il. 2.24E-10 1.23E-09

4.73E+027.26E+042.44E+060.00+003.39E+040.00+000.00+007.53E+061.67E+070.00E+000.002+00O.OOB+00O.OOE+000.00+00O.OOE+OO0.00+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.OOE+000.001+000.OOE+000.00E+00O0.00+000.002+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+000.0OE+OO0.OOE+00O.OOE+004.63E+00O.OOE+00O.OOE+00O.OOE+000.0OE+00O.OOE+00O.OOE+000.00+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+00

4.73E+027.26E+042.44E+061.82E+096.42E+062.032+071.34E-017.75E+062.00E+080.OOE+007.94E+072.39E+087.53E2071.24E+002.04E+062.18E+096.26E-130.00E+00O.OOE+001.42E-011.36E-280.00+004.74E+080.00E+00O.OOE+001.98E+081.05E+091.38E+059.81E+007.5 1E+051.84B-193.98E+069.88E-017.11 E+038.02B+052.71E+042.44E+080.00E+005.74E+075.59E+03O.OOE+001.03E+055.29E-011.04E+061.74E+10O.OOE+00O.OOE+005.48E+071.25E+085.17E+042.66E+082.20E-10

O.OOE+00O.OOB+00O.OOE+00O.OOE+00O.OOE+OOO.OOE+000.002+00O.OOE+00O.OOE+00

O.OOE+00O.OOE+000.00E+00O.OOE+000.00E2+00O.OOE+000.00E+00OOOE+00O.OOB+00O.OOE+00

0.002+00O.OOE+00O.OOE+000.00E+00O.OOE+00

O.OOE+OOO.OOE+00O.OOE+00

O.OOE+~O0.(002+00O.OOE+000.00+00O.OOE+00

0.0012±00O.OOE+00O.OOE+00O.OOE+00

0.002±,00O.OOE+00O.OOE+000.002+00

0.002±00O.OOE200O.OOE+00O.OOB+00O.OOE+00O.OOE+00

O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+OO0.00E+OO

RSP-0008 REV -12 PAGE 70 OF 103

ATTACHMENT 20PAGE 2OF2

TABLE 1-6: DOSE FACTOR TABLE: R (I) - ADULT, COWS MILKNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin

TE-131M 3.62E+OS 1.77E+05 1.47E+05 2.80E+05 1.79E+06 0.00E+00 1.76E+07 0.00E+00TE-131 3.95E-33 1.65E-33 1.25E-33 3.25E-33 1.73E-32 0.00E+O0 5.60E-34 0.OOE+00TE-132 2.40E+06 1.55E+06 1.46E+06 1.72E+06 1.50E+07 O.OOE+00 7.35B+07 0.00E+001-130 4.21E+05 1.24E+06 4.90E+05 1.95B+08 1.94E+06 O.OOE+00 1.07E+06 0.00E+001-131 2.91E+08 4.16E+08 2.38E+08 1.36E+11 7.13E+08 O.OOE+00 1.10E+08 0.00E+001-132 1.67E-01 4.47E-01 1.56E-01 1.56E+01 7.12E-01 0.OOE+00 8.39E-02 0.00E+00[-133 3.88E+06 6.74E+02 2.06E+06 9.91E+08 1.18+07 0.00E+00 6.06E+06 0.00E+001-134 2.11B-12 5.72E-12 2.056-12 9.92E-11 9.10E-12 O.OO+00 4.99E-15 0.00E+001-135 1.29E+04 3.38E+04 1.256+04 2.23E+06 5.42E+04 0.00E+00 3.82E+04 0.00E+00CS-134 4.41E+09 1.05E+10 8.57E+09 0.006+00 3.39E+09 1.13E+09 1.84E+08 0.00E+00CS-136 2.51E+08 9.91E+08 7.13E+08 0.00E+00 5.51E+08 7.56E+07 1.13E+08 0.00E+00CS-137 5.71E+09 7.81E+09 5.12E+09 0.006+00 2.65E+09 8.82E+08 1.51E+08 0.00E+00CS-138 9.72E-24 1.92E-23 9.506-24 0.00E+00 1.41E-23 1.39E-24 8.18E-29 0.006+00BA-139 4.54E-08 3.24E-11 1.33E-09 O.OOE+00 3.03E-11 1.84E-11 8.06E-08 0.00E+00BA-140 2.57E+07 3.23E+04 1.686+06 O.06E+00 1.10E+04 1.85E+04 5.29E+07 0.00E+00BA-141 0.00E+00 O.O0E+00 0.006+00 0.00E+00 0.00E+00. 0.00E+00 0.00E+00 0.00E+00BA-142 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00LA-140 4.52E+00 2.28E+00 6.01E-01 0.00E+00 0.00E+00 0.00E+00 1.67E+05 0.00E+00LA-142 1.90E-11 8.66E-12 2.16E-12 0.00E+00 0.00E+00 0.00E+00 6.32E-08 O.OOE+00CE-141 4.27E+03 2.89E+03 3.27E+02 0.00E+00 1.34E+03 0.00+00 1.10E+07 O.O0E+00CE-143 4.16E+01 3.08E+04 3.40E+00 0.00E+00 1.35E+00 O.00E+00 1.15E+06 0.00E+00CE-144 2.82E+05 1.18E+05 1.52E+04 0.00E+00 7.00E+04 O.OOE+00 9.55E+07 0.00E+00PR-143 1.50E+02 6.02E+01 7.44E+00 0.00E+00 3.48E+01 0.00E+00 6.58E+05 0.00E+00PR-144 0.00E+00 0.006+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00ND-147 9.106+01 1.05E+02 6.29E+00 O.00E+00 6.15E+01 0.00E+00 5.05E+05 0.00E+00W-187 6.52E+03 5.45E+03 1.90E+03 0.00E+00 0.00E+00 0.00E+00 1.786+06 0.006E+ONP-239 3.67E+00 3.61E-01 1.99E-01 0.00E+00 1.13E+00 0.00E+00 7.41E+04 0.00E+00

RSP-0008 REV - 12 PAGE 71 OF 103


TABLE 1-7: DOSE FACTOR TABLE: R (1) - TEEN, COWS MILK

TABLE 1-7DOSE FACTOR TABLE: R (i) - Teen, cows'milk

Units are m2*nremlyr per xCilsecNucllde Bone Liver Tbodv - Thyroid Kidney Lung GI Tract Skin

H-3 0.00E+OOC-14 6.70E+05NA-24 4.27E+06P-32 2.99E+10CR-51 0.00+00MN-54 0.00+00MN-56 0.00E+OOFE-55 3.47E+07FE-59 4.45E+07CO-57 0.00+00CO-58 0.OOE+00CO-60 0.OOE+OONI-63 9.15E+09NI-65 6.876-01CU-64 0.006+00ZN-65 1.67E+09ZN-69 4.01E-12ZN-69M 0.00+00BR-82 0.00+00BR-83 0.OOE+00BR-84 0.006+00BR-85 0.006+00RB-86 0.00+00RB-88 0.001+00RB-89 0.0OE+00SR-89 2.27E+09SR-90 5.12E+10SR-91 5.33E+04SR-92 9.07E-01y-go 1.30E3+02Y-91M 1.15E-19Y-91 1.33E+04Y-92 1.04E-04Y-93 4.13E-01ZR-95 1.38E+03ZR-97 7.90E-01NB-95 1.23E+05NB-97 0.006+00MO-99 O.OOE+00TC-99M 5.80E+00TC-101 0.006+00RU-103 1.57E+03RU-105 1.58E-03RU-106 2.95E+04AG-llOM 7.62E+07SB-124, O.OOE+00SB-125 0.00±+00TE-125M 2.53E+07TE-127M 6.86E+07TE-127 1.22E+03TE-129M 9.671E+07TE-129 5.37E-10

6.16E+021.34E+054.27B+061.856s+090.00+001.10E+077.46E-032.46E+071.04E+08O.pOE+006.60E+062.16E+076.46E+088.78E-024.26E+045.796+097.65E-12O.OOE+000.00+OO0.00+000.006+000.00+004.38E+090.006+000.00+000.00+00O.OOE+000.00+00O.OOE+000.00+000.00+000.00E+OOO.OOE+000.00+004.35E+021.56E-016.83E+040.p0E+0O4.47E+071.62E+01

O.OOE+000.00E+OO0;OOE+OO0.OOE+OO7.21E+07O.OOE+000.00+009.1 1E+062.43E+074.316+023.59B+072.00E-10

6.16E+021.34E+054.27E+061. 16E+094.46E+042.19E+061.336-035.73E+064.01 E+070.00+001.52E+074.86E+073.1OE+084.00E-022.00E+042.70E+095.35E-130.00+000.00+001.82E-013.09B-230.00+002.066+090.00+000.00+006.51E+071.26E+102.12E+033.86B-023.51E+004.39E-213.56E+023.016-061.13E-02

6.16E+021.34E+054.27E+06O.OOE+002.48E+040.0063+000.0016+000.0016+000.0063+000.0016+000.0061+000.0013±00O.OOE+000.00+00O.OOE+000.00+000.00E+000.00+000.00+000.00E+000.00Q+00O.OOE+00O.OOE+000.00+000.00E+OOO.OOE+00O.OOE+00O.OOE+000.00+00O.OOE+000.00p+00O.OOE+000.001+00

O.OOE+OO

6.16E+02 6.16E+021.34E+05 1.34E+054.27E+06 4.27E+06O.OOE+00 O.OOE+009.77E+03 6.366+043.30E+06 0.00+009.45E-03 0.00E+000.00+O0 1.56E+07O.OOE+00 3.27E+07O.OO+00 0.OOE+000.00E+OO 0.00+000.00+00 0.00E+000.00+00 0.00E+000.00+00 0.00+001.08E+05 O.OOE+003.71E+09 0.006+005.00E-12 0.006+00O.OOE+00 0.006+00O.OOE+00 0.00E+OO0.00E+OO 0.006+000.0OE+OO 0.001+000.006+00 O.0OE+000.006+00 0.006+OOO.OOE+O0 0.006+00O.OOE+O0 0.00E+000.00++00 0.0063+00O.OOE+00 0.00E+OO0.0OE+00 0.006+000.006+00 O.OOE+00O.OOE+00 0.006+0O0.006+00 0.006+000.006+00 O.OOE+000.006+00 0.006+000.00E+OO O.OOE+006.406+02 0.006+002.376-01 0.00E+006.62E+04 0.00E+OOO.OOE+00 0.006+001.026+08 0.006+002.416+02 8.97E+000.006+00 0.006+005.53E+03 0.00E+001.99E-02 0.00E+005.69E+04 O.OOE+001.386+08 0.006+O00.006+00 0.0011+000.006+00 0.00+00O.OOE+00 0-006+002.78E+08 O.OO+OO4.926+03 0.00E+OO4.046+08 0.006+OO2.25E-09 0.006+00

6.16E+021.34E+054.27E+062.51 E+097.49E+062.27E+074.91E-011.06E+072.456+080.00E+009.096+072.81E+081.03E+084.766+003.30E+062.45E+091.411E-ll0.00E+OO0.006+000.006+000.006+00O.OOE+006.48E+080.00E+O00.006+002.71 E+081.44E+092.42E+052.31 E+O 11.07E+065.42E-185.45E+062.86E+001.266+041.00+064.23E+042.926+08O.OOE+008.01E+07I .06E+040.006+001.316+051.27B+001.41E+062.036+100.00+000.006+007.46E+071.71E+089;38E+043.63E+082.94B-09

0.00+000.OOB+00O.OOE+000.00E+00O.OOE+00O.OOE+000.006+OOO.OOE+000.006+000.006+000.006+000.006+000.006+000.00+000.00E+OO0.006+000.00E+OO0.00+000.00+00O.OOE+000.006+000.006+00O.OOE+000.OOE+00O.OOE+000.00+00O.OOE+000.00E+OOO.OOE+000.00+000.006+000.006+000.00+000.00+000.00E+OO0.006+000.00+000.OOE+000.00+000.006+000.006+00O.OOE+000.006+00O.OOB+000.00E+OO0.00+000.006+000.00E+OO0.006+000.00+OOO.OO+000.006+00

2.99E+02 0.00+007.206-02 0.0OE+0O3.76E+04 0.00E+OOO.OOE+00 O.OOE+008.536+06 O.OOE+002.1 OE+02 0.00E+OO0.006+00 O.OOE+006.71E6+02 0.00E+OO6.13E-04 0.006+003.72E+03 O.OOE+004.396+07 0.006+00O.OOE+00 O.OOE+000.006+00 O.OOE+003.386+06 7.066+068.16E+06 1.63E+072.61E+02 8.386+021[53E+07 3.12E+071.31E-10 3.84E-10

RSP-0008 REV -12 PAGE 72 OF 103


TABLE 1-7: DOSE FACTOR TABLE: R O - TEEN, COWS MILKNudide Bone Liver Thody Thyroid Kidney Lung GI Tract Skin

TB-131M 6.58E+05 3.15E+05 2.63E+05 4.75E+05 3.29B+06 0.00E+00 2.53E+07 O.OOE+00TE-131 7.22E-33 2.98E-33 2.26E-33 5.57E-33 3.16E-32 0.00+00 5.93E-34 0.00E+OOTE-132 4.29E+06 2.726+06 2.56B+06 2.876+06 2.616+07 O.OOE+00 8.61E+07 0.00E+001-130 7.41E+05 2.14E606 8.56E+05 1.75E608 3.30E+06 0.00E+OO 1.65E+06 O.OOE+001-131 5.28E+08 739E+08 3.97E+08 2.16E+11 1.27E+09 0.00E+OO 1.46E+08 0.OOE+001-132 2.96E-01 7.75E-01 2.78E-01 2.61E+01 1.22E+00 O.OOE+00 3.38E-01 0.00E+OO1-133 7.08E+06 1.20E+07 3.66E+06 1.68E+09 2.11E+07 O.OOE+00 9.09E+06 O.OOE+001-134 3.74E-12 9.92E-12 3.56E-12 1.65E-10 1.566-11 0.00E+OO 1.31E-13 O.OOE+001-135 2.29E+04 5.90E+04 2.19E+04 3.80E+06 9.33E+04 0.00E+00 6.54E+04 O.OOE+00CS-134 7.65E+09 1.80E+10 8.36B+09 O.OO+00 5.72E+09 2.19E+09 2.24E+08 O.OOE+00CS-136 4.27E+08 1.68E+09 1.13B+09 O.OOE+00 9.15E+08 1.44E+08 1.35E+08 0.00E+OOCS-137 1.04E+10 1.38E+10 4.80E+09 O.OOE+00 4.69E+09 1.82E+09 1.96E+08 O.OOE+00CS-138 1.76E-23 3.38E-23 1.69E-23 0.OOE+00 2.50E-23 2.916-24 1.54E-26 O.OOE+00BA-139 8.40E-08 5.91E-11 2.45E-09 O.OOE+00 5.576-11 4.07E-11 7.50E-07 O.OOE+00BA-140 4.64E+07 5.68B+04 2.996+06 O.OOE+00 1.93E+04 3.82E+04 7.15E+07 0.00E+00BA-141 0.00E+0O 0.00E+00 0.00E+OO 0.00E+0O O.OOE+00 O.OOE+O0 O.OO+00 O.OOE+00BA-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.0OE+00 O.OOE+00 0.00E+00LA-140 8.118+00 3.98E+00 1.06E+00 O.OOE+00 O.OOE+00 0.00E+OO 2.29E+05 0.00E+00LA-142 3.43E-11 1.53E-11 3.80E-12 O.OOE+00 O.OOE+00 O.OOE+00 4.64E-07 0.00E+OOCE- 141 7.82E+03 5.22E+03 6.00E+02 O.OOE+00 2.46E+03 O.OO+00 1.49E+07 0.0OE+00CE-143 7.65E+01 5.56E+04 6.21E+00 O.OO6+00 2.50E+01 0.008+00 1.676+06 0.;OE+00CB-144 5.20E+05 2.15E+05 2.79E+04 O.OOE+00 1.28E+05 0.00E+00 1.31E+08 0.00E+OOPR-143 2.76E+02 1.10E+02 1.37E+01 O.OOE+00 6.40E+01 0.00+00 9.086+05 0.006+00PR-144 O.OOE+00 O.OOE++00 0.OE+00 O.OOE+00. 0.00E+00 O.OOE+00 O.OOE+00 0.OOE+00ND-147 1.75E+02 1.90E+02 1.14E+01 O.OOE+00 1.12E+02 O.OOE+00 6.87E+05 0.008+00W-187 1.19E+04 9.71E+03 3.408+03 0.00E+00 O.OOE+00 O.OOE+00 2.63E+06 0.00E+00NP-239 7.01E+00 6.61E-01 3.67E-01 O.OO+00 2.08E+00 O.OOE+00 1.06E+05 O.OOE+00

A-.

RSP-0008 . . REV- 12 PAGE 73 OF 103

ATTACMENT 22PAGE 1 OF 2

TABLE I-8: DOSE FACTOR TABLE R (1) - CmI LD, COWS MILK

TABLE I-8DOSE FACTOR TABLE: R (i) - Child, cows' milk

Units are mt *mrem/yr per uCi/secNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin

H-3 0.008+00 9.73E+02 9.73E+02 9.73E+02 9.73E+02 9.73E+02 9.73E+02 0.OOE+0OC-14 1.65E+06 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 O.OOE+00NA-24 8.88E+06 8.88E+06 8.88E+06 8.88E+06 8.88E+06 8.88E+06 8.88E+06 O.OOE+00P-32 7.37E+10 3.45E+09 2.84E+09 0.OOE+00 0.00+00 O.OO+0O 2.04E+09 O.OOE+00CR-51 O.OOE+00 0.008+00 9.09E+04 5.05E+04 1.38E+04 9.21E+04 4.82E+06 O.00E+00MN-54 O.OOE+00 1.65E+07 4.40E+06 0.00E+00 4.63E+00 O.OOE+00 1.39E+07 0.OOE+OOMN-56 0.008+00 1.30E-02 2.94E-03 O.OOE+00 1.57E-02 0.OOE+00 1.89E+00 O.OOE+00FP855 8.708+07 4.61E+07 1.43E+07 0.008+00 O.OOE+00 2.61E+07 8.55E+06 O.OOE+00FE-59 1.03E+08 1.678+08 8.31E+07 O.OOE+00 0.008+00 4.84E+07 1.74E+08 O.OOE+00C0-57 O.OOE+OO O.OO+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00C0-58 0.008+00 1.01E+07 3.08E+07 0.008+00 O.OOE+00 O.OOE+00 5.88E+07 O.OOE+00C0-60 0.00E+00 3.35E+07 9.88E+07 0.00E+00 0.008+00 O.OOE+00 1.86E+08 O.OOE+00NI-63 2.29E+10 1.238+09 7.80E+08 0.00E+00 O.OOE+00 O.OOE+O0 8.27E+07 O.OOE+00NI-65 1.68E+00 1.88E-01 9.24E-02 0.8OE+00 O.OOE+0O O.OOE800 1.94E+01 O.OOE+00CU-64 O.OOE+00 7.48E+04 4.52E+04 O.OOE+00 1.818+05 O.OOE+00 3.51E+06 0.OOE+00ZN-65 3.27E+09 8.72E+09 5.43E+09 O.OOE+0O 5.50E+09 O.OOE+00 1.53E+09 O.OOE+00ZN-69 9.87E-12 1.43E-11 1.32E-12 0.00E+00 8.65E-12 O.OOE+00 8.99E-10 O.OOE+00ZN-69M 0.008+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00BR-82 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OO+00 0.00E+00 0.00E+00 O.OOE+00BR-83 O.OOE+00 0.005+00 4.47E-01 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.OOE+00BR-84 O.OOE+00 0.00E+OO 7.00E-23 O.OOE+00 0.008+00 O.OOE+00 OOOE+00 O.OOE+00BR-85 O.OO+0O 0.005+00 O.OE+OO 0.008+00 0.00+00 0.00E+00 O.OOE+00 0.008+0ORB-86 O.OOE+00 8.128+09 4.99E+09 O.OOE+00 O.OOE+00 O.OOE+00 5.22E+08 O.OOE+00RB-88 0.OOE+O O.OOE+00 0.0O0,+0O O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00RB-89 O.OOE+00 O.OOE+00 0.008+00 0.00E+O0 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+0OSR-89 5.63E+09 O.OOE+O 1.61E+08 O.OO+00 0.00E+00 O.OOE+00 2.18E+08 O.OOE+00SR-90 8.65E+10 O.OOE+00 2.19E+10 O.OOE+00 O.OOE+00 O.OOf+00 1.16E+09 O.OOE+00SR-91 1.31E+05 O.OOE+00 4.948+03 0.00E+00 O.OOE+00 0.008+00 2.89E+05 0.00E+00SR-92 2.21E+00 O.OOE+00 8.888-02 O.OOE+00 O.OOE+00 0.00E+00 4.195+01 O.OOE+00Y-90 3.22E+02 0.00E+00 8.635+00 O.OOE+00 O.OO+00 O.OOE+00 9.18E+05 O.OOE+00Y-91M 2.80E-19 O.OOE+00 1.02E-20 0.00E+00 O.OOE+00 O.OO+00 5.49E-16 0.00E+00Y-91 3.28E+04 O.OOE+00 8.78E+02 O.OOE+00 O.OOE+00 0.00E+00 4.37E+06 O.OOE+00Y-92 2.56E-04 O.OOE+00 7.32E-06. O.OO+00 O.OO+00 0.00E+00 7.39E+00 O.OOE+00Y-93 1.028+0O O.OOE+00 2.79E-02 O.OOE+O 0.00E+00 O.OOE5+00 1.51E+04 0.08E+00ZR-95 3.20E+03 7.04E+02 6.27E+02 O.OOE+00 1.01E+03 O.OOE+00 7.35E+05 O.OOE+00ZR-97 1.925+00 2.788-01 1.64E-01 0.005+00 3.995-01 O.OOE+00 4.21E+04 0.005+00NB-95 2.78E+05 1.08E+05 7.74E+04 0.00E+00 1.02E+05 O.OOE+00 2.008+08 O.OOf+00NB-97 O.OOE+00 O.OO+00 O.OOE+00 O.OOE+800 O.OOE++00 0.00+00 .0080 0.00+00MO-99 0.00+00 8.14E+07 2.01E+07 0.00E+00 1.748+08 O.OOE+0O 6.73E+07 O.OOE+00TC-99M 1.33E+01 2.61E+01 4.32E+02 O.OOE+00 3.79E+02 1.32E+01 1.488+04 O.OOE+00TC-IOl O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+0O 0.0OE+00 O.OOE+00RU-103 3.71E+03 0.00E+00 1.43E+03 .000E++00 9.348+03 O.OOE+00 9.59E+04 0.0OE+00RU-I05 3.85E-03 0.00E+00 1.40E-03 0.005+00 3.39E-02 O.OOE+00 2.51E+00 O.OOE+00RU-106 7.26E+04 0.00E+00 9.06E+03 O.OOE+00 9.81E+04 0.00E+00 1.13E+06 O.OOE+00AG-I 10M 1.65E+08 1.12E+08 8.92E+07 O.OOE+00 2.08E+08 O.OOE+00 1.33E+10 O.OOE+00SB-124 0:00E+00 O.OOE+00 O.OOE+00 O.OOE800 O.OOE+00 0.0OE+00 O.OOE+00 O.OOE+00SB-125 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00TE-125M 6.21E+07 1.68E+07 8.28E+06 1.74E+07 O.OOE+00 0.008+00 5.998+07 O.OOE+00TE-127M 1.69E+08 4.55E+07 2.01E+07 4.04E+07 4.82E+08 O.OOE+00 1.37E+08 O.OOE+00TE-127 2.99E+03 8.06E+02 6.41E+02, 2.07E+03 8.50E+03 O.OO+00 1.17E+05 O.OOE+00TE-129M 2.38E+08 6.65E+07 3.70E+07' 7.68E+07 7.00E+08 0.08E+00 2.91E+08 O.OOE+00TE-129 1.33E-09 3.705-16 3.15.E-10 9.46E-10 3.88E-09 0.008+00 8.25E-08 O.OOE+O

RSP-0008 R EV -12 PAGE 74 OF 103


TABLE 1-8: DOSE FACTOR TABLE R M - CHILD, COWS MILKNuclide Bone- _ Liver Tbody Thyroid Kidney -Lun GI Tract Skin

TE-131M 1.60E+06 5.54E+05TE-131 1.77E-32 5.40E-33TB-132 1.02E+07 4.54E+061-130 1.73E+06 3.50E+061-131 1.28E+09 1.29E+091-132 7.01E-01 1.29E+00I-133 1.72B+07 2.13E+07I-134 8.87E-12 1.65B-111-135 5.43E+04 9.77E+04CS-134 1.77E+10 2.90E+1I-0CS-136 9.65E+08 2.65E+09CS-137 2.50E+10 2.39B+10CS-138 4.27E-23 5.94E-23BA-139 2.06E-07 1.10B-10BA-140 1.12E+08 9.80E+04BA-141 0.00E+00 0.00E+00BA-142 O.O0E+00 0.00E+00LA-140 1.94E+01 6.79E+00LA-142 8.30E-II 2.64E-11CE-141 1.93E+04 9.61E+03CE-143 1.88E+02 1.02E+05CE-144 .28E+06 4.02E+05PR-143 6.83E+02 2.05E+02PR-144 0.002+00 o.OOE+00ND -147 4.29E+02 3.4SE+02W-187 2.89E+04 1.71B+04NP-239 1.732+01 1.24E+00

5.89E+05 1.14E+06 5.36E+06 0.00E+005.27E-33 1.36E-32 5.36E-32 0.00E+005.48E+06 6.61E2+06 4.21E+07 0.00E+001.80B+06 3.86E+08 5.23E+06 0.00E+007.32E+08 4.26E+11 2.1 1E+09 0.00E+005.92E-01 5.97E+01 1.97E+00 O.OOE+008.05E+06 3.95E+09 3.55E+07 0.00E+007.57E-12 3.79E-10 2.52E-11 0.00B+004.62E+04 8.66E+06 1.50E+05 0.00E+006.1 1E+09 0.00E+00 8.98E+09 3.22E+091.72E+09 0.00E+00 1.41E+09 2.1 E+083.53E+09 0.00E+00 7.78E+09 2.80E+093.77E-23 0.00E+00 4.18E-23 4.502-245.98E-09 0.00E+00 .9.62E-11 6.48E-1 16.53E+06 0.00B+00 3.19E+04 5.84E+040.00E+00 0.00E+00 O.OOE+00 0.00E+00O.OE0.00+00 0.002+00 0.002+00 0.00E+002.29E+00 0.002+00 0.002E+00 .00£+008.282-12 0.00E+00 0.00E+00 0.00E+001.43E+03 0.00E+00 4.21E+03 0.002+O01.47E+01 0.00E+00 4.27E+01 0.00E+006.84E+04 0.002+00 2.22E+05 O.OOE+003.39E+01 O.OOE+00 1.11E+02 0.00E+000.00E+00 0.002+00 0.002+00 O.OOE+002.69E+01 0.002+00 1.912+02 0.00E+007.68E+03 0.00E+00 0.00E+00 O.OOE+008.71E-01 0.00E+00 3.58E+00 0.00E+00

2.25E+079.31E-324.57E+071.64E+061. 15E+081.52E+008.57E+061.092-117.45E+041.56E+089.32E+071.50E+082.74E-231.19E-055.67E+070.00E+000.00E+001.89E+055.24E-061.20E+071.49E+061.05E+087.37E+050.00E+005.51E+052.40E+069.17E+04

0.00E+000.00E+000.00E+000.00E+00O.OOE+00O.OOE+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+00

WW-4008 - --RV- 12 PG n5O 0R -0 0 _ .1 PA G 75 OF 10


TABLE 1-9: DOSE FACTOR TABLE: R (1) - INFANT, COWS MILK

TABLE 1-9DOSE FACTOR TABLE: R (i) - Infant, cows' milk

Units are mZ*mrem/yr per 1CI/secNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Sldn

H-3 0.00E+00C-14 3.23E+06NA-24 1.55E+07P-32 1.52E+11CR-51 0.00E+00MN-54 0.00E+00MN-56 O.00E+00FE-55 1.05E+08FE-59 1.92E+08CO-57 0.00E+00CO-58 O.O0E+00CO-60 0.00E+00NI-63 2.70E+10NI-65 3.56E+00CU-64 0.006E*OZN-65 4.40E+09ZN-69 2.106-11ZN-69M 0.00E+00BR-82 0.00E+00BR-83 0.00E+00BR-84 0.00E+00BR-85 0.00E+00RB-86 0.00E+00RB-8 8 0.00E+00RB-89 0.00E+00SR-89 1.07B+10SR-90 9.41E+10SR-91 2.73B+05SR-92 4.71E+00Y-90 6.82E+02Y-91M 5.94E-19Y-91 6.16E+04Y-92 5.44E-04Y-93 2.16E+00ZR-95 5.69E+03ZR-97 4.07E+00NB-95 5.19E+05NB-97 0.00E+00MO-99 0.00E+00TC-99M 2.77E+01TC-IOI 0.00E+00RU-103 7.51E+03RU-105 8.12E-03RU-106 1.50E+05AG-1OM 3.05E+08SB-124 0.00E+00SB-125 0.00E+00TE-125M 1.27E+08TE-127M 3.42E+08TE-127 6.34E+03TE-129M 4.89E+08TE-129 2.81E-09

1.48E+036.89E+051.55E+078.93E+090.00E+003.07B+073.19E-02.6.79E+073.36E+080.00E+002.02E+076.84E+071.67E+094.03B-011.86E+051.51t6+103.79E-1 10.00E+000.00E+000.00E+000.00E+000.00E+002.06E+100.00E+000.00E+000.00E+000.006+000.00E+000.00E+000.006+000.00E+000.00E+000.00E+000.00E+001.396+036.99E-012.14E+050.00E+002.08E+085.706+010.00E+00O.OOE+000.00E+000.00E+002.23E+080.00E+000.00E+004.24E+071.14E+082.13E+031.686+089.69E-10'

1.48E+03 1.48E+03 1.48E+03 1.48E+036.89E+05 6.89E+05 6.89E+05 6.89E+051.55E+07 1.55E+07 1.55E+07 1.55E+075.886+09 0.00E+00 0.00E+00 0.00E+001.44E+05 9.40E+04 2.05E+04 1.83E+056.976+06 0.00E+00 6.81E+06 0.00E+005.49E-03 0.00E+00 2.74E-02 0.00E+001.82B+07 0.006+00 O.OOE+00 3.32E+071.32E+08 0.00E+00 0.006+00 9.94E+070.00E+00 0.00E+00 0.00E+00 0.00E+005.03E+07 0.00E+00 0.00E+00 0.00E+001.62E+08 0.00E+00 0.00E+00 0.00E+009.38E+08 0.006+00 0.006+00 0.00E+001.83E-01 0.00E+00 0.00E+00 0.00E+008.61E+04 0.00E+00 3.15E+05 0.00E+006.95E+09 0.00E+00 7.31E+09 0.00E+002.82E-12 0.006E+O 1.57B-lI 0.00E+000.00E+00 0.00E+00 0.00E+00 0.00E+00O.00E+00 0.00E+00 0.00E+00 0.006+009.496-01 0.006+00 O.00E+00 0.006E+O1.35E-22 O.OO+00 O.00E+000 0.00E+00

.0.OOE+00 0.00E+00 0.00E+00 0.00E+001.02E+10 0.006+00 0.00E+00 O.00E+000.00E+00 O.00E+00 0.00E+00 0.00E+000.006+00 0.00E+00 0.006+00 0.00E+003.07E+08 O.OOE+00 O.00E+00 0.006+002.40E+10 0.00E+00 0.00E+00 0.00E+009.87E+03 0.00E+00 0.00E+00 0.00E+001.75E-01 0.00E+00 0.00E+00 0.00E+001.83E+01 0.00E+00 0.00E+00 O.00E+002.03E-20 0.00E+00 0.00E+00 0.006+00-1.64E+03 0.006+00 0.00E+00 O.OOE+001.53E-05 0.00E+00 O.00E+00 0.00E+005.90E-02 0.00E+00 0.00E+00 O.OOE+009.83E+02 0.00E+00 1.496+03 0.00E+003.19E-01 0.00E+00 7.04E-01 0.00E+001.24E+05 0.006+00 1.53E+05 O.00E+000.00E+00 0.00E+00 0.00E+00 0.00E+004.06E+07 0.006+00 3.11E+08 O.OOE+007.35E+02 O.O0E+00 6.14E+02 2.9SE+010.00E+00 0.00E+00 0.00E+00 0.00E+002.516+03 0.00E+00 1.56E+04 0.00E+002.74E-03 0.00E+O0 5.97E-02 0.00E+001.87E+04 0.006+00 1.77E+05 0.00E+001.48E+08 0.006+00 3.196+08 0.00E+000.00E+00 0.00E+00 0.00E+00 0.00E+000.00E+00 O.OOE+00 0.00E+00 0.0OE+001.72B+07 4.27E+07 0.00E+00 0.00E+004.14E+07 9.896+07 8.43E+08 0.00E+001.36E+03, 5.16B+03 1.55E+04 0.00E+007.54E+07' 1.88E+08 1.226+09 0.00+O006.56E-10, 2.36E-09 7.00E-09 0.00E+00

1.48E+036.89E4+051.55E+072.05E+094.20E+061.13E+072.90E+008.62E+061.61E+08O.OOE+005.026+071.63E+088.31E+073.076+013.82E+061.27E+103.096-090.00E+000.006+000.00E+000.00E+000.00E+005.27E+080.006+000.00E+002.20E+081.18E+093.23E+055.08E+019.41E+051.986-154.42E+061.04E+011.71E+046.91B+054.46E+041.80E+080.00E+006.85E+071.66E+040.00E+009.14E+043.23E+001.14E+061.16E+10O.OOE+000.006+006.05E+071.386+081.33E+052.92E+082.25E-07

0.00E+000.00E+000.00E+000.00E+000.00E+000.006+000.00E+000.00E+000.00E+00O.OOE+00O.00E+000.00B+000.00E+000.006+000.006+00O.OOE+000.00E+000.00E+000.006+000.006+000.006+000.00E+000.006+00O.OOE+00O.OOE+000.00E+000.006+000.006+000.006+000.00E+000.00E+000.00E+000.00E+000.00E+000.006+000.00E+000.00E+000.00E+00O.OOE+000.00E+000.00E+000.006+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+00O.OOE+00O.OOE+00

RSP-0008 REV -12 PAGE 76 OF 103


TABLE 1-9: DOSE FACTOR TABLE: R U - FMANT, COWS MILKNuclide Bone Liver Tbody Thyroid Kidney LURE GI Tract Skin

TE-131M 3.38E+06 1.36E+06TE-131 3.76E-32 1.39E-32TE-132 2.11 E+07 1.05E+071-130 3.56E+06 7.83E+061-131 2.67E+09 3.1SE+091-132 1.45E+00 2.95E+001-133 3.63B+07 5.29E+07.1-134 1.84E-11 3.77E-II1-135 1.13E+05 2.25E+05CS-134 2.84E+10 5.30E+10CS-136 1.88E+09 5.54E+09CS-137 3.986+10 4.66E+10CS-138 9.01E-23 1.47E-22BA-139 4.39E-07 2.916-10BA-140 2.30E+08 2.30E+05BA-141 O.OOE+00 0.OOE+00BA-142 O.OO+00 O.OOE+00LA-140 . 4.06E+01 1.60E+01LA-142 1.74B-10 6.40& I ICE-141 3.82E+04 2.33E+04CE-143 3.97E+02 2.64E+05CE-144 1.84E+06 7.52B+05PR-143 1.41B+03 2.28E+02PR-144 O.OOE+00 0.006+00ND-147 8.51E+02 8.74E+02W-1 87 6.08E+04 4.2363+04NP-239 3.65E+01 3.26E+00

1.12E+061.05E-329.756+063.14E+061.38E+091.05E+001.55E+071.34B-118.19E+045.36E+092.07E+093.30E+097.10E-231.27E-081.19E+07O.OOB+OOO.OOE+004.1 1E+001.53E-112.746+033.01E+011.03E+057.00E+01O.OOE+005.36E+011.46E+041.S4E+00

2.76E+06 9.31E+06 O.OOE+003.35E-32 9.61E-32 0.OOE+001.54E+07 6.53E+07 O.OOE+008.78B+08 8.60B+06 O.OO+001.03E+12 3.68E+09 O.OOE+001.38E+02 3.29E+00 O.OOE+OO9.62E+09 6.226+07 0.006+008.78E-10 4.21E-I I O.OOE+002.01E+07 2.50E+05 O.OOE+00O.OOE+00 1.37E+10 5.60E+09O:OOE+00 2.21E+09 4.51E+08O.OOE+00 1.25E+10 5.07E+09O.OOE+00 7.31E-23 1.14E-23O.OOE+00 1.75E-10 1.77E-10O.OOE+00 5.47E+04 1.41E+05O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 7.18E+03 0.00E+00O.OOE+O0 7.68E+01 O.OOE+00O.OOE+00 3.04E+05 0.OOE+00O.OOE+00 1.96E+02 O.OOE+00O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 3.37E+02 O.OOE+00O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 6.51E+00 O.0OE+00

2.29E+071.52E-303.87E+071.68E+061.12E+082.39E+008.95E+063.89E-I i8.13E+041.44E+088.41E+071.46E+082.34E-222.78E-055.66E+070.00+00O.OOE+001.88E+051.09E-051.20E+071.54E+061.05E+087.45E+05O.OOE+005.54E+052.49E+069.43E+04

O.OOE+000.00E+00O.OOE+00O.OOE+000.OOE+000.00+OOO.OOE+00O.OOE+00O.OOE+00O.OOE+00O.oOE+000.00+00O.OOE+00O.OO+OOO.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00+00O.OOE+00O.OOE+00O.OOE+000.OOE+OO

RSP-0008 REV -12 PAGE 77 OF 103


TABLE 1-10: DOSE FACTOR TABLE: R (I) - ADULT, GOATS MILK

TABLE1I-10DOSE FACTOR TABLE: R (i) - Adult goats' milk

Units are mn*mrem/yr per xCi/secNuclide Bone Liver Thody Thyroid Kidney Lung GI Tract Skin

H-3 O.OOE+00 9.65E+02 9.65E+02 9.65E+02 9.65E+02 9.65E+02 9.65E+02 O.OOE+00C-14 3.63B+05 7.268+04 7.26E+04 7.26E+04 7.26E+04 7.26E+04 7.268+04 0.00+00NA-24 2.93E+05 2.93E+05 2.93E+05 2.93E+05 2.93E+05 2.938+05 2.93E+05 O.OOE+00P-32 1.94E+10 1.21E8-09 7.518+08 0.008+00 O.OOE+00 O.OOE+00 2.18E+09 O.OOE+00CR-51 O.OO800 0.008E+00 3.06E+03 1.83E+03 6.75E+02 4.06E+03 7.70E+05 O.OO+00MN-54 O.OOE+00 7.96E+05 1.52E+05 0.008+00 2.37E+05 0.00E+00 2.44E+06 O.OOE+00MN-56 0.008+00 5.05E-04 g.96E-05 0.00E+00 6.41E-04 O.OOE+00 1.61E-02 0.00+00FE-55 .2.54E+05 1.76E+05 4.09E+04 0.008+00 0.OOE+00 9.79E+04 1.01+05 O.OOE+00FE-59 3.31E+05 7.79E+05 2.98E+05 0.0E++00 0.008+00 2.18E+05 2.60E+06 0.008+00CO-57 0.00E+OO 0.00E+OO O.OOE+800 0.008+00 0.00+00 0.008+00 O.OOE+00 O.OOE+00CO-58 0.00E+OO 4.70E+05 1.05E+06 0.00+00 O.OOE+800 0.008+00 9.538+06 0.00E+OOCO-60 0.001+00 1.53E+06 3.37E+06 0.00E+0O 08OE+00 0.0011+00 2.87E+07 O.OOE+OONI-63 6.25E+08 4.33E+07 2.10B+07 O.OOE+00 0.008+00 0.00E+00 9.03E+06 O.OOE+00NI-65 4.51E-02 5.86E-03 2.67E-03 0.00E+00 0.00E+0O 0.00+00 1.498-01 O.OOE+00CU-64 O.OOE+00 2.66E+03 1.25E+03 O.OOE+00 6.7 1E+03 0.008+00 2.27E+05 0.008+00ZN-65 1.30E+08 4.15E+08 I.88E+08 O.OOE+00 2.788+08 0.00E+OO 2.61E+08 0.008+00ZN-69 2.62E-13 5.00E-13 3.48E-14 O.OOE+00 3.25E 13 O.OOE+00 7.52E-14 O.OOE+00ZN-69M 0.00E+00 0.008+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.008+OO 0.00E+00BR-82 0.00E+00 O.OOE+00 O.OOE+00 0.008+00 0.008+00 O.OOE+00 O.OOE+00 O.OOE+00BR-83 O.OOE+00 0.00Q+0O 1.18E-02 O.OOE+00 0.0OE+00 O.OOE+00 1.718-02 O.OOE+00BR-84 0.001+00 O.OOE+O 2.08E-24 O.OOE+00 0.008+00 0.0011+00 1.63E-29 0.008+00BR-85 O.OOE800 0.008+00 0.00+00 0.008E+O0 O.OOE+00 0.00E+00 0.008+00 0.00E+00RB-86 0.008+00 2.88E+08 1.34E+08 0.008+00 0.OOE+00 O:OOE800 5.68E+07 O.OOE+00RB-88 0.008+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+OO 0.00E+00 O.OOE+00 0.008+00RB-89 0.008+00 0.008+00 0.008+OO 0.008+00 O.OOE+00 0.008+00 0.00E+OO 0.008+00SR-89 2.59E+09 0.00E+O0 7.43E+07 0.00E+00 O.OOE+00 0.00E+00 4.15E+08 0.00E+00SR-90 7.61E+10 0.00E+OO 1.87E+10 O.OOE+00 0.008+00 0.00E+OO 2.208+09 O.OOE+00SR-91 6.10E+04 O.OOE+00 2.46E+03 O.OOE+00 O.OOE+00 0.00E+00 2,90E+05 0.00E+00SR-92 1.04E+00 0.008+00 4.508-02 O.OOE+00 0.008+00 0.008+00 2.06E+01 O.OOE+00Y-90 8.508+00 0.00E+OO 2.28E-01 0.008+00 O.OOE+00 0.008+00 9.02E+04 0.0011+00Y-91M 7.52E-21 0.00E+OO 2.91E-22 0.OOE+00 O.OOE+00 0.00E+00 2.21E-20 O.OE+00Y-91 8.678+02 0.008+00 2.32E+01 O.OOE+00 O.OOE+00 0.00E+OO 4.77E+05 0.008+00Y-92 6.77E-06 0.001+00 1.98E-07 0.001+00 O.OOE+00 0.00E+00 1.19E-01 0.0OE+00Y-93 2.69E-02 O.OO+00 7.43E-04 O.OOE+00 O.OOE+00 0.00E+00 8.53E+02 O.OOE+00ZR-95 9.47E+01 3.04E+01 2.06E+01 0.008+00 4.76E+01 0.00E+00 9.628+04 0.00E+OOZR-97 5.21E-02 1.05E-02 4.818-03 0.00E+OO 1.59E-02: O.OOE+00 3.268+03 0.8OE+00NB-95 8.678+03 4.82E+03 2.59E+03 0.008+00 4.77E+03 O.OOE+00 .2.93E+07 0.00+00NB-97 0.008+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00MO-99 O.OOE+00 2.97E+06 5.66E+05 0.00+00 6.738+06 0.00E+OO 6.89E+06 O.OOE+00TC-99M 4.01E-01 1.13E+00 1.44E+01 O.OOE+00 1.72E+01 5.55E-01 6.71E+02 O.OOE+00TC-IOI O.OOE+00 0.008+00 O.OOE+00 0.60E+00 O.OOE+00 0.00E+00 0.008+00 O.OOE+00RU-103 1.068+02 0.00E+OO 4.568+01 0.008+00 4.04E+02 O.OOE+00 1.248+04 0.0OB+00RU-105 1.04E-04 O.OOE+00 4.09E-05 0.00E+OO 1.34E-03 O.OOE+00 6.34E-02 0.008+00RU-106 1.92E+03 0.008+00 2.43B+02 0.008+00 3.718+03 0.008+00 1.258+05 O.OO+00AG-I10M 5.53E+06 5.128+06 3.04E+06 O.OOE+00 1.01E+07 O.OOE+00 2.09E+09 O.OOE+00SB-124 O.OE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.001+00 0.008+00 0.00E+OOSB-125 O.OOE+00 O.OE+00 O.OOE+00 O.OOE+00 0.00E+0O 0.0011+00 O.OE+00 0.0E+00TE-125M 1.65E+06 5.96E+05 2.20E+05 4.95E+05 6.69E+06 0.008+00 6.57E4+06 O.OOE+00TE-127M 4.47E+06 1.608+06 5.448+05 1.14B+06 1.81E+07 O.OOE100 1.50E+07 O.OO+00TE-127 7.87E+01 2.82E+01 1.70E+01. 5.83E+01 3.20E+02 0.008+00 6.21E+03 O.OOE+O0TE -129M 6.34E+06 2.378+06 1.008+06 2.188+06 2.6511+07 0.00E+00 3.198+07 0.00E+00

- TE-129 3.50-1I 1.328-11 8.53B-12; 2.698-11 .1.478-10 O.OOE+00 2.64E-II 0.00E+0O

RSP-0008 REV -12 PAGE 78 OF 103


TABLE 1-10: DOSE FACTOR TABLE: R (I - ADULT, GOATS MILKNuclide Bone Liver Tbody Thyroid Kidney . Lune GI Tract Skin

TB-131M 4.34E+04 2.12E+04TE-131 4.74E-34 1.98E-34TE-132 2.88E+05 1.86E+05I-130 5.06E+05 1.49E+061-131 3.49E+08 4.99E+081-132 2.00E-01 5.36E-011-133 4.65E+06 8.09E+06I-134 2.53E-12 6.87E-121-135 1.556+04 4.06B+04C5-134 1.32E+10 3.15E+10CS-136 7.53E+08 2.97E+09CS-137 1.71E+10 2.34E+10CS-138 2.91 E-23 5.76E-23BA-139 5.45E-09 3.88E-12BA-140 3.08E+06 3.87E+03BA-141 0.00E+00 O.OOE+00BA-142 O.OOE+00 O.OOE+00LA-140 5.42E-01 2.73E-01LA-142 2.28E-12 1.04E-12CE-141 5.12E+02 3.46E+02CE-143 4.99E+00 3.69E+03CE-144 3.396+04 1.426+04PR-143 1.80E+01 7.23E+00PR-144 O.OOE+00 0.00E+00ND-147 I.09E+01 1.26E+01W-187 7.826+02 6.54E+02NP-239 4.41E-01 4.34E-02

1.77E+04 3.36E+04 2.15E+051.50E-34 3.90E-34 2.08E-331.75E+05 2.06E+05 1.80E+065.89E+05 1.26E+08 2.33E+062.86E+08 1.64E+11 8.S6E+081.88E-01 1.88E+01 8.54E-012.47E+06 1.19E+09 1.41E+072.46E-12 1.19-10 1.09E-l I1.50E+04 2.68E+06 6.51E+042.57E+10 O.OOE+00 L02E+102.14E+09 0.00E+00 1.65E+091.54E+10 O.OOE+00 7.96E+092.85E-23 O.OOE+00 4.23B-231.60E-10 O.OOE+00 3.63E-122.02E+05 O.OOE+00 i.32E+03O.OO+00 O.OOE+00 O.OOE+000.006+00 O.OOE+00 0.00E+007.22E-02 O.OOE+00 0.00E+002.59E-13 O.OOE+00 0.006+003.93E+01 O.OOE+00 1.61E+024.09E-01 0.006+00 1.63E+001.82E+03 O.OOE+00 8.40E+038.93E-01 O.OOE+00 4.17E+00O.OOE+00 O.OOE+00 O.OOE+007.55E-01 O.OOE+00 7.37E+002.29E+02 O.OOE+00 O.OOE+002.39E-02 O.OOE+00 1.35E-01

O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+003.38E+092.27E+082.65E+094.18E-242.20E-122.22E+03O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOB+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00

2.11E+066.72E-358.82E+061.28E+061.32E+081.01E-017.27E+065.99E-154.58E+045.51 E+083.38E+084.54E+082.46E-289.67E-096.35E+06O.OOE+000.00+002.00E+047.58E-091.32E+061.38E+05I. 15E+077.89E+040.00E+006.06E+042.14E+058.89E+03

O.OOE+000.00E+00O.OOE+000.00+00O.OOE+000.00+00O.OOE+OOO.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.0OE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+OOO.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+00

RSP-0008 REV - 12 PAGE 79 OF 103RSP-0008 REV-12 PAGE79OF1O3


TABLE I-ll: DOSE FACTOR TABLE: R (I) - TEEN, GOATS MILK

TABLE 1-11DOSE FACIOR TABLE: R (i) - Teen, goats' milk

Units are m2*mrem/yr per LCi/secNuclide Bone Liver Thody Thyroid Kidney Lung GI Tract Skin

H-3 O.OOE+OOC-14 6.70E+05NA-24 5.12E+05P-32 3.58E+10CR-SI O.OOE+OOMN-54 O.OOE+OOMN-56 O.OOE+OOFE-55 4.5IE+05FE-59 5.78E+05CO-57 O.OOE+OOCO-58 O.OOE+OOCO-60 O.OOE+OONI-63 1.IOE+09NI-65 8.25E-02CU-64 O.OOE+OQZN-65 2.OOE+08ZN-69 4.82E- 13ZN-69M O.OOB+OOBR-82 O.OOE+OOBR-83 O.OOE+OOBR-84 O.OOE+OOBR-85 O.OOE+OOR13-86 O.OOE+OORB-88 O.OOE+OORBE89 O.OOE+OOSR-89 4.77E+09SR-90 1.07E+l ISR-91 1.12E+05SR-92 1.90E+OOY-90 1.56E+O1Y-91M 1.38E-20Y-91 1.59E+03Y-92 1.25E-05Y-93 4.96E-02ZR-95 1.66E+02ZR-97 9.48E-02NB-95 1 .48E+04NB-97 O.OOE+OOMO-99 O.OOE+OOTC-99M 6.96E-O1TC-1O1 O.OOE+WORU- 103 1.88E+02RU-105 1.89E-04RU-106 3.54E+03AG-IlOM 9.14E+06SB-124, O.OOE+OOSB- 125 O.OOE+OOTE-125M 3.03E+06TE-127M 8.23E+06TE-127 1.46E+02TE-129M 1.16E+07TE--129 6.45E1l1

1.26E+03 1.26E+03 1.26E+031.34E+OS 1.34E+05 1.34E+055.12E+05 5.12E+05 5.12E+052.22E+09 1.39E+09 O.OOE+OOO.OOE+OO 535E+03 2.97E+031.33E+06 2.63E+05 O.OOE+OO8.95E-04 I.59E-04 O.OOE+OO3.19E+05 7.45E+04 O.OOE+OO1.35E+06 5.21E+05 O.OOB+OOO.OOE+OO O.OOE+OO O.OOE+OO7.92E+05 1.82E+06 O.OOE+OO2.59E+06 5.83E+06 O.OOE+OO7.75E+07 3.72E+07 O.OOE+OO.I.05E-02 4.80E-03 O.OOE+OO4.74E+03 2.23E+03 O.OOE+OO6.95E+08 3.24E+08 O.OOE+OO9,18E-13 6.42E-14 O.OOE+OOO.OOE+OO O.QOE+OO O.OOE+OOO.OOE+OO O.OOE+OO O.OOE+OOO.OOE+OO 2.18E-02 O.OOE+OOO.OOE+OO 3.71E-24 O.OOE+OOO.OOE+OO O.OOE+OO O.OOE+OO5.25E+08 2.47B+08 O.OOE+OQO.OOE+OO O.OOE+OO O.OOE+OOO.OOE+OO O.OOE+OO O.OOE+OOO.OOE+OO 1.37E+08 O.OOE+OOO.OOE+OO 2.65E+10 O.OOE+OOO.OOE+OO 4.46E+03 O.OOE+OOO.OOE+OO 8.11 E-02 OOOE+OOO.OOE+OO 4.21E-01 O.OOE+OOO.OOE+OO 5.26E-22 O.OOE+OOO.OOE+OO 4.28E+O1 O.OOE+OOO.OOE+OO 3.62E-07 O.OOE+OOO.OOE+OO 1.36E-03 O.OOE+OO5.22E+01 3.59E+O1 O.OQE+OO1.88E-02 8.64E-03 O.OOE+OO8.20E+03 4.51E+03 O.OOE+OOO.OOE+OO O.OOE+OO O.OOE+OO5.37E+06 1.02E+06 O.OOE+OO1.94E+00 2.51E+O1 O.OOE+OOO.OOE+OO O.OOE+OO O.OOE+OOO.OOE+OO 8.05E+O1 O.OOE+OOO.OOB+OO 7.35E-05 O.OOE-OOO.OOE+OO 4.46B+02 O.QOE+OO8.65E+06 5.26BtO6 O.OOE+OOO.OOE+OO O.OOE+OO O.OOE+OOO.OOE+OO O.OOE+OO O.OOE+OO1.09E+06 4.06E+05 8.48E+052.92E+06 9.79E+05 1.96E+065.17B+O1 3.14E+OI I.O1E+024.31E+06 1.84E+06 3.74E+062.40E-Il 1.57E-11 4.61B-II

1.26E+031.34B+055.12E+05O.OOE+OO1.17E+033.95E+051.13E-03O.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OO1.20E+044.45E+086.OOE-13O.0E+4OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OO7.67E+O12.84B-027.95E+03O.OOE+OO1.23E+07

2.89E+O1O.OOE+OO6.64E+022.39E-036.82E+031.65E+07O.OOE+OOO.OOE+OOO.OOE+OO3.34E+075.91E+024.85E+072.71 B-10

1.26E+031.34E+055. 12E+05O.OOE+OO7.64E+03O.OOE+OOO.OOE+OO2.03E+05-4.25E+05O.OOB+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO,OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OO1.08E+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO;OOE+00

O.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+00O.OOE+00

1.26E+031.34E+055. 12E+053.0 I E+098.99E+052.72E+065.89E-021 .38E+053.19E+06O.OOE+001.09E+073.37E+071.23E+07

5.72E-OI3.68E+052.94E+081.69E-12

O.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OO7.77E+07O.OOE+OOO.OOE+OO5.69E+083.02E+095.08E+054.85E+ol1.29E+056.50E-196.54E-+053.43E-O11.52E+031.21E+055.08E+033.51E+07O.OOE+OO9.61E+061.27E+03O.OOE+OO1.57E+041.53E-O11.70B+052.43E+09O.OOE+00O.OOE+008.95E+062.05E+071.13E+044.36E+073.53E-10

O.OOE+00O.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOB+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+00O.OOE+OOO.OOE+OOO.OOE+OOO.OOE+00O.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+O0O.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOB+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OO0.00E+00O.OOE+OOO.OOE+00O.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OOO.OOE+OO

RSP-0008 REV - 12 PAGE 80 OF 103


TABLE I-1i1: DOSE FACTOR TABLE: R () - TEEN, GOATS MILKNuclide Bone Liver Tbody Thyroid Kidney Lune GI Tract Sidn

TE-131M 7.89B+04 3.79E+04 3.16E+04 5.69E+04 3.95B+05 O.OOE+00 3.04E+06 O.OOE+00TE-131 8.67E-34 3.57E-34 2.71E-34 6.68E-34 3.79E-33 O.OOE+OO 7.11E-35 0.00+00TE-132 5.15E+05 3.26E+05 3.07E+05 3.44E+05 3.13E+-06 0.OOE+OO 1.03E+07 O.OOE+001-130 8.89E+05 2.57E+06 1.03E+06 2.10E+08 3.96E+06 O.OOE+00 1.98E+06 O.OOE+OO1-131 6.33E+08 8.87E+08 4.76E+08 2.59E+11 1.53E+09 0.OOE+00 1.75E+08 O.OOE+001-132 3.55E-01 9.30E-01 3.34E-01 3.13E+01 1.47E+00 0.00+00 4.0SE-01 O.OOE+00I-133 8.50E+06 1.44E+07 4.40E+06 2.01E+09 2.53E+07 O.OOE+00 1.09E+07 0.00E+OO1-134 4.49E-12 1.19E-li 4.28E-12 1.98E-10 1.88E-l1 0.008+00 1.57E-13 O.0OE+00I-135 2.75E+04 7.09E+04 2.63E+04 4.56E+06 1.12E+05 O.OOE+00 7.85E+04 O.OOE+00CS-134 2.30E+10 5.408+10 2.51E+10 O.OOE+00 1.72E+10 6.56E+09 6.72E+08 O.OOE+00CS-136 1.28E+09 5.04E+09 3.39E+09 O.OOE+00 2.75E+09 4.33E+08 4.06E+08 O.OOE+00CS-137 3.11E+10 4.13E+10 1.44E+10 0.00E+00 1.41E+10 5.47E+09 5.88E+08 0.00E+00CS-138 5.298-23 1.02E-22 5.08E-23 0.00+00 7.49E-23 8.72E-24 4.61E-26 O.OOE+00BA-139 1.01E-08 7.09E-12 2.94E-10 0.008+00 6.698-12 4.89E-12 8.998-08 O.OOE+00BA-140 5.56E+06 6.82E+03 3.58E+05 O.OOE+00 2.31E+03 4.58E+03 8.58E+06 0.008+OOBA-141 0.00E+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00B+0O O.OOE+00 O.OE+00BA-142 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+OO 0.008+00LA-140 9.73E-01 4.78E-01 1.27E-01 O.OOE+00 0.00E+OO O.OOE+00 2.75E+04 O.008+00LA-142 4.128-12 1.83E-12 4.56E-13 O.OOE+00 O.OOE+00 0.OE+00 5.57E-08 O.OOE+00CE-141 9.39E+02 6.27E+02 7.20E+01 O.OOE+00 2.958+02 0.00E+00 1.79E+06 O.OOE+00CE-143 9.18E+00 6.68E+03 7.46E-01 0.008+00 2.99E+00 O.OOE+00 2.01E+05 O.OOE+00CE-144 6.24E+04 2.58E+04 3.35E+03 O.OOE+00 i.54E+04 0.00E+00 1.57E+07 O.OOE+00PR-143 3.31E+01 1.32E+01 1.65E+00 O.OOE+00 7.68B+00 0.OOE+OO 1.09E+05 O.OOE+00 -

PR-144 O.OOE+00 O.OOE+00 O.OOE+00 0.008+00 0.00E+O 0.00E+00 O.OOE+00 0-008+00ND-147 2.10E+01 2.28E+01 1.37E+00 0.00E+0O 1.34E+01 O.OOE+00 8.24E+04 O.OO+00

W-187 1.43E+03 1.17E+03 4.08E+02 O.OOE+00 . O.OOE+00 O.OOE+00 3.15E+05 0.00E+OONP-239 8.42E-01 7.94E-02 4.41E-02 O.OOE+00 2.498-O1 0.008+00 1.28B+04 O.OOE+00

RSP-0008 ____-REV - 12 PkGE. 81 OF 103RSP-0008 _ REV-fl PAGE81OF1O3

ATTACHMENT 26PAGE] 1OF2

TABLE 1-12: DOSE FACTOR TABLE: R (1) - CHILD, GOATS MILK

TABLE 1-12DOSE FACTOR TABLE: R (i) - Child, goats' milk

Units are mZ*mrem/yr per MCi/secNuclide Bone Liver Thody Thyroid Kidney Lung GI Tract Skin

H-3 0.OOE+00C-14 1.65E+06NA-24 1.07E+06P-32 8.84E+10CR-51 O.OOE+00MN-54 0.OOE+00MN-56 O.OOE+00FE-55 1.13E+06FE-59 1.34E+06CO-57 O.OOE+00CO-58 0.OOE+00CO-60 O.OOE+OONI-63 2.75E+09NI-65 2.02E-01CU-64 O.OOE+O0ZN-65 3.93E+08ZN-69 I.ISE-12ZN-69M O.OOB+00BR-82 O.OOE+00BR-83 O.OOE+O0BR-84 O.OOE+0OBR-85 O.OOE+00RB-86 0.OOE+00RB-88 O.OOE+00RB3-89 0.00+00SR-89 1.18E+10SR-90 1.82E+1ISR-91 2.75E+05SR-92 4.65E+00Y-90 3.87E+01Y-91M 3.36E-20Y-91 3.94E+03Y-92 3.07E-05Y-93 1.22B-01ZR-95 3.85E+02ZR-97 2.3 IE-OINB-95 3.34E+04NB-97 0.00+00MO-99 O.OOE+00TC-99M 1.60E+00TC-101 0.00E+00RU-103 4.45B+02RU-105 4.62B-04RU-106 8.71E+03AG-I IOM 1.98E+07SB-124, 0.00+00SB-125 0.00+00TE-125M .7.45E+06TE-127M 2.03E+07TE-127 3.59E+02TE-129M 2.86E+07TE-129 1.59E-10

1.99E+033.29E+051.07E+064.14E+09O.OOE+OO1.98E+061 .56E-036.OOE+052.17E+060.OOE+001.21E+064.02E+061.47E+081.90E-028.34E+031.05E+091.71B-120.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+009.74E+080.00E+00O.OOE+000.00E+000.00E+00O.OOE+00O.OQE+00O.QOE+OOO.OQE+00O.OOB+00O.OOB+00O.OOE+008.45E+013.33E-021.30E+04O.OOE+009.77E+063.13E+00O.OOE+00O.OOE+0OO.OOE±00O.OOE+001.34B+1070.00E+00O.OOE+002.02E+065.46E+069.67E+017.99E+064.44E- I

1.99E+03 1.99E+033.29E+05 3.29E+051.07E+06 1.07E+063.412E+09 O.OOE+001.09E+04 6.05E+035.28E+05 O.OOE+003.53E-04 O.OOE+001.86E+05 O.OOE+OO1.08E+06 . O.OOE+000.00E+00 O.OOE+003.70E+06 0.00E+001.19E+07 O.OOE+009.36E+07 O.OOE+001.11 E-02 O.OOE+005.04E+03 O.OOE+006.51E+08 O.OOE+001.58E-13 0.OOE+00O.OOE+00 O.OOE+00O.OOE+00 O.OOE+005.36E-02 O.OOE+008.40E-24 O.OOE+00O.OOE+00 O.OOE+005.99E+08 O.OOE+00O.OOE+00 O.OOE+00O.OOE+00 O.OOE+003.37B+08 O.OOE+004.60E+10 O.OOE+001.04E+04 O.OOE+001.86E-01 O.OO+001.042+00 O.OOE+001.22E-21 0.00+00l.05E+02 0.00E+008.78E-07 0.004E003.35E-03 O.OOE+007.53E+01 0.00+001.97E-02 O.OOE+009.29E+03 O.OOE+00O.O0E+00 O.O0E+002.42E+06 0.00+005.19E+01 0.OOE+00O.OOE+00 O.OE+001.71E+02 O.OOE+001.68E-04 0.OOE+001.09E+03 O.OOE+001.07E+07 0.00+00O:.OOE+00 .OOE+000.00E+00 O.OOE+009.94E+05 2.09E+062.41 E+06 4.85E+067.69E+01 2.48E+024.44E+06 9.22E+063.78E-11, 1.14E-10

1.99E+033.29E+051.07E+06O.OOE+001.65E+035.56E+051.89E-030.00+00O.OOE+000.00+000.00E+000.OOE+000.00E+000.00E+002.02E+046.60E+081.042-120.OOE+000.00+000.00E+000.00E+000.00E+000.00+000.00E+00O.OOE+00O.00E+000.OOE+000.002+00O.OOE+000.00E+000.00E+000.00+00O.OOE+00O.OOE+001.21E+024.79E-021.22E+040.00E+002.09E+074.55E+010.00E+001.12E+034.06E-031. 18E+042.50E+07O.OOE+000.OOE+00O.OO+005.79E+071.02E+038.40E+074.65B-10

1.99E+033.29E+051.07E+06O.OOE+001.11 E+040.00E+O0O.OOE+003.39E+056.29E+05O.OOE+00O.OOE+00O.OOE+0O0.00E+00O.OOE+00O.OOE+00O.OOE+00O.0OE+00O.OOE+000.00E+00O.OOE+000.00E+00O.OOE+000.00E+00O.OOE+000.OOB+000.00+00O.OOE+00O.OOE+00O.OOE+00O.OO+000.002+000.00E+00O.OOE+00O.OOE+00O.OOE+0OO.OOE+OOO.OOE+000.00+00O.OO+001.59E+00

0.OOE+00O.OOE+00O.OOE+O0O.OOE+000.00E+000.00+00O.0OE+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00

1.99E+033.29E+051.07E+062.44E+095.79E+051.66E+062.26E-011.11 E+052.26E206O.OOE+007.05E+062.23E+079.92E+062.33E+003.91E+051.84E+081.08E-10O.OOE+000.OOE+000.0OE+000.OOE+00O.OOE+O06.27E+07O.OO+00O.OO+004.57E+082.45E+096.07E+058.81E+011. I OE+056.56E-175.25E+058.87E-011.82E+038;82E+045.05E+032.40E+070.00+008.08E+06} .78E+030.00+001.15E+043.02E-011.36E+051.59E+09O.OOE+000.00E+007.19E+061.64E+071.40E+043.49E+079.90E-09

O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+000.00+00O.OOE+00O.OOE+00O.OOE+000.00E+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+O00.00+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.002+00O.OOE+000.002+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OO+00O.OOE+00O.OOE+O0O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+000.00E+00OO.OOB+0O

RSP-0008 REV -12 -PAGE 82 OF 103


TABLE 1-12: DOSE FACTOR TABLE: R (I3 - CHILD, GOATS MILKNu clide Rona Liver Tbodv Thvroid KidneY Lune GI Tract Skin

TE-13IMTE-131TE-1321-1301-1311-132I-133I-134I-135CS-134CS-136CS-137CS-138BA-139BA-140BA-141BA-142LA-140LA-142CE-141CE-143CE-144PR-143PR-144ND-147W-187NP-239

I.92E+05 6.65E+042.13B-33 6.48E-341.23E+06 5.44E+052.08E+06 4.20E+061.54E+09 1.55E2+098.41E-01 1.54E+002.06E+07 2.55E+071.06E- 11 1.98E-1 I6.52E+04 1.17E+055.30E+10 8.69E+102.89E+09 7.59E+097.492+10 7.17E+101.28B-22 1.78E-222.482-08 1.32E-111.34E+07 1.18E+040.00E+0O 0.002+00O.OOE+OO 0.002+OO2.33E+00 8. 14E-019.95E-12 .3.17E-122.31E+03 l.15E+032.25E+01 1.22E+041.54B+05 4.82E+048.19E+01 2.46E+010.002+00 0.002+005.15E+01 4.17E+013.472+03 2.05E+032.07B+00 1.49E-01

7.07E+046.33E-346.57E+052.16E+068.78E+087.10E-019.66E+069.09E-125.55E+041.83E+105.15E+091.06E+10I. 13E-227.18E-107.84E+050.OOE+OOO.OOE+002.75E-019.94E-131.7 1E+021.77E+008.21E+034.07E+00O.OOE+003.23E+009.21E+021.05E-01

1.37E+05 6.432+05 O.OOE+001.63E-33 6.43E-33 0.2OE+O07.93E+05 5.05E+06 O.OOE+004.63E+08 6.28E+06 O.OOE+005.iIE+li 2.54E+09 0.002+007.17E+01 2.36E+00 O.OOE+004.74E+09 4.25E+07 O.OOE+004.54E-10 3.02E-lI O.OOE+001.04E+07 1.80E+05 O.OOE+000.00E+0O 2.69E+10 9.66E+09O.OOE+00 4.24E+09 6.32E+080.002+00 2.33E+10 8.40E+09O.OOE+00 1.25E-22 1.35E-23O.OOE+00 1.ISE-11 7.78E-12O.OOE+00 3.83E+03 7.01E+03O.OOE+00 0.00E+OO 0.00E+00O.OOE+00 0.00+00 O.OOE+00O.OQE+00 O.OOE+00 O.OOE+000.00+00 O.OOE+00 0.00E+000.00+00 5.05E+02 O.QOE+000.00E+00 5.12E+00 0.00+00O.OOE+00 2.67E+04 0.00+000.00E+OO 1.33E+01 O.OOE+00O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 2.29E+01 O.OOE+000.00E+OO O.OOE+00 O.OOE+00O.OOE+00 4.30E-01 O.OOE+00

2.70E+061. 12E-325.48E+061 97E+061.38E+081.82E+001.03E+071.31B-II8.94E+044.682+082.80E+084.49B+088.21 E-231.43E-066.80E+060.00+00O.OOE+002.27E+046.29E-071.44E+061.79E+051.26E+078.84E+04O.OOE+006.61E+042.89E+051.1OE+04

0.00+000.00+00O.OOE+000.00E+OO0.OQE+00O.OOE+000.00+000.00+000.00+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+OO0.00Q+000.00E+000.00+000.00+OO0.00+OOO.OOE+000.00E+OOO.OOE+00O.OOE+00O.OOE+00O.OOE+000.00+000.00E+OO

-r

RSP-0008 REV- 12 PAGE 83 OF 103


TABLE 1-13: DOSE FACTOR TABLE: R (I) - INFANT, GOATS MILK

TABLE 1-13DOSE FACTOR TABLE: R (i) - Infant, goats' milk

Units are mZ*mrem/yr per gCi/secNuclide Bone Liver Thody T hyroid Kidney Lung GI Tract Skin

H-3 O.OOE+00 3.01E+03 3.01E+03 3.01E+03 3.01E+03C-14 3.23E+06 6.89E+05 6.89E+05 6.89E+05 6.89E+05NA-24 1.85E+06 1.85E+06 1.85E+06 1.85E+06 1.85E+06P-32 1.82E+l I 1.07E+10 7.06E+09 O.OOE+00 O.OOE+00CR-51 O.OOE+00 O.OOE+00 1.71E+04 1.13E+04 2.46E+03MN-54 0.008+00 3.69E+06 8.36E+05 O.OOE+00 8.17E+05MN-56 0.008+00 3.82E-03 6.59E-04 O.OOE+00 3.29E-03FE-55 1.37E+06 8.83E+05 2.36E+05 O.OOE+00 O.OOE+00FE-59 2.50E+06 4.37E+06 1.72E+06 O.OOE+00 O.OOE+00CO-57 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00CO-58 O.OOE+00 2.42E+06 6.03E+06 O.OOE+00 O.OOE+00CO-60 O.OOE+00 8.21E+06 1.94E+07 o.ooe+00 0.00E+00NI-63 3.24E+09 2.0 1E+08 1.13E+08 O.OOE+00 O.OOE+00NI-65 4.27E-01 4.83E-02 2.20E-02 0.00E+00 O.OOE+00CU-64 0.00+00 2.07E+04 9.608+03 O.OOE+00 3.51E+04ZN-65 5.28E+08 1.81E+09 8.35E+08 O.OOE+00 8.78E+08ZN-69 2.52E-12 4.54E-12 3.38E-13 O.OOE+00 1.89E-12ZN-69M O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.OOE+00BR-82 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00BR-83 O.OOE+00 0.00+00 1.14E-01 0.00E+00 O.OOE+00BR-84 0.00E+00 O.OOE+00 1.62E-23 O.OOE+00 0.00E+00BR-85 O.OOE+00 O.OOE+00 O.OO+00 O.OOE+00 0.00E+00RB-86 0.00E+00 2.47B+09 1.22E+09 O.OOE+00 O.OOE+00RB-88 O.OOE+00 O.OO+00 O.OOE+00 O.OOE+00 O.OOE+OORB-89 O.OOE+00 O.OO+00 O.OOE+00 0.OE+00 O.OOE+00SR-89 2.25E+10 O.OOE+00 6.44E+08 O.OOE+00 O.OOE+00SR-90 1.98E+11 O.OOE+00 5.03E+10 O.OOE+00 0.00E+00SR-91 5.73E+05 O.OOE+00 2.07E+04 O.OOE+00 O.OOE+00SR-92 9.89E+00 O.OOE+00 3.67E-01 0.00+00 0.00E+00Y-90 8.18E+OI O.OOB+00 2.19E+00 0.00E+00 0.00E+00Y-91M 7.13E-20 O.OOE+00 2.43E-21 O.OOE+00 0.00E+00Y-91 7.40E+03 O.OOE+00 1.97E+02 0.00E+00 O.OOE+00Y-92 6.52E-05 O.OOE+00 1.83E-06 O.OOE+00 O.OOE+00Y-93 2.60E-01 O.OOE+00 7.08E-03 O.OOE+00 O.OOE+00ZR-95 6.83E+02 1.66E+02 1.18E+02 O.OOE+00 1.79E+02ZR-97 4.89E-01 8.38E-02 3.83E-02 O.OOE+00 8.45E-02NB-95 6.23E+04 2.57E+04 1.48E+04 0.00E+00 1.84E+04NB-97 O.OOB+OO O.OOE+00 0.OOE+00 0.00+00 0.00E+00MO-99 0.00+00 2.50E+07 4.87E+06 0.00+00 3.73E+07TC-99M 3.32E+00 6.84E+00 8.82B+01 O.OOE+00 7.36E+01TG-101 O.OOE+00 O.OOE+00. O.OOE+00 0.OOE+00 O.OOE+00RU-103 9.02E+02 O.OOE+00 3.02E+02 O.OOE+00 1.88E+03RU-IOS 9.75E-04 O.OOE+00 3.28E-04 O.OOE+00 7.178-03RU-106 1.79E+04 O.OOE.+00 224E+03 O.OOE+00 2.12E+04AG-11 OM. 3.67E+07 2.68E+07 1.77E+07 O.OO+00 3.83E+07SB-124. O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00SB-125 0.00+00 0.00E+00 0.00E+00 O.OOE+000 0.00+00TE-125M 1.52E+07 5.09E+06 2.06E+06 5.12B+06 0.00B+00TE-127M 4.11E+07 1.36E+07 4.97E+06 1.19E+07 1.01E+08

3.01E+03 3.01E+036.89E+05 6.89B+051.85E+06 1.858+06O.OOE+00 2.46E+092.19E+04 5.04E+050.00E+00 1.36E+060.00+00 3.47E-014.32E+05 1.12E+051.29E+06 2.09E+06O.OOE+00 O.OOE+00O.OOE+00 6.03B+06O.OOE+00 L.95E+07O.OOE+00 9.98E+06O.OO+00 3.68E+000.00E+00 4.25E+050.00E+00 1.53E+090.00+OO 3.70E-100.008+00 O.OOE+00O.OOE+00 O.OOE+000.00+00 0.00E+000.008+00 O.OOE+00O.OOE+00 O.OOE+00O.OOE+00 6.33E+07O.OOE+00 0.00+00O.OOE+00 O.OOE+00O.OOE+00 4.62E+08O.OOE+00 2.47E+09O.OOE+00 6.78E+05O.OOE+00 1.07E+02O.OOE+00 1.13E+050.00+00 2.38E-160.00E+00 5.30E+OSO.OO+00 1.24E+000.00E+ 2.05E+03O.OOE+00 8.29E+040.00+00 5.35E+03O.OOE+00 2.17E+070.OOE+00 O.OOE+000.00E+00 8.23E+063.58E+00 1.99B+03O.OOE+00 0.00E+00O.OOE+00 1. lOE+04O.OOE+00 3.S8E-01O.OOE+00 1.36E+05O.OOE+00 1.39E+09O.OOE+00 O.OOE+00O.OOE+00 0.00E+00O.OOE+00 7.26B+06O.OOE+00 1.66E+07

O.OOE+00O.OOE+00O.OOE+00O.OOE+0O0.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.008+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.0OE+000.00E+000.0OE+000.008+00O.OOE+000.00E+00O.OOE+000.001+000.008E00O.OOE+00O.OOE+00O.OOE+000.00-+00O.0OE+00O.OOE400O.OOE00O.OOE8000.0E0+000.00E+00O.OOE00O.OOE4000.00E+O00.008+000.0OE+00O.OOE+000.00E+00O.OOE+00O.OOE8000.008+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+000.00E+00

TE-127 7.61E+02 2.55E+02 1.64E+02 . 6.20E+02 1.86E+03 0.00E+00 1.60E+04TE-129M 5.87E+07 2.01E+07 9.04BE+0 2.25E+07 1.47E+08 O.OOE+00 3.51E+07

, E-- -129 3.37E-10 1.16E-10 7.87E-11 2.838-10 8.40E-10 O.OOE+00 2.70E-08

RSP-0008 REV- 12 PAGE 84 OF 103

AITACIMENT 27PAGE 2 OF 2

TABLE I-13: DOSE FACTOR TABLE: R ( - INFANT, GOATS MILKNuclide Bone Liver Tbody Thyroid Kidney Lumn GI Tract SkIn

TE-131M 4.06B+05 1.63E+05 1.35B+05 3.31-E+05 1.12B+06 0.003+00 2.75E+06 O.OOE+00TE-131 4.51E-33 1.67E-33 1.27E-33 4.02E-33 1.15E-32 0.00+00 1.82B-31 O.OOE+00TE-132 2.53E+06 1.25E+06 1.17E+06 1.85E+06 7.84E+06 0.00E+00 4.64E+06 0.008+001-130 4.27E+06 9.40E+06 3.77E+06 1.05E+09 1.03E+07 O.OOE+00 2.01E+06 0.008+001-131 3.21E+09 3.78E+09 1.66E+09 1.24E+12 4.41E+09 0.0E+00 1.35E+08 O.OOE+001-132 1.74E+00 3,54E+00 1.26B+00 1.66E+02 3.95E+00 0-00.+00 2.87E+00 O.OOE+001-133 4.36B+07 6,35E+07 1.86B+07 1.15E+10 7.46E+07 0.OOE+00 1.07E+07 O.OOE+0O1-134 2.21E-11 4.52E-11 1.61B-11 1.05B-09 5.05E-11 0.OOE+00 4.67E-1II 0.00+OO1-135 1.36E+05 2.70B+05 9.83E+04 2.42E+07 3.00E+05 O.OOE+00 9.76E+04 O.OOE+00CS-134 8.53E+10 1.59E+11 1.61E+10 O.OOE+00 4.10E+10 1.68E+10 4.32E+08 0.OOE+00CS-136 5.65E+09 1.66E+10 6.21E+09 0.008+00 6.628+09 1.35E+09 2.52E+08 O.OOE+00OCS-137 1.19E+11 1.40E+11 9.918+09 O.OOE+00 3.75E+10 1.528+10 4.37E+08 0.00-E00CS-138 2.708-22 4.40E-22 2.138-22 O.OOE+0O 2.19E-22 3.428-23 7.03E-22 O.OOE+00BA-139 5.27E-08 3.49E-11 1.53E-09 O.OOE+00 2.10E-11 2.12E-11 3.34E-06 0.00E+00BA-140 2.76E+07 2.76E+04 1.42E+06 O.OOE+00 6.56E+03 1.70E+04 6.79E+06 0.00E+00BA-141 O.OOE+00 0.008+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00B+00BA-142 0.00E+0O OOOE+OO 0.00++00 0.00E+00 0.00O+00 0.OOE+00 0.00E+00 0.008+00LA-140 4.87E+00 1.92E+00 4.94E-01 0.00E+00 0.00+00 0.00E+00 2.258+04 0.0OE+00LA-142 2.09E-11 7.67E-12 1.84E-12 0.008+00 O.OOE+OO 0.00+00 1.30E-06 O.OO+00CE-141 4.58E+03 2.79E+03 3.29E+02 0.008+00 8.62E+02 0.00E+00 1.44E+06 0.00E+00CB-143 4.77E+01 3.16E+04 3.61E+00 O.OOE+00 9.21E+00 0.001+00 1.85E+05 .OOE+OOCB-144 2.20E+05 9.02E+04 1.23E+04 0.008+00 3.64E+04 0.008+00 1.26E+07 0.008+00PR-143 1.70E+02 6.34E+01 8.40E+OO 0.008+00 2.36E+01 0.00E+00 8.95E+04 0.008+00PR-144 O.OOE+00 0.008+00 0.OOE+00 0.00E+00 0.00E+00 0.008+00 0.00E+00 0.00+00ND-147 1.02E+02 1.05B+02 6.438+00 O.OOE+00 4.05E+01 O.OOE+00 6.65E+04 0.008+00W-187 7.30E+03 5.08E+03 1.75E+03 0.008+00 0.00E+00 O.OOE+00 2.98E+05 0.00E+00NP-239 4.38E+00 3.92E-01 2.21E-01 O.OOE+00 7.81E-01 O.OOE+00 1.138+04 0.00E+00

RSP-0008 REV - 12 .PAGE 85. OF 103RS-OO _E 1 PA _ESOF1O_


TABLE 1-14: DOSE FACTOR TABLE: R (I) - ADULT, MEAT

TABLE 1-14DOSE FACTOR TABLE: R (i) - Adult, meat

Units are m2*mremlnr per WClsecNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin

H-3 O.OOE+OO 2.01E+02 2.01E+02 2.01E+02 2.01E+02 2.0IE+02 2.01E+02C-14 3.33E+05 6.66E+04 6.66E+04 6.66E+04 6.66E+04 6.66E+04 6.66E+04NA-24 1.39E-03 1.39E-03 1.39E-03 1.39E-03 1.39E-03 1.39E-03 1.39E-03P-32 4.41E+09 2.74E+08 1.71E+08 O.OOE+OO O.OOE+OO O.OOE+OO 4.96E+08.CR-51 O.OOE+OO O.OOE+OO 6.30E+03 3.76E+03 1.39E+03 8.36E+03 1.58E+06MN-54 O.OOE+OO 7.24E+06 1.38EF+06 Q.OOE+OO 2.15E+06 O.OOE+OO 2.22E+07MN-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00+00 O.OOE+OO O.OOE+OOFE-55 2.28E+08 1.58E+08 3.68E+07 O.OOE+OO O.OOE+OO 8.80E+07 9.05E+07FE-59 2.28E+08 5.36E+08 2.05E+08 O.OOE+OO O.OOE+OO 1.50E+08 1.79E+09CO-57 O.OOE+OO O.OOE+OO O.OO+OO 0.OO+OO O.OOE+OO O.OOE+OO O.OOE+OOCO-58 O.OO-+00 1.52E+07 3.40E+07 O.OOE+OO O.OOE+OO O.OOE+OO 3.07E+08CO-60 O.OOE+OO 5.84E+07 1.29E+08 O.OOE+OO O.OOE+OO O.OOE+OO I.IOE+09NI-63 1.46E+10 I.OlE+09 4.90E+08 O.OOE+OO O.OOB+O O.OOE+OO 2.1 IE+08NI-65 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOCU-64 O.OOE+OO 2.79E-07 1.31 E-07 O.OOE+OO 7.03E-07 O.OOE+OO 2.38E-O5ZN-65 2.82E+08 8.97E+08 4.05E+08 O.OOE+OO 6.OOE+08 O.OOE+OO 5.65E+08ZN-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+O0 O.OOE+OO O.OOE+OOZN-69M O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+ O.OOEf+OO O.OOE+OOBR-82 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOB+OO O.OOE+OO O.OOE+OOBR-83 O.OOE+OO O O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO .OOE+OO O.OOE+OOBR-84 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOB+OO O.OOE+OOBR-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.00E+OORB-86 O.OOE+OO 4.51 E+08 2.10E+08 O.OOE+OO O.OOE+OO O.OOE+OO 8.90E+07RB-88 O.OOE+OO O.OOE+OQ O.OOE+OO O.OOE+OO O.OOE+OO O.0OE+OO O.OOE+OORB-89 O.OOE+OO O.OOE+0 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOSR-89 2.56E+08 O.OOE+OO 7.36E+06 O.OOE+OO O.OOE+OO O.OOE+O0 4.1 1E+07SR-90 9.63E+09 O.OOE+OO 2.36E+09 O.OOE+OO O.OOE+OO O.OOE+OO 2.78E+08SR-91 1.58E-10 O.OOE+OO 6.39E-12 O.OOE+OO O.OOE+O O.OOE+OO 7.53E-10SR-92 O.OOE+OO O.OQE+OO O.OOE+OQ O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOY-90 1.08E+02 O.OOE+OO 2.90E+OO O.OOE+OO O.OOE+OO 0.OO+OO I. 15E+06Y-91M O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOY-91 9.53E+05 O.OOE+OO 2.55E+04 OO.OOE+OO O.OOE+OO O.OOE+OO 5.24E+08Y-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO OOOB+OO O.OOE+OOY-93 4.87E-12 O.OOE+OO 1.35E-13 O.OOE+OO O.OOE+OO O.OOE+OO 1.55E-07ZR-95 1.57E+-06 5.02E+05 3.40E+05 O.OOE+OO 7.88E+05 O.OOE+OO 1.59E+09ZR-97 2.1 1E-05 4.27E-06 1.95E-06 O.OOE+OO 6.44E-06 O.OOE+OO 1.32E+-OONB-95 2.01E+06 1.12BE06 6.01E+05 O.OOE+OO 1.IIE+06 O.OOE+OO 6.79E+09NB-97 O.OOE+OO O..OOE+ O O O.OOE+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOMO-99 O.OOE+OO 1.OIE+05 I.91E+04 O.OOB+0 2.28E+05 O.OOE+OO 2.33E+05TC-99M 4.74E-21 1.34E-20 1.71E-19 O.OOEE+00 2.04E-19 6.57E-21 7.93E-18TC-101 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Q.OOE+OO O.OOE+OORU-103 9.12E+07 O.OOE+OO 3.93E+07 O.OOE+OO 3.48E+08 O.OOE+OO 1.06E+10RU-105 6.30E-28 O.OOE+OO 2.49E-28 O.OOE+OO 8.14E-27 O.OOE+OO 3.85E-25RU-106 2.20E+09 O.OOE+OO 2.78E+08 O.OOE+OO 4.25E+09 O.OOE+OO 1.42E+I IAG-I IOM 5.29E+06 4.89E+06 2.91E+06 0.00+00 9.62E+06 O.OOE+00 2.OOE+09SB-124 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+OO O.OOB+00 O.OOE+00 O.OOE+00SB-125 O.OOE+0 0.00+00 00+ OOOE+ 00 0.00E+OO O.OOB+OO 0.00E+00 O.OOE+00TE-125M 3.02B+08 1.09E+08 4.05E+07 9.09B+07 1.23E+09 O.OOE+00 1.21E+09TE-127M 9.07E+08 3.24E+08 I.IOE+08 2.32E+08 3.68E+09 .00E+0O 3.04E+09TE-127 2.21E-10 7.94E-11 4.78E-11 1.64B-10 9.01E-10 0.00E+00 1.74E-08TE-129M 9.96E+08 3.72E+08 1.58E+08' 3;42E4-08 4.16E+09 O.OOE+OO 5.02E+09TE-129 0.00E+OO 0.00E+00 O.OE+00, O.OOE+00 0.00E+00 0.OOE+00 O.OOE+OO

O.OOE+00O.OOE+000.0OE+000.OOE+O0O.OOE+00O.OOE+00O.OOE+0 O

.0.E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.OOE+O0O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+O0O.OOE+000.OOE+00O.OOE+00O.OOE+000.00E+000.00E+O0O.OOE+00O.OOE+000.002+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.002+000.00E+000.00E+00O.OOE+00O.OOE+000.OOE+000.OOE+060.OOE+00O.OOE+00O.OOE+000.00F+000.002+00O.OOE+00O.OOE+00.O.OOE+O0O.OOE+00

RSP-0008 REV -12 PAGE 86 OF 103


TABLE 1-14: DOSE FACTOR TABLE: R (1 - ADULT, MEATNuclide Bone Liver Thody Thyroid Kidney LuLU GI Tract Skin

TE-131M 4.57E+02 2.23E+02TE-131 O.OOE+00 0.00E+O0TE-132 1.43E+06 9.22E+051-130 2.18E-06 6.42E-061-131 1.06E+07 1.51E+071-132 O.OOE+00 0.OOE++O1-133 3.72E-01 6.47E-011-134 O.OOE+00 0.00E+001-135 4.69E-17 1.23E-16CS-134 5.13E+08 1.22E+09CS-136 1.15E+07 4.54E+07CS-137 6.75E+08 9.23E+08CS-138 O.OOE+00 O.OOE+00BA-139 O.OOE+OO O.OOE+00BA-140 2.75E+07 3.45E+04BA-141 O.OOE+00 O.OOE+00BA-142 O.OOE+0O O.OOE+00LA-140 3.74E-02 1.89E-02LA- 42 O.OOE+00 O.OOE+0OCE-141 1.24E+04 8.37E+03CE-143 2.03E-02 1.50E+01CE-144 1.15E+06 4.81E+05PR-143 2.00E+04 8.00E+03PR-144 O.OOE+00 O.OOE+00ND-147 6.84E+03 7.90E+03W-187 2.08E-02 1.74E-02NP-239 2.61E-01 2.56E-02

1.86E+02O.OOE+008.66E+052.53E-068.66E+060.002+001.972-01O.OOE+004.53E-179.98E+083.27E+076.05E+08O.OOE+O0O.OOE+001.80E+06O.OOE+00O.OOE+004.98E-03O.OOE+009.49E+021.66E-036.18E+049.89E+020.00+004.73E+026.09E-031.41E-02

3.54E+02 2.26E+03 O.OOE+00 2.22E+04O.OOE+00 O.OOE+00 O.OOE+OO O.OOE+001.02E+06 8.88E+06 O.OOE+0O 4.36E+075.44E-04 I.OOE-05 0.00E+00 5.52E-064.95E209 2.59E+07 0.00E+00 3.99E+06O.OOE+00 O.OOE+00 0.00E+00 O.OOE+009.51E+01 1.13E+00 O.OOE+00 5-82E-01O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+008.10E-15 1.97E-16 0.002+00 1.39E-16O.OOE+00 3.95E+08 1.31E+08 2.14E+07O.OOE+00 2.53E+07 3.46E+06 5.16E+06O.OOE+00 3.132+08 1.04E+08 1.79E+070.00E+00 0.OOE+00 0.0OE+00 O.OOEt00O.OOE+00 0.00E+00 O.OO+00 O.OOE+00O.OOE+00 1.17E+04 1.98E+04 5.66E+07O.OOE+00 0.00E+00 O.OOE+00 0.002+000.002+00 O.OOE+00 O.OOE+00 O.OOE+0OO.OOE+00 O.OOE+00 O.OOE+0O 1.38E+03O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 3.89E+03 0.00E+00 3.20E+07O.OOE+00 6.61E-03 O.OOE+00 5.61E+02O.OOE+00 2.85E+05 O.OE+00 3.89E+08O.OOE+00 4.622+03 O.OOE+00 8.74E+070.OOE+00 0.OOE+00 O.OOE+00 0.00+00O.OOE+00 4.62E+03 O.OOE+00 3.79E+070.00E+00 0.O02+00 O.OO+00 5.70E+00O.OOE+00 8.00E+02 O.OOE+00 5.26E+03

0.OOE+00O.OOE+00O.OOE+000.0OE+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+000.00E+00.OOOE+000.00E+00O.OOE+000.00E+000.OOE+000.OOE+00O.OOE+00

RSP-0008 REV - 12 PAGE 87 OF 103RSP-0008 REV �t2 PAGE 87 OF 103


TABLE 1-15: DOSE FACTOR TABLE: R (1) - TEEN, MEAT

TABLE I-15DOSE FACTOR TABLE: R (i) -Teen, meat

Units are m2*mrem/yr per pCi/secNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Sldn

H-3 O.OOE+OO 1.20E+02 1.20E+02 1.ZOE+02 1.20E+02 1.20E+02 1.20E+02 O.OOE+OOC-14 2.81E+OS 5.62E+04 5.62E+04 5.62E+04 5.62E+04 5.62E+04 5.62E+04 O.OOE+OONA-24 -1.I1E-03 1.IIE-03 1.IlE-03 1.lIE-03 I.IIE-03 1.lIB-03 I.IIE-03 O.OOE+OOP-32 3.73E+09 2.3 1E+08 1.45E+08 O.OOE+OO O.OOE+OO O.OOE+OO 3.13E+08 O.OOE+OOCR-51 O.OOE+OO O.OOE+OO 5.04E+03 2.80E+03 1. 1OE+03 7.19E+03 8.46E+05 O.OOE+OOMN-54 O.OOE+OO 5.52E+06 1.09E+06 O.OOE+OO 1.65E+06 O.OOE+OO 1.13E+07 O.OOE+OOMN-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOFE-55 1.85E+08 1.3 1E+08 3.07E+07 O.OOE+OO O.OOE+OO 8.34E+07 5.69E+07 O.OOE+OOFE-59 1.82E+08 4.25E+08 1.64E+08 O.OOE+OO O.OOE+OO 1.34E+08 1.OIE+09 O.OOE+OOCO-57 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.0E+OQ O.OOE+OOC0-58 O.OOE+OO 1.17E+07 2.69E+07 O.OOE+OOO O.OOE-O0 O.OOE+OO 1.61E+08 O.OOE+OOCO-60 O.OOE+OO 4.53E+07 1.02B+08 O.OOE+OO O.OOE+OO O.OOE+OO 5.90E+08 O.OOE+OONl-63 1.18E+10 8.30E+08 3.98E+08 O.OOE+OO O.OOE+OO O.OOE+OO 1.32E+08 O.OOE+OONI-65 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOCU-64 O.OOE+OO 2;28E-07 1.07E-07 O.OOE+OO 5.76E-07 O.OOE+OO 1.77E-05 O.OOE+OOZN-65 1.98E+08 6.88E+08 3.21E+08 O.OOE+OO 4.40E+08 O.OOE+OO 2.91E+08 O.OOE+OOZN-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOZN-69M O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE±OOBR-82 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOBR-83 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+0 O.OOE+OO O.OOE+OO O.OOE+OOBR-84 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOBR-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE-OO O.OOE+OO O.OOE+OORB-86 O.OOE+OO 3.77E+08 1.77E+08 O.OOE+OO O.OOE+OO O.OOE+OO 5.57E-07 O.OOE+OORB-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OORB-89 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOSR-89 2.16E+Q8 O.OOE+OO 6.20E+06 O.OOE+OO O.OOE+OO O.OOE+OO 2.58E+07 O.OOE+OOSR-90 6.23E+09 O.OOE+OO 1.54E+09 O.OOE+OO O.OOE+OO O.OOE+OO 1.75E+08 O.OOE+OOSR-91 1.33E-10 O.OOE+OO 5.29E-12 O.OOE+OO O.OOE+OO O.OOE+OO 6.30-10 O.OOE+OOSR-92 O.OOE+OO O.OOE+0O O.OOE+OO O.OOE+OO O.OOE+OO O.OOB+0O O.OOE+OO O.OOE+OOY-90 9.IIE+OI O.OOE+OO 2.45E+OO O.OOE+OO O.OOE+OO 0.OOE+OO 7.SIE+05 O.OOE+OOY-91M O.OOE+OO Q.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOY-91 8.03E+05 O.OOE+OO 2.15E+04 0.OOE+OO O.OOE+O0 O.OOE+OO 3.29E+08 O.OOE+OOY-92 O.OOE+OO 0.OG+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE0 +OO O.OOE+OO O.OO+OOY-93 411E-12 O.OOE+OO 1.13E-13 O.OOE+OO O.OOE+0O O.OOE+OO 1.26E07 0.OOE+OOZR-95 1.25E+06 3.96E+05 2.72E+05 O.-OOE+OO 5.82E+05 O.OOE+OO 9.13E+08 O.OOE+-OOZR-97 1.76E-05 3.49E-06 1.61E-06 O.OOE+0O 5.29E-06 O.OOE+0O 9.44E-O1 O.OOE+OONB-95 1.57E+06 8.71E+05 4.79E+05 O.OOE+OO 8.44E+05 O.OOE+0O 3.72E+09 O.OOE+OONB-97 O.OOE+OO O.OOE+OO O .OOE+O O 0.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OOMO-99 O.OOE+00 8.31-E+04 1.58E+04 O.OOE+OO I.90E+S05 O.OOE+-O0 lA9E+05 0.BOE+OOTC-99M 3.77E-21 1.05E-20 1.36E-19 O.OOE+OO 1.57E-19 5.83E-21 6.90E-18 O.O0E+-OTC-O101 0.0B--O 0.OOE+OO O.GOE+OO O.OOE+OO 0-f-GO O.OOE+O0 O.OOE+OO O.OOE+OORU-103 7.43E+07 0.OOE+OO 3.17E+07 O.OOE+OO 2.62E+08 O.OOE+OO 6.20B+09 O.OOE+OORU-IOS 5.27E-28 0.OOE+OO 2.04E-28 O.OOE+OO 6.65E-27 0.OOE+OO 4.25E-25 0.0OE+OORU-106 1.85E+09 O.OOE+OO 2.34E+08 0.OOE+OO 3.57E+O9 O.OOE+O0 8.89E+10 O.OOE+OOAG-iI OM 4.OOE+06 3.79E+06 2.3 1E+06 O.OOE+OO 7.23E+06 O.OOE+OO 1.06E+09 O.OOE+OOSB-124 O.OOE+OO O.OOE+O O O.OOE00 0.OOE+OO O.OOOE+EO O.OOE+0O O.OOE+0O O.OOE+OOSB-125 O.OOE+00 0.GOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOEG-O O.OB-+OO O.OOE+OOTE-125M 2.55E+08 9.19E+07 3.41EE+07 7.13E+07 O.O0E+OO O.OOE+OO 7.53E+08 0.ooe+oo.TE-127M 7.65E+08 2.71E+08 9.10E+07 1.82E+08 3.1OE+09 O.OOEGOO 1.91E+09 QOAOE+OO.TE-127 1.8BE- 10 6.65E-11 4.04E-I1 1.29E-10 7.60E-10 O.OOE+OO 1.45E-08 O.OOE+OOTE-129M 8.34E+08 3.1OE+08 1.32E+08' 2.69E+08 3.49E+09 O.GOE+OO 3.13E+09 O.OOB+OOTE-129 O:OOE+OO -. OOE+OO O.OOB+OO .O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOB+GO

RSP-0008 REV- 12 PAGE 88 OF 103


TABLE 1-15: DOSE FACTOR TABLE: R (p - TEEN, MEATNuclide Bone Liver Tbody Thyroid Kidney hLu- GI Tract Skin

TE-131M 3.81E+02TE-131 0.OOE+00TE-132 1.17E+061-130 1.75E-061-131 8.78E+061-132 0.OOE+00I-133 3.1IE-011-134 0.OOE+001-135 3.82E-17CS-134 4.08E408CS-136 8.97E+06CS-137 5.60E+08CS-138 O.OOE+00BA-139 O.OOE+00BA-140 2.27E+07BA-141 O.OOE+00BA-142 O.OOE+00LA-140 3.OSE-02LA-142 0.OOE+00CE-141 1.04E+04CE-143 1.71E-02CE-144 9.70E+05PR-143 1.68E+04PR-144 O.OOE+00ND-147 6.02E+03W-187 1.74E-02NP-239 2.28E-01

1.83E+02O.OOE+007.39E+055.07E-061.23E+07O.OOE+005.28E-01O.OOE+009.82E-179.60E+083.53E+077.46E+08O.OOE+000.OOB+002.7SE+040.OOE+000.OOE+001.51lE-020.OOE+006.94B+031.24E+014.01E+056.70E+030.OOE+006.55E+031.42E-022.15E-02

1.52E+02O.OOE+006.95E+052.02E-066.60E+06O.OOE+001.61B-01O.OOE+003.64E-174.45E+082.37E+072.60E+08O.OOE+00O.OOE+001.46E+060.OOE+00O.OOE+004.02E-030.OOE+007.97E+021.39E-035.21E+048.36E+02O.OOE+003.92E+024.98E-031.19E-02

2.75E+02 1.90E+03O.OOE+00 O.OOE+007.79E+05 7.09E+064.13E-04 7.80E-063.59E+09 2.12E+07O.OOE+00 O.OOE+007.37E+01 9.26E-01O.OOE00 OO.OOE+006.32E-15 1.55E-16O.OOE+00 3.05E+08O.OOB+00 1.92E+07O.OOE+00 2.54E+08O.OOE+00 O.OOE+00O.OOE+00 O.OOE+00O.OOE+00 9.44E+030.OOE+00 O.OOE+00O.OOE+00 0.OOE+00O.OOE+00 0.OOE+000.00+00 O.OOE+00O.OOE+00 3.27E+03O.OOE+00 5.58E-03O.OOE+00 2.40E+05O.OOE+00 3.90E+03O.OOE+00 O.OOE+00O.OOE+00 3..85E+03O.OOE+00 O.OOE+00O.OOE+00 6.75E-02

O.OOE+00O.OOE+00O.OOE+000.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+00

0.00E+001.16E+083.03E+069.86E+07O.OOE+00O.OOE+001.87E+04O.OOE+000.OOE+00O.OOE+000.00E+00O.OOE+000.OOE+000.00E+000.00E+00O.OOE+00O.OOE+000.00E+000.00+00

I.472+040.OOE+002.34E+073.89E-062.43E+060.00E+003.99E-010.O0+00

1.09E-T61. 19E+072.84E+061.06E+07

O.OOE+00O.OOE+003.50E+070.00E+000.OOE+008.69E+02O.OOE+001.98E+073.74E+022.44E+085.52E+07O.OOE+002.36E+073.85E+003.46E+03

O.OOE+00O.OOE+000.002+000.00E+000.OOE+000.00+00O.OOE+00O.OOE+00

0.00+00O.OOE+000.00E+00O.OOE+00O.OOE+000.OOE+00O.OOE+00O.OOE+000.00+00O.OOE+000.OOE+00O.OOE+00O.OOE+00O.OOE+000.002+000.00+000.00+00O.OOE+00O.OOB+00

RSP-0008- RE Y2:AE89O 0RS 0 -EV .1 PA G 89 OF 10


TABLE 1-16: DOSE FACTOR TABLE: R (1) - CHILD, MEAT

TABLE 1-16DOSE FACTOR TABLE: R (i) - Child, meat

Units are mZ*mrem/yr per tCi/secNucide Bone Liver Tbody Thyroid Kidney Lung __ Tract Skin

H-3 0.00E+00C-14 5.29E+05NA-24 1.77E-03P-32 7.03E+09CR-51 0.00E+O0MN-54 O.OOE+00MN-56 O.OOB+00FE-55 3.56B+08FE-59 3.23E+08CO-57 O.OOE+00CO-58 O.OOE+00CO-60 O.OO+00NI-63 2.25E+10NI-65 0.O08+00CU-64 O.OOE+00ZN-65 2.97E+08ZN-69 O.OOE+00ZN-69M O.OOE+00BR-82 O.OOB+00BR-83 0.OOE+OOBR-84 0.00E+00BR-85 0.OOE+OORB3-86 O.OOE+00RB-88 0.OOE+00RB-89 O.OOE+00SR-89 4.10E+08SR-90 8.05E+09SR-91 2.50E-10SR-92 O.OOE+00Y-90 1.72E+02Y-91M O.OOE+OOY-91 1.52B+06Y-92 0.00+00Y-93 7.73E-12ZR-95 2.23E+06ZR-97 3.28E-05NB-95 2.71E+06NB-97 O.OOE+00MO-99 O.OOE+00TC-99M 6.61E-21TC-101 O.OOE+00RU-103 1.34E+08RU-105 9.83E-28RU-106 3.49E+09AG-IIOM 6.64E+06SB-124, O.O+00SB-125 O.OOE+00TB-125M 4.79E+08TE-127M 1.44B+09TE-127 3.53E-10TE-129M 1.57E+09TE-129 0.008+00

1.45E+021.06E+051.77E-033.29E+080.OOE+006.31B+060.00E+001.89E+085.23E+08O.OOE+001.36E+075.38E+071.21E+09O.OOE+003.06E-077.92E+08O.OOE+000.OOE+000.00E+000.00E+000.00E+00O.OOE+005.34E+080.00+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+000.00E+00O.OOE+00Q.OOE+00O.OOE+004.90E+054.748-061.06E+06Q.OOE+001.16E+051.30E-20O.OOt+00O.OOE+000.0OE+O0O.OOE+004.49E+06O.OOE+00O.OOE+001.308+083.88E+089.51E-114.39E+080.00E+00

1.45E+02 1.45E+02 1.45E+02 1.45E+021.06E+05 1.06E+05 1.06E+05 1.06E+051.77E-03 1.77E-03 1.77E-03 1.77E-032.71E+08' O.OOE+00 O.OOE+00 0.00+007.85E+03 4.368+03 1.19E+03 7.96E+031.68E+06 O.OOE+00 1.77E+06 O.OOE+00O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+005.85E+07 O.OOE+0O O.OOE+00 1.07B+082.60E+08 O.OOE+00 0.00E+00 1.51 E+080.008+00 O.OOE+00 O.OOE+00 0.008+004.18E+07 0.008+00 O.OOE+00 O.OOE+001.59E+08 O.O+00 0.OOE*+O 0.0OE+007.668+08 O.OOE+00 0.008+00 O.OOE+00O.OOE+00 O.OOE+00 0.00+00 O.OOE+001.85E-07 O.OOE+00 7.398-07 O.OOB+004.93E+08 O.OOE+00 4.99E+08 0.008+000.00E+00 O.OOE+00 O.OOE+00 O.OOE+000.00E+00 O.OOE+00 O.OOE+00 O.OOE+000.008+00 O.OOE+00 O.OOE+00 0.00E+00O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+003.28E+08 O.OOE+00 O.OOE+00 0.OOE+00O.OOE+00 O.OOE+00 0.OOE+00 0.008+00O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+OO1.17E+07 O.OOE+00 O.OOE+00 0.008+002.04E+09 0.00E+00 O.OOE800 0.8OE+09.42E-12 0.008+00 0.008E+0 0.00E+000.00E+O0 0.008E+0 0.008E+0 O.OOE+004.61E+00 O.OOE+00 0.00E+00 0.008E+00.00+00 O.OOE+00 O.OOE+08 O.OE+.0004.05E+04 0.00E+00 0.008+00 0.008+000.00E+00 O.OOE+00 O.OOE+00 0.00E+002.12E-13 O.OOE+00 O.OOE+00 O.OOE8004.36E+05 0.00E+00 7.018+05 0.008+002.808-06 0.00E+00 6.80E-06 0.00E+007.54E+05 0.008E+0 9.92E+05 0.00E+00O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+002.86E+04 O.0OE+OO 2.47E+05 O.OOE+002.158-19 0.008+00 1.88E-19 6.58E-21O.OOE+00 0008E+00 O.OOE+0 0.008E+005.16E+07 0.00+00 3.38E+08 O.OO8+003.57E-28 0.00+00 8:64E-27 O.OOE+004.35E+08 0.00+00 4.71E+09 0.00E+OO3.59E+06 0.00E+OO 8.36E+06 0.00E+00O.OOE+00 O.OOE+00 0.8OE+00 0.008E+0O.OOE+0 0.OOE+00 O.OOE+00 O.OOE+OO6.39E+07 1.34E+08 O.OOE+0 .OOE+001.71E+08 3.45E+08 4.11E+09 0.00E+007.57E-11 2.44E-10 1.00E-09 O.OOE+002.44E+0 5.07E+08 4.628+09 O.OOE+000.008E+ 0.00+00 0.008+00 0.008E+O

1.45E+021.06E+051.77E-031.94E+084.16E+055.30E+060.008+003.50E+075.44E+08O.OOE+007.96E+072.98E+088.13E+07O.OOE+1.44E-051.39E+080.00+00O.OOB+00O.OOE+000.00+000.OOE+OO0.OOE+003.44E+070.00+00O.OOE+001.59E+071.08E+085.51E-100.00E+004.91E+050.00E+002.02E+080.00E+001.15E-075.11 E+087.18E-011.95E+09O.OOE+009.56E+047.37E-180.00+003.47E+096.42E-255.43E+105.34E+080.00+00O.OOE+004.62E+081.17E+091.38E-081.92E+09O.OOE00

0.00+00O.OOE+00O.OOE+O00.00E+000.00E+00O.OOE+000.00E+000.00+00O.OOE+00O.OOE+00O.OOE+000.008+000.008+000.00E+000.00+000.00E+000.00+00O.OOE+000.00+000.00E+000.00E+000.00E+OOO.OOE+00O.OOE+O00.00E+000.OOE+00O.OOE+00o.0E8+00O.OOE+000.00E+000.008+000.00+00O.OOE+00O.OOE+000.00E+00O.OOE000.00E+000.00E+000.00E+000.00+00O.OOB+000.00E+OOO.OOE+00O.OOE+000.008+00O.OOE+O0O.OOE000.00E+O0O.OOE+00O.OOE+000.00E+000.00E+OO

RSP-0008 REV- 12 PAGE 90 OF 103

AflACHMENT 30PAGE 2 OF 2

TABLE 1-16: DOSE FACTOR TABLE: R (I) - CURD, MEATNuclide Bone Liver Tbody Thyroid lUdne y GI Tract Skin

TE-131M 7.09E+02 2.45E102 2.61B+02 5.0411+02 2.37E+03 0.00E+00 9.94E+03 0.00E+00TE-131 0.00+00 O.OOE+OO O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00+00 0.0011+00TE-132 2.13E+06 9.43E+05 1.14E+06 1.37E+06 8.75E+06 O.OOE+00 9.49B+06 O.OOE+001-130 3.13E-06 6.33E-06 3.26E-06 6.97E-04 9.46E,-06 O.OOE+00 2.96E-06 O.OOE+001-131 1.63E+07 1.64E+07 9.30E+06 5.41E+09 2.69E+07 0.0OE+00 1.46E+06 O.OOE+001-132 0.00+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+001-133 5.78E-01 7.151-01 2.70E-01 1.33E+02 1.19E+00 O.OOE+00 2.88E-01 O.OOE+00[-134 O,OOE+00 0.00E+00 0.00+00 O.OOE+00 0.0011+00 0.0OE+0O 0.00+00 O.OOE+00I-135 6.91E-17 1.24E-16 5;88E-17 1.10E-14 1.91E-16 O.OOE+00 9.47E1-17 O.OOE+00CS-134 7.19E+08 1.18E+09 2.49E+08 O.OOE+00 3.66E+08 1.31E+08 6.36E+06 O.OOE+00CS-136 1.55E+07 4.25E+07 2.75E+07 O.OOB+00 2.27E+07 3.38E+06 1.50E+06 0.0011+00CS-137 1.03E+09 9.88E+08 1.46E+08 O.OO+00 3.22E+08 1.16E+08 6.19E+06 O.OOE+00CS-138 0.00E+00 O.OOE+00 O.OOE+00 0.01E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0 OBA-139 0.00+00 O.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 O.OOE+00 O.01+00 O.OOE+00BA-140 4.19E+07 3.67E+04 2.45E+06 O.OOE+00 1.20E+04 2.19E+04 2.12E+07 O.OOE+00BA-141 O.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00BA-142 O.OOE+00 O.OOE+00 0.00+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OO+00 O.OOE+00LA-140 5.64E-02 1.97E-02 6.64E-03 0.00E+00 0.00E+00 0.OOE+00 5.49E+02 0.00E+00LA-142 0.001+00 O.0OE+00 O.OOE+00 O.OOE+00 0.00E+00 0.001+00 0.00E+00 0.00E+00CE-141 1.96E+04 9.76E+03 1.45E1+03 O.OOE+00 4.2811+03 0.00E+00 1.22E+07 O.OOE+00CE- 143 3.21E-02 1.74E+01 2.52E-03 OOOE+00 7.29E-03 O.OOE+00 2.55E+02 O.OOE+00CE-144 1.83E+06 5.73E+05 9.76E+04 O.OOE+00 3.17E+05 O.OOE+00 1.49E+08 0.00E+00PR-143 3.181E+04 9.54E+03 1.58E+03 O.OOE+00 5.17E+03 O.OOE+00 3.43E+07 O.OOE+00PR-144 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.0011+00 0.00+00 0.00OE+00ND-147 1.13E+04 9.16E+03 7.09E+02 O.OOE+00 5.02E+03 0.00E+0O 1.45E+07 0.00E+00W-187 3.23E-02 1.91E-02 8.59E-03 0.00E+00 0.00E+OO 0.OOE+00 2.69E+00 O.OOE+00NP-239 4.29E-01 3.081-02 2.161-02 O.OOE+00 8.90E-02 O.OOE+00 2.28E+03 O.OOE+00

RSP-0008 ,REV -12 PAGE 91 OF 103


TABLE 1-17: DOSE FACTOR TABLE: R (I) - ADULT, VEGETATION

TABLE 1-17DOSE FACTOR TABLE: R (i)- Adult, vegetation

Units are m2*mrem/yr per MCi/secNuclide Bone Liver Tbodv Thvroid Kidney Lung Gl Tract Skin

H-3 O.OOE+00 1.40E+03C-14 8.97E+05 1.79E1+05NA-24 2.68E+05 2.68E+05P-32 1.40E+09 8.72E+07CR-51 0.OOE+0O 0.00E+00MN-54 O.OOE+00 3.101E+08MN-56 O.OOE+00 1.54E+01FE-55 2.08E+08 1.43E+08FE-59 1.26B+08 2.96E+08CO-57 O.OOE+00 O.OOE+00CO-58 O.OOE+00 3.06E+07CO-60 0.QOE+00 1.65E+08NI-63 1.03E+10 7.14B+08NI-65 5.96E+01 7.75E+00CU-64 0.OOE+00 9.14E+03ZN-65 3.15E+08 1.00E+09ZN-69 5.06E-06 9.67E-06ZN-69M O.OOE+00 O.OOE+00BR-82 O.OOE+0O O.OOE+00BR-83 O.OOE+00 O.OOE+00BR-84 O.OOE+00 O.OOB+00BR-85 O.OOE+00 0.00E+00RB-86 O.OO+00 2.19E+08RB-88 0.00E+00 2.64E-22RB-89 O.OOE+00 2.88E-26SR-89 9.94E+09 O.OO+00SR-90 5.98E+1 I O.OO+00SR-91 3.02E+05 O.OOE+00SR-92 4.15E+02 O.OOE+00Y-90 1.33E+04 O.OOE+00Y-91M 4.76M-09 O.OOE+00Y-91 5.09E+06 O.OOE-+-00Y-92 8.96E-01 O.OOE+00Y-93 1.68E+02 0.00+00ZR-95 1.17E+06 3.75E+05ZR-97 3.36E+02 6.78E+01NB-95 1.42E+05 7.90E104NB-97 O.OOE+00 O.OOE+00MO-99 O.OOE+00 6.144E+06TC-99M 3.06E+00 8.66E+00TC-l01 5.93E-31 8.55E-31RU-103 4.761+06 O.OOE+00RU-105 5.29E+01 0.00E+00RU-106 1.91E+08 O.OOE+00AG-lIOM 1.05E+07 9.67E+06SB-124 0.0011+00 O.OOE+00SB-125 O.OOE+00 0.OOE+00TE-125M 9.62E+07 3.49E+07TE-127M 3.47E+08 1.241+08TE-127 5.611E+03 2.02E+03TE-129M 2.51E+08 9.3611+07TE-129 7.13E-04 2.68E-04

1.40E+03 1.40E+03 1.401+031.79E+05 1.79E+05 1.79E+052.68E+05 2.68E+05 2.68E+055.42E1+07 O.OOE+00 O.OOE+004.64E+04 2.771E+04 1.02E+045.92E+07 O.OOE+00 9.23E+072.74E+00 O.OOE+00 1.96B+OI03.34E+07 0.001+00 O.OOE+001.13E+08 - 0.00+00 O.OOE+000.00E+00 O.OOE+00 O.OOE+006.86E+07 O.OO+00 0.0011+003.65E+08 O.OOE+00 O.OOE+003.45E+08 O.OOE+00 O.OOE+003.54E+00 O.OOE+00 O.OOE+004.29E+03 O.OOE+00 2.311E+044.53E+08 O.OOE+00 6.70E+086.72E-07 O.OoE+00 6.28E-06O.OOE+00 O.OOE+00 O.OOE+000.00E+00 O.OOE1+0 0.00E+003.01E+00 0.001+00 O.OOE+002.141-1I O.OO+00 O.OOE+00O.OOE+00 O.OO+00 O.OOE+001.02E+08 0.OOE+00 0.00E+001.40E-22 O.OOE+00 0.00E+002.03E-26 O.OOE+00 O.01E+002.85E+08 O.OOE+00 O.OOE+001.47E+I I O.OOE+00 0.001+001.22E+04 0.001+00 0.00E+001.79E+01 O.OOE+00 O.OOE+003.56E+02 0.00E+00 O.OO+001.84E-10 O.OOE+00 O.OOE+001.36E+05 0.00E+00 O.OOE+002.62E-02 0.00E+00 O.OOE+004.65E+00 0.001+00 O.OOE+002.54E+05 O.OOE+00 5.89E+053.iOE+01 0.0011+00 1.02E+024.25B+04 O.OOE+O0 7.811E+040.00E+00 O.OOE+00 O.OOE+001.17E+06 O.OOE+00 1.39E+071.11OE+02 O.OOE+00 1.31E+028.39E-30 0.001E+00 1.54E-292.05E+06 O.OOE+00 1.82E+072.09E+01 O.OOE+00 6.84E+022.42E+07 O.OOE+00 3.69E+085.74E+06 O.OO+0O 1.90E+0700011+00 0.00+00 O.OOE+000.001+00 O.OOE+00 O.OOE+001.29E+07 2.891+07 3.91E+084.23E+07 8.87E+07 1.41E+091.21E+03 4.161E+03 2.29E+043.97E+07 8.611E+07 1.05B+091.74E-04 5.48E-04 3.00E-03

1.40E1+031.79E+052.68E+05O.OOE+006.15E+04O.OOE+00O.OOE+008.00E+078.26E+07O.OOE+00O.OOE+OOO.OOE+00.O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+000.00+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00O+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+000.OOE000.OOE+00O.OOE+00O.OOE+004.24E+004.37E-31O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00+O0O.OOE+00O.OOE+00O.OOE+000.00E+000.OOE+00O.OOB+00

1.40E+031.79E+052.68E+051.58E+081.17E+079.50E+084.92E+028.23E+079.85E+08O.OOE+006.20E+083.1 IE+091.49E+081.97E+027.79E+056.311E+081.45E-06O.OOE+000.00E+004.33E+001.68E- 160.OOE+004.32E+073.65E-33O.OOE+001.59E1+091.73E+101.44E+068.21E+031.41 E+081.40E-082.80E+091.57E+045.34E+061.19E+092.10B1+074.80E+08O.OOE+001.42E1+075. 12E+03O.OOE+005.56E1+083.24B+041.24B+103.95E+090.001+00O.OOE+003.84E+081. 16E1+09.4.43E+051.26E+095.3 BB-04

O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+000.00E+000.00E+000.00E+000.00E+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+000.00E+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+000.00E+00O.OOE+000.00E+00O.OOE000.(0f+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OO+00O.OOE+00O.OOE+00O.OO+00O.OOE+000.00E+000.00E+000.00E+0O0.OOE+00O.OOB+00O.OO+00

RSP-0008 REV -12 PAGE 92 OF 103


TABLE 1-17: DOSE FACTOR TABLE: R (1) - ADULT, VEGETATIONNuclide Bone Liver Tbody Thyroid Kidney Lune G0 Tract Skin

TE-131M 9.10B+05 4.45E+05 3.711E+05 7.05E+05 4.51E+06 O.OOE+00 4.42E+07 O.OOE+00TE-131 1.25E-15 5.21E-16 3.94E-16 1.03E-15 5.471-15 o.ooe400 1.77E-16 O.OOE+00TE-132 4.30E+06 2.78E+06 2.61 E+06 3.07E+06 2.6BE+07 O.OOE+00 1.31E+08 O.OOE+001-130 3.90E+05 1.15E+06 4.54E+05 9.75E+07 1.79E+06 O.OO+00 9.90E+05 O.OOE+001-131 8.07E+07 1.15E+08 6.61B+07 3.78E+10 1.98E+08 O.OOE+00 3.04E+07 O.OOE+001-132 5.57E+01 1.49E+02 5.21E+01 5.21E+03 2.37E+02 O.OOE+00 2.80E+01 O.OOE+00

1-133 2.08E+06 3.611E+06 1.IOE+06 5.31E+08 6.31E+06 O.OOE+00 3.25E+06 O.OOE+001-134 8.84E-05 2AOE-04 8.59E-05 4.16E-03 3.82E-04 O.OOE+00 2.09E-07 O.OOE+001-135 3.85E+04 1.01E+05 3.72E+04 6.65E+06 1.62E+05 O.OOE+00 1.14E+05 O.OOE+00CS-134 4.62E+09 1.10E+10 8.99E+09 O.OOE+00 3.56E+09 1.18E+09 192E+08 O.OOE+00CS-136 4.26E+07 1.68E+08 1.21E+08 O.OOE+00 9.37E+07 1.28E+07 1.9 11E+07 O.OO.+00CS-137 6.29E+09 8.61E+09 5.64E+09 O.OOE+00 2.92E+09 9.71E+08 1.67E+08 0.00E+00CS-138 3.39E-11 6.70E-11 3.32E-II O.OOE+00 4.92E-11 4.86E-12 2.86E-16 0.00E+00BA-139 2.70E-02 1.92E-05 7.91E-04 0.00E+00 1.80E-05 1.09E-05 4.79E-02 O.OOE+00BA-140 1.28E+08 1.61E+05 8.41E+06 O.OOE+00 5.48E+04 9.23E+04 2.64E+08 O.OO+00BA-141 8.94E-22 6.76E-25 3.02E-23 0.00+00 6.28E-25 3.83E-25 4.21E-31 O.OOE+00BA-142 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00

LA-140 1.97E+03 9.95E+02 2.63E+02 O.OOE+00 O.OOE+00 O.OOE+00 7.30E+07 0.00+-00LA-142 1.92E-04 8.75E-05 2.18E-05 O.OOE+00 0.00E+0 0.001E+00 6.39E-01 0.OOE+00CE-141 1.97E+05 1.33E+05 1.51E+04 O.OOE+00 6.18E+04 0.00E+00 5.09E+08 .01OE+OOCE-143 9.95E+02 7.36E+05 8.14E+01. 0.00E+00 3.24E+02 O.OOE+00 2.75E+07 O.OOE+00CE-144 3.26E+07 1.36E+07 1.75E+06 O.OOE+00 8.09E+06 O.OO1+00 1.10E+10 O.OOE+00PR-143 6.25E+04 2.5 11E+04 3.101E+03 0.00E+00 1.45E+04 O.OOE+00 2.74E+08 O.OOE+00PR-144 2.36E-26 9.811E-27 1.20E-27 O.OOE+00 5.531E-27 O.OOE+00 3.40E-33 O.OOE+00ND-147 3.33E+04 3.85E+04 2.30E+03 0.008+00 2.25E+04 O.OOE+00 1.85E+08 O.OOE+00W-187 3.79E+04 3.17E+04 1.11E1+04 O.OOE+00 0.001+00 O.OOE+00 1.04E+07 O.OOE+00NP-239 1.43E+03 1.40E+02 7.73E+01 O.OOE+00 4.37E+02 O.OOE+00 2.881+07 O.OOE+00

RSP-0008 REV -12 PAGE 93 OF 103


TABLE 1-18: DOSE FACTOR TABLE: R (1) - TEEN, VEGETATION

TABLE 1-18DOSE FACTOR TABLE: R (i)- Teen, vegetation

Units are m2*mremlyr per gCi/secNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Sidn

H-3 O.OOE+00 1.60E+03 1.60E+03 1.60E+03 1.60E+03 1.60E+03 1.60E+03 O.OOE+OOC-14 1.45E+06 2.91E+05 2,91E+05 2.91E+05 2.91E+05 2.91E+05 2,9tE+05 O.OOE+OONA-24 2.38E+05 2.38B+05 2.38E+05 2.38E+05 2.38E+05 2.38E+05 2.38E+05 O.OOE+00P-32 1.61E+09 9.95E+07 6.23E+07 O.OOE+OO O.OOE+OO 0.00E+OO 1.35E+08 0.OOB+O0CR-51 O.OOE+O O.OOE+0O 6.16E+04 3.42E+04 1.35E+04 8.79E+04 1.03B+07 O.OOE+00MN-54 O.OOE+OO 4.51 E+08 8.94E+07 0.OOE+OO 1.34B+08 o.0o0+00 9.24E+08 O.OOE+O0MN-56 O.OOE+00 1.392+01 2.47E+00 O.OOE+00 1.76E+01 O.0OE+OO 9.16E+02 O.OOE+00FE-55 3.23E+08 2.29E+08 5.34E+07 O.OOE+OO O.OOB+OO 1.45E+08 9.90E+07 O.OOE+OOFE-59 1.79E+08 4.17E+08 1.61E+08 O.OOE+00 O.OOE+00 1.32E+08 9.87E+08 O.OOE+O0CO-57 O.OOE+OO O.OOE+00 0.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+O0 O.OOE+OOCO-58 O.OOE+0O 4.34E+07 1.OOE+08 0.OOE+O0 O.OOE+OO O.OOE+0 O 5.98E+08 0.OOE+00CO-60 0.00B+00 2.46E+08 5.54B+08 O.OOE+OO O.OO+00 O.OOE+00 3.21E+09 0.OOB+00NI-63. 1.59E+10 1.12E+09 5.39E+08 O.OOE+OO O.OOE+00 O.0OE+O0 1.79E+08 O.OOE+00NI-65 5.55E+01 7.09E+00 3.23E+00 O.OOE+OO O.O0E+OO O.O0E+O0 3.85E+02 O.OOE+00CU-64 O.OOE+00 8.28E+03 3.902+03 O.OOE200 2.10E+04 O.OOE+00 6.43E+05 O.OOE+00ZN-65 4.202+08 1.46E+09 6.81SE+08 0.OOE+OO 9.34E+08 O.O0E+O0 6.18E+08 O.OOE+OOZN-69 4.73E-06 9.022-06 6.31E-07 0.OOE+OO 5.89E-06 O.OOE+OO 1,66E-05 O.OOE+0OZN-69M O.OOE+OO 0.00E+00 O.OOE+0O O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00BR-82 O.OE+00 O.OE+OO 0.00E+OO 0.OOE+OO O.OOE+O0 0.00E+00 OOOE+00 O.OOE+O0BR-83 O.OOE+00 O.0OE+O0 2.82E+00 O.OOE+00 O.00E+0 O.0OE+OO O.OE+OO O.OOE00BR-84 O.OOE+OO O.OOE+00 1.95E-1 I O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 .0OE+OOBR-85 O.OOE+OO O.OOE+OO O.O0E+O0 O.O0E+OO O.OOE+00 0.OO+OO O.0OE+OO O.OOE+00RB-86 O.OOE+OO 2.732+08 1.28E+08 O.OOE+00 O.OO+OO O.OOE+00 4.04E+07 O.OOE+O0RB-88 0.0OE+OO 2.442-22 1.302-22 O.O0E+0O O.OOE+00 0.OOE+OO 2.09E-29 O.O2E+00RB-89 O.OOE+OO 2.59E-26 1.83E-26 O.OOE+00 O.OOE+00 O.OOE+00 3.98E-05 O.OOE+O0SR-89 1.51E+10 0.OOE+00 4.32E+08 O.OOE+OO O.OE+00 O.OOE+00 1.80E+09 0.0OE+00SR-90 7.43E+ I O.OOE+00 1.84E+11 0.OOE+OO O.0OE+OO O.OO+0 2.09E+10 O.OOE+00SR-91 2.82E+05 0.OOE+O0 1.12E+04 O.OE+O0 O.OE+OO o00 .Oo+o0 1.28E+06 O.OOE+00SR-92 3.862+02 OOOE+00 1.652+01 O.OOE+00 O.OOE+OO O.OOE+00 9.83E+03 O.OE+OOY-90 1.24E+04 O.O0E+OO 3.34E+02 O.0OE+O0 O.OOE+O0 O.OO+OO 1.02E+08 O.0OE+OOY-91M 4.43E-09 O.OOE+OO 1.69E-10 O.0OE+OO O.OOE+00 o.oOE+oo 2.09E-07 O.OOE+00Y-91 7.81E+06 0.00+00 2.09E+05 O.2OE+OO O.O0E+00 O.OOE+OO 3.20E+09 O.OOE+00Y-92 8.42E-01 O.O0E+OO 2.43E-02 0.OOE+OO 0.OOE+OO O.OOE+OO 2.31E+04 O.0OE+OOY-93 1.58E+02 O.OOE+OO 4.33E+00 O.00E+O0 OOOE+OO O.OOE+00 4.822+06 O.OOE+00ZR-95 1.71E+06 5.41E+05 3.72E+05 O.OOB+00 7.95E+05 O.OOE+00 1.25E+09 O.OOE+00ZR-97 3.11E+02 6.15E+01 2.83E+01 O.OOE+00 9.33E+01 O.OOE+OO 1.67E+07 0.002+00NB-95 1.92E+05 1.06E+05 5.86E+04 O.OOE+00 1.03E+05 0.0OE+OO 4.55E+08 O.OOE+OONB-97 O.OOE+OO O.OOE+00 O.0OE+0O O.0OE+OO O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+00MO-99 O.OO2+00 5.64E+06 1.08E+06 O.OO2+00 1.29E+07 0.0OE+00 1.01E+07 O.OOE+00TC-99M 2.70E+00 7.54E+00 9.77E+O O.OOE+00 1.12E+02 4.18E+00 4.95E+03 O.2OE+00TC-101 5.52E-31 7.852-31 7.71E-30 O.O0+OO 1.42E-29 4.78E-31. 1.34E-37 O.OOE+O0RU-103 6.802+06 O.OOE+00 2.91E+06 O.00E+OO 2.40E+07 O.OOE+OO 5.682+08 O.OOE+O0RU-105 4.92E+01 O.OOE+00 1.91 EOI O.OO2+00 6.20E+02 O.OOE+00 3.97E+04 O.OOE+OORU-106 3.07E+08 O.OOE+00 3.87E+07 O.OOE+00. 5.92E+08 O.OOE+OO 1.47E+10 O.OOE+O0AG-I OM l.50B+07 1.42E+07 8.65E+06 O.OOE+00 2.71E+07 O.O0E+OO 4.00E+09 O.OOE+00SB-124 O.OOE+OO O.OOE+00 O.OOE+00 O0.OOE+OO O.OOE+00 O.OOE+00 0.OOB+00 O.OOE+OOSB-125 0.OOE+00 O.00E+O0 O.OOB+00 O.OOE+OO O.OOE+O0 O.OOE+00 O.OO+OO O.OOE+00TE125M 1.48E+08 5.32E+07 1.97E+07 4.13E+07 0.00E+00 O.OOE+0O 4.36E+08 O.OOE+OOTE-127M 5.48E+08 1.94E+08 6.522+07 1.302+08 2.22E+09 O.OOE+00 1.37E+09 O.O0E+O0TE-127 5.29E+03 1.88E+03 1.14E+03. 3.65E+03 2.14E+04 O.OOE+OO 4.09E+05 O.O0+O0TE-129M 3.61E+08 1.34E+08 5.71E+07' 1.16E+08 1.51E+09 O.OOE+OO 1.35B+09 O.OOE+OOTE -129 6.68E-04 2.49E-04 1.63E-04, 4.77E-04 2.802-03 O.OOE+OO 3.652-03 O.OOE+00

RSP-0008_ REV -12 PAGE 94 OF 103


TABLE 1-18: DOSE FACTOR TABLE: R ( - TEEN, VEGETATIONNuclide Bone Liver Tbody Thyroid Kidney Lunt GI Tract Skin

TE-131M 8.42E+05 4.04E+05 3.37E+05 6.07E+05 4.21E+06 O.OOE+00 3.24E+07 0.OOE+00TE-131 1.16E-15 4.78E-16 3.62E-16 8.93E-16 5.07E-15 O.0OE+00 9.52E-17 O.OOE+00TE-132 3.90E+06 2.47E+06 2.33E+06 2.61E+06 2.37E+07 O.OOE+00 7.83E+07 0.00E+001-130 3.49E+05 1.01E+06 4.03E+05 8.22E+07 1.55E+06 O.OOE+00 7.75E+05 0.00E+OO1-131 7.67E+07 1.07E+08 5.77E+07 3.14E+10 1.85E+08 O.OO+00 2.13E+07 O.OOE+00I-132 5.02E+01 1.31E+02 4.72E+01 4.43E+03 2.07E+02 O.OOE+O0 5.72E+01 O.OOE+001-133 1.93E+06 3.27E+06 9.99E+05 4.57E+08 5.74E+06 0.00E+00 2.48E+06 O.OOE+001-134 7.99E-05 2.12E-04 7.61E-05 3.53E-03 3.34E-04 0.008+00 2.79E-06 O.OOE+001-135 3.48E+04 8.96E+04 3.32E+04 5.76E+06 1.42E+05 O.OO0+OO 9.93E+04. O.OOE+00CS-134 7.03E+09 1.66E+10 7.68B+09 O.OOE+00 5.26E+09 2.01E+09 2.06E+08 0.OOE+00CS-136 4.37B+07 1.72E+08 1.15E+08 O.OOE+00 9.36E+07 1.47E+07 1.38E+07 O.OOE+00CS-137 1.00E+10 1.33E+10 4.65E+O9 0.00E+OO 4.54E+09 1.76E+09 1.90E+08 0.00£+00CS-138 3.13E-1I 6.01E-11 3.00E-1I 0.00E+OO 4.44E-11 5,16E-12. 2.736-14 O.OOE+00BA-139 2.54E-02 1.79B-05 7.40E-04 O.OOE+00 1.69E-05 1.23E-05 2.27E-01 O.OOE+00BA-140 1.38E+08 1.698+05 8.898+06 0.008+00 5.73E+04 1.14E+05 2.13E+08 O.OOE+00BA- 141 8.36E-22 6.248-25 2.798-23 O.OOE+00 5.79E-25 4.278-25 1.78E-27 O.0OE+00BA-142 0.00+00 0.008+00 O.OOE+00 0.008+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00LA-140 1.80B+03 8.868+02 2.36E+02 O.OOE+00 0.00E+OO 0.00E+OO 5.09E+07 O.OOE+00LA-142 1.77E-04 7.84E-05 1.95E-05 O.OOE+00 0.00E+0O O.OOE+00 2.39E+00 0.008+00CE-141 2.82E+05 1.89E+05 2.17E+04 0.00E+OO 8.87E+04 0.00E+00 5.39E+08 0.00E+OOCE-143 9.30E+02 6.77E+05 7.56E+01 O.OOE+00 3.048+02 O.OOE+00 2.04E+07 0.008+00CE-144 5.23E+07 2.16E+07 2.81E+06 O.OOE+00 1.29E+07 O.OOE+00 1.32E+10 0.008+00PR-143 6.99E+04 2.79E+04 3.48E+03 0.00E+OO 1.62E+04 O.OOE+00 2.30E+08 O.OOE+00PR-144 2.22E-26 9.07E-27 1.12E-27 O.OOE+00 5.20E-27 O.OOE+00 2.44E-29 O.OOE00ND-147 3.62E+04 3.93E+04 2.36E+03 O.OOE+00 2.31E+04 O.OOE+00 1.42E+08 O.OOE+00W-187 3.52E+04 2.87E+04 1.01E+04 O.OOE+00 O.OOE+00 O.OOE+00 7.77E+06 O.OOE+00NP-239 1.38E+03 1.318+02 7.25E+01 O.OOE+00 4.10E+02 O.OOE+00 2.10E+07 O.OOE+00

RSP-0008 REV - 12 PAGE 95 OF 103RSP-OOO8 REV-fl PAGE9SOF1O3


TABLE 1-19: DOSE FACTOR TABLE: R (I) - CHILD, VEGETATION

TABLE 1-19DOSE FACTOR TABLE: R (i)- Child, vegetation

Units are m2 *mremlyr per jiCi/secNuclide Bone Liver Tbody Thyroid Kidney Lung GI Tract Skin

H-3 O.OOE+00C-14 3.50E+06NA-24 3.71E+05P-32 3.36E+09CR-51 0.00E+00MN-54 0.00E+00MN-56 0.00+00FE-55 7.94E+08FE-59 3.96E+08CO-57 O.OOE+00CO-58 O.OOE+00CO-60 O.OOE+O0NI-63 3.91E+10NI-65 1.02E+02CU-64 0.OOE+OOZN-65 8.06B+08ZN-69 8.73E-06ZN-69M O.OOE+00BR-82 O.OOE+00BR-83 O.OOE+00BR-84 O.OOE+00BR-85 0.00E+00RB-86 O.OOEtO0RB-88 O.OOE+00RB-89 0.00+O0SR-89 3.58E+10SR-90 1.23E+12SR-91 5.20E+05SR-92 7.07B+02Y-90 2.30E+04Y-91M 8.12E-09Y-91 -1.6E+07Y-92 1.55E+00Y-93 2.91E+02ZR-95 3.84E+06ZR-97 5.68E+02NB-95 4;09E+05NB-97 O.OOE+00MO-99 0.00+00TC-99M 4.65E+00TC-101 1.02E-30RU--103 1.53E+07RU-105 9.01E+01RU-106 7.39E+08AG-110M 3.19E+07SB-124. 0.OOE+00SB-125 0.00E+00TE-125M 3.49B+08TE-127M 1.31E+09TE-127 9.76B+03TE-129M 8.39E+08TE-129 1.24E-03

2.49E+03 2.49E+037.01E+05 7.01E+053.71E+05 3.712+051.57E+08 1.30E+08

0.OOE+00 1.17E+056.59E+08 1.76E+081.82E+01 4.1 1E+004.21E+08 1.30E+086.41B+08 3.19E+08O.OOE+00 O.OOE+OO6.41E+07 1.96E+083.75E+08 1.10E+092.09E+09 1.33E+099.59E+00 5.60E+001.09E+04 6.60E+032.15E+09 1.34E+091.26E-05 1.17E-06O.OOE+00 O.OOE+OOO.OOE+00 O.OOE+00O.OOE+00 5.20E+000.00+00 3.30E- IO.OOE+00 O.OOE+004.51E+08 2.78E+083.77E-22 2.34B-223.42E-26 3.04E-26O.OOE+00 1.02E+090.0OE+00 3.12E+11O.OOE+00 1.96B+04O.OOE+00 2.84E+01O.OOE+00 6.17E+02O.OOE+00 2.95E-10O.OOE+00 4.97B+05O.OOE+0O 4.43B-02O.OOE+00 7.98E+008.44E+05 7.52E+058.20E+01 4.84E+011.59E+05 1.14E+05O.OOE+00 0.OOE+OO7.70E+06 1.91E+069.12E+00 1.51E+021.06E-30 1.35E-29O.OOE+00 5.88E+06O.OOE+OO 3.27E+01O.OOE+OO 9.22E+072.15E+07 1.72E+07O.OOB+00 0.00E+00O.OOE+00 O.OOE+009.47E+07 4.66E+073.54B+08 1.56E+082.63E+03 2.09E+032.34E+08 1.30E+083.45E-04 2.94E-04

2.49E+03 2.49E+037.01E+05 7.01E+053.71E+05 3.71E+05O.OOE+00 O.OOE+006.49E+04 1.77E+04O.OOE+00 1.85E+08O.OOE+00 2.20E+01O.OOE+00 O.OOE+000.OOE+0O 0.OOE+00O.OOE+00 O.OOE+00O.OOE+OO O.OOE+00O.OOE+00 0.00E+00O.OOE+00 O.OOE00O.OOE+00 0.00E+00O.OOE+00 2.64E+040.00+00 1.35E+09O.OOE+00 7.66E-06O.OOE+00 O.OOE+00O.OOE+00 O.OOE+00O.OOE+00 O.OOE+00O.OOE+00 O.OOE+000.00E+00 0.00E+00O.OOE+00 O.OOE+00O.OOE+00 O.OOE+000.00B+00 0.OOE+00O.OOE+00 0.OOE+OO0.00E+00 0.00+00O.OOE+00 O.OOE+00O.OOE+00 O.OOE+000.00+00 O.OOE+00O.OOE+0O 0.00E+00O.OOE+00 O.OOE+000.002±00 O.OOE+00O.OOE+00 O.OO+00O.OOE+00 1.21E+060.00+00 1.18E+02O.OOE+0O 1.50E+050.OOE+00 O.OOE+00O.OOE+00 1.64E+070.00+00 1.32E+02O.OOE+0O 1.81E-29O.OOE+00 3.85E+07O.OOE+00 7.92E+020.00E+00 9.98B+08O.OOE+00 4.01E+07O.OOE+00 O.OOE+000.00E+00 O.OOE+009.80E+07 O.OO+003.14E+08 3.75E+096.76E+03 2.78E+042.71E+08 2.46E+098.82E-04 3.62E-03

2.49E+037.01E+053.71E+05O.OOE+001.18E+05O.OOE+O0O.OOE+002.38E+081.86E+08O.OOE+00O.OOE+000.00E+00O.OOE+000.00E+O00.00E+00O.OOE+00O.OOB+000.00+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.OOE+00O.OOE+000.OOE+000.OOE+00O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+O0O.OOE+00O.OOE+00O.OOE+000.00+OO0.OOE+00O.OOE+00O.OOE+004.63E+005.62E-31O.OOE+00O.OOE+000.OOE+00O.OOE+00O.OOE+00O.OOE+000.00+00O.OOE+OO

.OOE+000.00E+00O.OOE+00

2.49E+037.0 1E+053.7IE+059.30e+076.20E+065.53E+082.64E+037.80E+076.68E+08O.OOE+003.74E+082.07E+091.41E+081. 17E+035.13E+053.77E+087.96E-04O.OOE+00O,OOE+00O.OOE+000.OOE+000.OOE+002.90E+071.65E-232.98E-281.39E+091.66E+101.15E+061.34E+046.56E+071.59E-052.47E+094.48E+044.34E+068.81E+081.24E+072.95E+08O.OOE+006.37E+065.19E+033.38E-303.95E+085.88E+041.15E+102.56E+09O.OO+000.OOE+003.37E+081.06E+093.81E+051.02E+097.70E-02

O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+00O.OOE+000.OOE+0OO.OOE+00O.OOE+00O.OOE+00O.OOE+000.OOE+00O.OOE+000.00+00O.OOE+00O.00B+00O.OOE+00O.OOE+0OO.OOE+000.002+00O.OOE+00O.OOE+0O0.00+00O.OOE+00O.OOE+00O.OOE+000.0OE+00O.OOE+00O.OOE+00O.OO+00O.OOE+00O.OOE+0O0.002+000.002+000.00E+00O.OOE+00O.OOE+00O.OOE+00O.OOE+00o.ooE+00O.OOE+00O.OOE+00O.OO+00O.OOE+00O.OOE+000.00+00O.OOE+00O.OOE+000.OOE+00O.OOE+00O.OOE+000.00E+00

RSP-OO0O REV -12 PAGE 96 OF 103


TABLE 1-19: DOSE FACTOR TABLE: R (I) - CHID, VEGETATIONNulicde RBone Liver Tbody Thyroid Kidney Lung CI Tract Skin

TE-131M 1.54E+06 5.32E+05TE-131 2.142-15 6.51B-16TE-132 6.99E+06 3.10E+06I-130 6.12E+05 1.24E+061-131 1.43E+08 1.44E+081-132 8.91E+01 1.64E+02I-133 3.522+06 4.35E+061-134 1.42E-04 2.64E-041-135 6.18E+04 1.1I E+05CS-134 1.59E+10 2.61E+10CS-136 8.23E+07 2.26E+08CS-137 2.37E+10 2.27E+10CS-138 5.69E-11 7.91E-IIBA-139 4.69E-02 2.50E-05BA-140 2.76E+08 2.42E+05BA-141 1.54E-21 8.64E-25BA-142 O.OOE+00 O.OO+00LA-140 3.24E+03 1.13E+03LA-142 3.20E-04 1.02E-04CE-141 6.55E+05 3.26E+05CE-143 1.71E+03 9.29E+05CE-144 1.26E+08 3.95E+07PR-143 1.45E+05 4.36B+04PR-144 4.11E-26 1.27E-26ND-147 7.14E+04 5.78E+04W-187 6.41E+04 3.79E+04NP-239 2.56E+03 1.83E+02

5.66E+056.35E-163.74E+066.37E+058.16E+077.53E+011.65E+061.21E-045.26E+045.50E+091.46E+083.35E+095.02E-111.36E-031.60E+075.02E-230.00E+003.82E+023.19E-054.85E+041.35E+026.73E+067.21E+032.07E-274.48E+031.70E+041.29B+02

1.09E+06 5.15E+06 O.OOE+001.63B-15 6.46E-15 O.OOE+004.51E+06 2.87E+07 O.OOE+001.36E+08 1.85E+06 0.002+004.75E+10 2.36E+08 O.OOE+O07.60E+03 2.5 1E+02 O.OOE+008.08E+08 7.25E+06 0.002+006.07E-03 4.03E-04 O.OOE+009.86E+06 1.71E+05 0.00E+00O.OOE+00 8.08E+09 2.90E+090.00E+00 1.20E+08 1.80E+070.002+00 7.39E+09 2.66E+09O.OOE+00 5.57E-11 5.99E-12O.OOE+00 2.18E-05 1.47E-05O.OOE+00 7.88E+04 1.44E+05O.OOE+00 7.47E-25 5.072-24O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 0,00E+00 O.OOE+000.00E+00 O.OOE+00 O.OOE+00O.OOE+00 1.43E+05 O.OO+00O.OOE+00 3.902+02 O.OOE+00O.OOE+00 2.19E+07 O.OOE+00O.OOE+00 2.36E+04 O.OOE+000.00+00 6.732-27 0.00+00O.OOE+00 2.17B+04 O.OO+00O.OOE+00 O.OOE+00 O.OOE+00O.OOE+00 5.31E+02 O.OOE+00

2.16E+071.12E- 143.12E+075.78E+051.28E+071.93E+021.75E+061.75E-04

8.48E+041.41E+087.95E+061.42E+083.64E-I I2.70E+001.40E+088.79E-22O.OOE+003.16E+072.02E+014.07E+081.36E+071.03E+101.572+082.742-239.16E+075.33E+061.362+07

O.OOE+00O.OOE+00O.OOE+000.002+000.002+00O.OOE+000.00+00O.OOE+00

O.OOE+00O.OO+00O.OOE+00O.OOE+000.00+000.00E+000.00+000.002+000.00+00O.OOE+O00.OOE+O0O.OOE+00O.OOE+00O.OOE+00O.OOE+000.00E+000.002+00O.OOE+00O.OO+00

RSP-0008 REV- 12 PAGE 97 OF 103


FIGURE 1: RESTRICTED AREA AND NEAR-FIELD ENVIRONMENTAL MONITORINGLOCATIONS

C(NE)

I(ENE)

_ -

E(E)

F(ESE,

I% GN (SE)

II 'S

I %I

I 'S

I H| (SSE)

___ FIGURE 1 I

IA 1 Ak uuiplm

71 .nwj swnflq Wei- upgraiitMV -wp Wei - Dmwnrdhi*t

GMI onameaal

RSP-0008 REV - 12 - PAGE 98 OF 103RSP000 .E-1 iE9OF


FIGURE 2: SCHEMATIC OF GASEOUS RADWASTE SYSTEM

RSP-0008 RFV - 12 PA.GF 99 OF 103RSP-0008 REV-fl PAGE99OFIfI3

qAE.3 wflUEfit kCL*Em IrqT3 -

not

00,

w .. 50

MOVE . OSOPY at

< act (

- FOR INFORMATiON ONLY - NOTA PERMANENT RECORD

z0

A

O"

a

:4nC�9

nzm

�l0Itt"0--4

to

(.I!i0-4tv

9

1-3mW0-iw

9

4

ATTACHMENT 38PAGE l OF 1

FIGURE 5: FAR-FIELD RADIOLOGICAL ENVIRONMENTAL MONITORING LOCATIONS

a(NW)

IIf

IiI

8(M#E)

/C

(NE)/

f

.- D(ENE)

/ Jacksonf /. 1 -~

N(W)

E(E)

p1 . (ESE)

1(IM

JJ I

/

L(SW)

/

/K

(SSw). .. . . .

F1?URE 5. , .

- W SON adlboE6 hduk Lacuhg

I

II

I

II

Ii.I

I

II

i

G,,..(SE,

I'

I

IFws

1W .0 e .. _:w

AC Air Sampler ControlA S Air Sampler SpecialT I TLD IndicatorsTC 'TLDControlsTS Special TLDsGQC Vegetation ControlSWU Upstream Surface WaterSWD Downstream Surfce WaterSEDD Downstream SedimentFU Upstream Fish/InvertebratesFD Downstream Fish/Invertebrates

1. ", . -

Ii

(5) (SSE)

RSP-0008 EV- 12 PAGE 102 OF 103


FIGURE 6: SCHEMATIC OF THE SOLID WASTE TREATMENT SYSTEM

I Fuel Pool DeminSpent Rens17 GPD

I Radwaste Auto Strainer 13400 GPD

I Radwaste Filter Sludge2004 GPD

Permanent Portabe (2

I Fuel Pool Filter Sludge29 GPD

I RW Demnin Spent Resin18GPD

Cond Demin Spent Resin747 GPD

MTo Waste Deweter

WteSystem (40828P0)Slucgo a

Tank

To oSoridficaion)

PlantConnection

Stand

S

S RWCU Filter! Demin Sludge323 GPD

I.i

Dcon & Lab Drains (3)600 GPD

Compressable Waste

(NotAvailabe)

55 GailonDrum

NOTE: (1) Flowrat Include Transfer Waer and Sdids() Refer oTopical Report Cns1-2 (43114.013540OPA For Details(3) Suspend Solids are Assumed to bo Negligible, and ae Not

Consideed

RSP-0008 REV- 12 PAGE 103 OF 103

TRACPING NO. RSP-0008R1tPR-12

EPAR PAGE 1 OF 1

PROCEDURE ACTION REQUESTPROCEDURE NO CURRENT REV PROCEDURE TITLE

RSP-t008 11 Offite Dose Calclaton Maual (ODCLMTYPE OF ACTION:IY PROCEDURE REVISION (PR) OI EDITORIAL CHANGE (EC) O INCORP EC D&AEDIATELYO NEW PROCEDURE (NP) O COMMENT (CM)O CHANGE NOTICE (CN) Q OTHER a CANCEL PROCEDURE (CX)

Ckange Notice () is not allowed if there is a Change ofintent 0 COMPUTER PROGRAM CHANGEPROCEDURE AcION BASIS (po'idedt addcripion ofthe odrece and the basis forthat chaarwe Indlude reference

to awflcaMe d cs change: adtaci co M sheets if necessary):

* Attachment 14 - Add a sttement to evaluate the National Guard and/or State Police dose while they are stationed on site asmembers of the public.

* Change the components of Steps 7.2 and 73 which refer to 10CER 20 to TRM 3.11.1.1 which is approved by LAR 2003-07.* Step 7.2.21, page 1 1, change the (ECLfi reference from Appendix A to Attachment 2.- Formula 7.2-2.1-1, page 1 1- Add minus sign (-) in the denominator to the fl calculattio

K SAFETY EVALUATION SCREENING RVI (KCN/DATE)Must be 50.59 qwUfied

tach ap Z(cable frmsfo -101)

1 VERIFY LICENSEE COMMITMENTS (All changes) TRAINING PROGRAM AFFECTED0 Yes, TEAR#_ _El No

CHANGE TO THIE TECH SPEC / SIW LSFT CROSSREFERENCE MATRIX TRAINING REQUIRED:O Yes (Attach change requesfifomADM-001S ifappicable) O Before IssueONo Date tlaining completed: _

O After IssueE None

CROSS DISCIPLINE REVIEW REQUIRED:E YesCl No

REVEW AND APPROVAL:

SIGNAYUR/KCN/DATE SIGTU K /

1AM4 AI~ '/Z o ~ VALIDATION

SUPVITECH VERIF* 4ZO / '-j,?FRC REVIEW V

Oy) F__ _ _ _ .RC MEETING NO (9003_OI1)APPROVAL I? 3g 5 PROOFER (CNhwop)

COMP'UTER PROGRAMUPDATE EFFECTIVE DATE: MAR 1 2003*cMast be an id-idua othrm thnte preperei)

REV22 (4112/01)

EN-S NUCLEAR QuALrY ReLATED -1401 Revision 2MANAGEMENT ADmimsTRArivEEnterg MANUAL

UsE Page 1 of 6

ATTACHMENT 9.1 50.59 REVIEW FORM Page of

1. OVERVIEW I SIGNATURES

Facility: River Bend Station

Document Reviewed: RSP-0008 Change/Rev. 12

System Designator(s)IDescription: Offisite Dose Calculation Manual (ODCM) Changes

Description of Proposed Change1. Editorial and tIooaraphical chances as defined in Section 5.2,2.1

a. Attachment 14 - Add a statement to evaluate the dose to the National Guard and/or StatePolice while they are stationed on site as members of the public.

b. Ste2 7.2.2.1. Daae 11. change the (ECL)1 reference from Apoendix A to Attachment 2.c. Add minus sin -) to the denominator of the definition for fain Formula 7 2.2.1-1.

2. Incorporate chances from previously evaluated LAR 2002-07. Modify Sections 7.2 and 7.3 tosugwort this chance.

If the proposed activity, in its entirety, Involves any one of the criteria below, check the appropriate box,provide a justification/basis in the Description above, and forward to a Reviewer. No further 50.59Review is required. If none of the criteria is applicable, continue with the 50.59 Review.

E The proposed activity Is editorial I typographical as defined in Section 5.2.2.1.

0 The proposed activity represents an UFSAR-only" change as allowed in Section 5.2.2.2. (Insert item #from Section 5.2.2.2).

a3 The proposed activity Is controlled by another regulation per Section 5.2.2.a

If further 50.59 Review is required, check the applicable review(s): (Only the sections indicated mustbe included in the Review.)

El SCREENING Sections 1, 11, and III required

E 50.59 EVALUATION EXEMPTION Sections 1, 11, HI, and IVrequired

o 50.59 EVALUATION (#: ) Sections 1, II, Ill, and V required

Preparer: JfP0 /oName (print) / Signature I C&pahy Depa~rment I Date

Reviewer. /.&(,t1*~/ ~?ifg/ /P°T C/ / 3 S63Name (pint) I Signat ~r5omfany I Department I Date

OSRC:Chairman's Name (print) / Signature I Date[Required only for Programmatic Exclusion Screenings (see Section 5.8) and 50.59 Evaluations.]

Ust of AssistinglContnbuting Personnel:Name: Scope of Assistance:

Greg Norris 50.59 Preparation

C,4t<K h,-c.LJ -Sc0 5'?~ P8drF4,"7 61%

* EN-S NUCLEAR QUAUTYRELATD LI-101 Revision 2E MANAGEMENT AcTRFTivAL77CTfY I MANUAL

PRPERENCEUsE Page 2 of 6

ATTACHMENT 9.1 50.59 REVIEW FORM Page

II. SCREENING

A. Licensing Basis Document Review

1. Does the proposed activity impact the facility or a procedure as described in any of thefollowing Licensing Basis Documents? (Check "NIAW for those documents that are notapplicable to the facility.)

Operating UcenW YES NO NIA CHANGE# andor SECTIONS IMPACTED

Operaing License _.,

TS CI _

NRC Orders 3 D a

If "YES", obtain NRC approval prior to tiplne he change. (See Section 5.1.13 for exceptions.)

LBDs controlled under 50.69 YES NO NIA CHANGE # (if applicable) and/or SECTIONS IMPACTED

FSAR Ei 0

TS Bases D2

Technical Reqiurements Manual 13 E

Core Operating Umits Report 03 0

Offlte Dose Calculatrons Manual El 3 YeT-auJ5 1.72 7.3 & 4AT72camfwr i4*NRC Safety Evaluation Raports1 0 1

I "YES", perfoun an Exemption Review per Section IV perlorn a 50.5 Evaluation per Section V.

LBDs controlled under other regulations YES NO WA CHANGE # (if applicable) and/or SECTIONS IMPACTED

Quajty Assurance Program ManUal2 D 0

Emergency Plan2 E0

Securlty panZ3 0 E

Fre Protection Program4 03 i l(Includes the Fire Hazards Analysis)

IF 'YES", evaluatelprocess any changes in accordance with the appropriate regulation.

2. Does the proposed activity involve a test or experiment not described in theFSAR?If "yes," perform an Exemption Review per Section V OR perform a 50.59Evaluation per Section V.

3. Does the proposed activity potentially impact equipment, procedures, orfacilities utilized for storing spent fuel at an Independent Spent Fuel StorageInstallation?(Check UNIA7 If dry fuel storage is not applicable to the facility.)If "yes," perform a 7ZA8 Review in accordance with NMM Procedure U-I12.(See Sections 1.5 and 5.3.1.5 of the EOI I0CFR50.59 Review Program Guidelines.)

E3

0

0

YesNo

YesNoN/A

If' YES, see Section 5.1.5.2 If 'YES,' notify the rsosib department and ensure a 50.54 Evaluation Is performed.3 The Security Pkan is classified as safeguards and can only be reviewed by personnel with the appropriate security clearance. The

Preparer should notify the security department of potertial changes to the Security Plan.4 If 'YES,' evaluate the change in accordance with the requirements of the facility's Operating License Condition.

EN4 NUCLEAR QAUTYRW.ATM L4l01 Revision 2a MANAGEMENT ADBRAT1Va

I JEFrgy CE USE Page 3 of 6

IE I

IATTACHMEN 9.150.59 REVIEW FORMPaeo

B. Basis(Provide a clear, concise basis for the answers given in the applicable sections above. Adequate basis mustbe provided within the Screening such that a third-party reviewer carl reach the same conclusions. Simplystating that the change does not affect TS or the FSAR is not an acceptable basis.)

The changes to the ODCM are to 1) revise Sections 7.2 and 7.3 to be in line with TLCO 3.11.1.1and Technical Soecification 5.5.4.b. 2) add the National GuardlState Police to the dose to thepublic evaluation in Attachment 14 nd 3) Sten 7.2.2.1. paue 11, change the ECL)j referencefrom Aooendlx A to Attachment 2

The wording of TLCO 3.11.1.1 was changed in LAR 2003-07 to read. iThe congentration ofradioactive Material released In kiguid effluents to UNRESTRICTED AREAS (see USAR Section2.1) shall be limited to ten times the concentrations soecified.in 10 CFR 20. Appendix S. Table 2.Column 2 for radionuclides other than dissolved or entrained noble oases. For dissolved orentrained noble oases the concentration shall be limited to 2 x 107 microcuriesfmi total activity

The limits in TS 5,5.4.b essentially have the same nunerical limits that the site had orior to theImrroved Technical Snecification fITS) and the 10CFR20 chanue. The ITS Section 5.5.4.b wasapproved by the NRC which allowed RBS to have limits on the concentrations of radioactivematerial released in liquid effluents to unrestricted areas to ten times the concentration values in10 CFR 20 Apoendix B. Table 2. Column 2. This chance was to allow operational flexibilitycompatible with considerations of health and safety and maintaining dose to the public ALARA,The site is required by I 0CFR50 to maintain control over radioactive mnaterial produced in normalreactor operations as low as reasonably achievable (ALARA). The dose limits in 1QCFR50Anoendix I are smaller than the limits found in 1 OCFR20. The site exhibited the ability prior to ITSto operate and meet limits similar to TS 5.5.4.b.

The addition to Attachment 14 is to add a reminder to evaluate the dose to the National Guard orState Police while stationed within the site boundary and nerformino non-emeruency duties. Thechange of the Step 7.2.2.1 reference is editorial. The chance to Formula 7.2.2.1-1 istrooaraghical. The changes to the ODCM do not impact the facility. There is no change to thefaciltiv as described in the SAR. The dose limits from liquid effluents are discussed in the SARIhowever, this chanue does not change the information presented in the SAR. This chanae is not atest or experiment. The Porammatic controls for lquid effluent releases are established.impLemented. and maintained In operatinag Procedures to control radioactive effluents consistentwith the requirements of 1O CFR 20.1302. 40 CFR Part 190. 10 CFR 50.36a. and 10 CFR Part 50.ADwendix }.

C. References

[Discuss the methodology for performing the LED search. State the location of relevant licensingdocument information and explain the scope of the review such as electronic search criteria used (e.g., keywords) or the general extent of manual searches per Section 5.3.6.4 of U-01.]

LBDslDocuments Reviewed: Keywords:

SER Amendment No. 81. Amendment No. ODCM. O.D.C.M.. unrestricted area, liguid81a. 40CFR190: I OCFR20: IOCFR50 effluent, Pathway, offsite dose. off site dose.ADpendix 1: Technical Requirement Manual IOCFR2M. 10 CFR 20. Agoendix B. 40CFR1 90.(Definitions. 3.11. Chanter 5): Technical 40 cfr 190. 1.109. Member of the ublic. RETS,Specification Chaoter 5. USAR 2. 11. 15): releaseReulatory Guide 11097- RPP0097: NUREG-0543. NUREG -0133

_ EN-S NUCLEAR QUATY RBATED LI-101 Revision 2MANAGEMENT ADM mwt'A~mE

lEnte i MAUAL __REENECE USE Page 4 of

ATTACHMENT 9.1 60.59 REVIEW FORM Page of

D. Is the validity of this Review dependent on any other Cl Yeschange? (See Section 5.3.4 of the E1 O10CFR50.59 Program E NoReview Guidelines.)

If "Yes," list the required changes.

Ill. ENVIRONMENTAL SCREENING

If any of the following questions is answered "yes," an Environmental Review must be performed inaccordance with NMM Procedure EV-115, "Environmental Evaluations," and attached to this 50.59Review.

Will the proposed Change being evaluated:

Yes No

a El Involve a land disturbance of previously disturbed land areas in excess of one acre (i.e.,grading activities, construction of buildings, excavations, reforestation, creation or removal ofponds)?

• RI Involve a land disturbance of undisturbed land areas (i.e., grading activities, construction,excavations, reforestation, creating, or removing ponds)?

O 21 Involve dredging activities in a lake, river, pond, or stream?

O El Increase the amount of thermal heat being discharged to the river or lake?

O El Increase the concentration or quantity of chemicals being discharged to the river, lake, orair?

C] El Discharge any chemicals new or different from that previously discharged?

O 21 Change the design or operation of the intake or discharge structures?

0 El Modify the design or operation of the cooling tower that will change water or air flowcharacteristics?

o 21 Modify the design or operation of the plant that will change the path of an existing waterdischarge or that will result in a new water discharge?

O1 21 Modify existing stationary fuel burning equipment (i.e., diesel fuel oil, butane, gasoline,propane, and kerosene)?'

o 21 Involve the installation of stationary fuel burning equipment or use of portable fuel burningequipment (i.e., diesel fuel oil, butane, gasoline, propane, and kerosene)?1

o 21 Involve the installation or use of equipment that will result in an air emission discharge?

0 21 Involve the installation or modification of a stationary or mobile tank?

Cl El Involve the use or storage of oils or chemicals?

E 121 Involve burial or placement of any solid wastes in the site area that may effect runoff,surface water, or groundwater?

' See NMM Procedure EV-1 17, 'Air Emissions Management Program,- for guidance In answering this question.

EN-S NUCLEAR QUALM RELATEDI 1I01 Revision 2MANAGEMENT Aiomiwam

L*Entes MANUALATACMET .USE Page 6 of _

HMENT 9.1 50.69 REVIEW FORM Page of

IV. 50.59 EVALUATION EXEMPTION

Enter this section only if a "yes" box was checked in Section IhA, above.

A. Check the applicable boxes below. If any of the boxes are checked, a 50.59 Evaluation is notrequired. If none of the boxes are checked, perform a 50.59 Evaluation In accordance withSection V. Provide supporting documentation or references as appropriate.

0 The proposed acfivity meets all of the following criteria regarding design function per Section 5.5.1.1:

The proposed activty does not adversely affect the design function of an SSC as described in theFSAR; ANDThe proposed activity does not adversely affect a method of performing or controlling a designfunction of an SSC as described in the FSAR; AN

The proposed activity does not adversely affect a method of evaluation that demonstrates intendeddesign function(s) of an SSC described in the FSAR will be accomplished.

E An approved, valid 50.59 Review(s) covering associated aspects of the proposed activity alreadyexists per Section 5.5.1.2. Reference 50.59 Evaluation # LAR 2003-07 (if applicable) or attachdocumentation. Verify the previous 50.59 Review remains valid.

1 The NRC has approved the proposed activity or portions thereof per Section 5.5.1.3.Reference: Amendment No. 81a. LAR 1993-014

B. Basis

(Provide a clear, concise basis for determining the proposed activity may be exempted such that a third-partyreviewer can reach the same conclusions. See Section 5.5.6 of the EOI 10CFR50.59 Review Program Guidelines forguidance.)

LAR 2003-07 - The ODCM sections 7.2 and 7.3 are applicable to this LAR_ This LAR chanaed TLCO3.11.1 1 to equal the limits in RBS Technical Specification 5.5.4.b. RBS chose not to implement thischagge when the site implemented Imprved Technical Specifications. See the Basis in Section II Babove for more details. No chances have occurred at the site or in the regulations to revoke the originalapproval of this amendment.

ATTACIMENT 4PAGE I OF 1

CROSS-DISCIPLINE REVIEW FORM, TYPICAL

PROCEDURE a-o REVISION

PART 1 CROSS DISCIPLINE REVIEW

Cross Discipline Review Group Cross Discipline Reviewer

PART 2 RETURN

RtETURlNTO < '° MA CO1DE: /- t ) BsY: Z g

PARtT 3 RtEVIEW SUAMMARY

YES NO [] Submitted procedure changes are consistent with departmental processes. If'no", commentbWow:

Comments1

YES 2 NO 5 Changes to other department procedures must be made due to the submitted procedurechange. If "yes, list description of required changes and tracking numbers below:

Description of required procedure changes(preparer should identify effectedproceduresfirst1 reviewer should identify any additionalprocedures):

Other Comments:

REVGNWED BY:KN/DT °SIGNATURE KCN/DATE